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ABSTRACT
The faithful and complete replication of DNA is necessary for the maintenance 
of genome stability. The endonuclease MUS81 has recently been implicated in 
the repair of blocked forks during DNA replication.
MUS81 is related to the nucleotide excision repair proteins XPF and 
ERCC1, due to the common ERCC4 nuclease domain that they share. Based 
on database searches for proteins containing the ERCC4 domain, we have 
identified four novel members of the MUS81 family. We named two of them 
EME1 and EME2, because of their similarity with S. pombe Eme1 protein. We 
showed that EME1 and EME2 interact with MUS81 and that MUS81/EME1 and 
MUS81/EME2 complexes are endonucleases that exhibit a high specificity for 
synthetic replication fork and 3’-flap structures in vitro. In particular, the 
MUS81/EME2 heterodimer is 10-fold more active than MUS81/EME1.
Besides EME1 and EME2, we have identified two additional proteins of the 
MUS81 family, HEF and HIP. HEF, also referred to as FANC-M, is a 250 kDa 
protein that is associated with the genetic disorder of Fanconi Anemia. HIP 
(HEF Interacting Protein) is a novel 24 KDa protein interacting with HEF/FANC- 
M. We showed that HIP forms a complex with HEF/FANC-M both in vitro and in 
vivo and that it is part of the Fanconi Anemia core complex.
HEF/FANC-M contains a DEAH helicase domain, which is required for 
translocase activity, and an ERCC4 nuclease domain. We showed that the 
ERCC4 nuclease domain of HEF/FANC-M is inactive, as suggested by 
sequence analysis. Based on the similarity with other members of the MUS81 
family, we propose a role for the complex between HEF/FANC-M and HIP in 
recognising branched DNA structures, which could arise after DNA replication 
fork blockage. Therefore, HEF/FANC-M and HIP may be involved in targeting 
the Fanconi Anemia core complex to blocked replication forks.
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Introduction
I. Dna Damage
1.1 DNA DAMAGING AGENTS
The faithful conservation of genomic information is an essential process for cell 
survival. In order to maintain genomic integrity, DNA has to be protected from 
damage induced by environmental agents or generated spontaneously during 
DNA metabolism.
Environmental DNA damage can be produced by physical or chemical 
sources. Examples of physical genotoxic agents are ultraviolet (UV) light and 
ionizing radiation (IR). UV light is a component of sunlight. Extensive exposure 
to UV light can cause adjacent DNA bases to become covalently linked by the 
formation of pyrimidine dimers and (6-4) photoproducts (Cleaver et al., 1988; 
Setlow, 1966). IR can be generated either by natural sources (e.g. cosmic 
radiation) or by man-made sources used for medical (e.g. X-rays) or industrial 
purposes. IR exposure can induce oxidation of DNA bases and generate breaks 
on one or both DNA strands (Hutchinson, 1985; Teoule, 1987), referred to as 
single-strand and double-strand breaks, respectively. Chemical agents can 
cause a variety of DNA lesions: alkylating agents, such as methyl-methane 
sulfonate (MMS), insert alkyl groups into DNA bases (Singer, 1975), while 
cross-linking agents, such as mitomycin C (MMC), cis-platin, psoralen and 
nitrogen mustard (Brendel and Ruhland, 1984), introduce cross-links between 
bases of the same DNA strand (intrastrand cross-links) or of different DNA 
strands (interstrand cross-links or ICLs). Other chemical agents, such as the 
topoisomerase inhibitor camptothecin (CPT), induce the formation of single­
strand breaks (SSBs) by trapping the topoisomerase-DNA covalent complex
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(Liu et al., 2000). Hydroxyurea (HU), instead, does not induce any specific DNA 
lesion, but affect DNA metabolism by depleting dNTP levels through the 
inhibition of ribonucleotide reductase (Bianchi et al., 1986).
The main spontaneous DNA alteration arising during DNA metabolism is 
the misincorporation of DNA bases during DNA replication (Echols and 
Goodman, 1991). This can result in mismatches in the DNA sequence. DNA 
mismatches can also be generated by the spontaneous interconversion 
between DNA bases due to the loss of amino groups (e.g. deamination of 
cytosine and 5-methylcytosine into uracil and thymine, respectively) (Lindahl, 
1993). Another source of spontaneous DNA damage is constituted by reactive 
oxygen species (hydrogen peroxide, peroxide and hydroxyl radicals) derived 
from normal cellular metabolism. Reactive oxygen radicals can cause 
fragmentation of DNA bases or sugars and induce SSBs (Imlay and Linn, 
1988).
1.2 MOLECULAR AND CELLULAR EFFECTS OF DNA LESIONS
DNA lesions can interfere with basic cellular processes such as DNA replication 
and gene transcription. DNA damage generated during G1 and G2 phases of 
the cell cycle can block transcription of genes, while DNA lesions in S phase 
primarily affect DNA replication. It has been reported that cross-linking agents 
and UV radiation can block RNA polymerase (Selby et al., 1997; Tornaletti et 
al., 2003; Tremeau-Bravard et al., 2004) and lead to its polyubiquitination and 
degradation (Bregman et al., 1996; Ratner et al., 1998). Persistent blockage of 
RNA synthesis has been linked with induction of apoptotic cell death dependent 
on p53 (Latonen and Laiho, 2005).
DNA replication can be affected by the presence of DNA lesions induced 
by UV radiation. Early studies carried out in E  coli, S. cerevisiae and 
mammalian cells showed that after UV radiation, the newly synthesised DNA 
was significantly smaller compared to the DNA of non-irradiated cells 
(Lehmann, 1972; Prakash, 1981; Rupp et al., 1971). This was attributed to the 
presence of discontinuities left opposite the UV lesions by the DNA polymerase. 
Recently, these discontinuities have been visualised by electron-microscopy in
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UV-irradiated S. cerevisiae cells (Lopes et al., 2006). Besides UV lesions, 
damage induced by alkylating agents, such as MMS, have been shown to slow 
down DNA replication in S. cerevisiae (Tercero and Diffley, 2001). Lesions 
induced by cross-linking agents cause one of the most severe blockages of 
DNA replication: covalently linking two DNA strands together, interstrand cross­
links (ICLs) can impede strand separation and replication progression 
(Niedernhofer et al., 2005). Instead SSBs, which can be generated by CPT, IR 
or reactive oxygen species, can be converted to double-strand breaks (DSBs) 
during DNA replication, and therefore induce the collapse of the replication fork 
(Kuzminov, 2001b).
In addition to DNA replication and transcription, mitosis can also be 
affected by DNA lesions. The presence of DSBs in the chromosomal DNA can 
prevent proper chromosome segregation and can lead to uneven distribution of 
the genome between the two daughter cells. DSBs can also induce the 
formation of chromosomal deletions and translocations, which are a hallmark of 
cancer cells (Hoeijmakers, 2000).
II. Dna Repair Mechanisms
In order to counteract the deleterious effects generated by DNA damaging 
agents, repair mechanisms specific for each type of DNA lesion have evolved to 
protect genomic integrity (Friedberg, 2003). Mispaired DNA bases are replaced 
with correct bases by mismatch repair (MMR) (Kunkel, 1995) and small 
chemical alterations of DNA bases are repaired by base excision repair (BER) 
through excision of the damaged base (Lindahl and Wood, 1999). More 
complex lesions, such as pyrimidine dimers and intrastrand cross-links, are 
corrected by nucleotide excision repair (NER) through the removal of a 
nucleotide of approximately 30 bp containing the damaged bases (Friedberg, 
2001), while ICLs are excised by interstrand cross-link repair (ICL repair) with 
the assistance of proteins involved in the genetic syndrome Fanconi Anemia 
(Niedernhofer et al., 2005). DSBs are processed either by non-homologous end
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joining (NHEJ) or homologous recombination repair (HRR) according to the cell 
cycle phase during which they are generated: during G1 phase DSBs are 
repaired primarily by NHEJ through the inaccurate religation of the broken ends, 
while during S and G2 phases sister chromatids are used as a template for the 
precise repair of the DSBs by HRR (West, 2003).
As previously mentioned, DNA damage during S phase can result in DNA 
replication blockage (Section 1.2). The processes by which stalled replication 
forks are repaired are referred to as DNA-damage-tolerance mechanisms 
(Friedberg, 2005). A DNA lesion in a replication fork can be bypassed by error- 
prone DNA polymerases in a process known as translesion DNA synthesis 
(TLS). In an alternative to TLS, the discontinuities left opposite the lesion can be 
repaired with high fidelity by HRR (Friedberg, 2005). NER, HRR, DNA-damage- 
tolerance mechanisms and ICL repair will be discussed in greater details in 
future sections.
1.3 NUCLEOTIDE EXCISION REPAIR
The general mechanism of NER is conserved from bacteria to humans, but the 
proteins involved share little similarity and many steps are more complex in the 
mammalian system. In bacteria, NER is catalysed by the UvrABC system 
(Truglio et al., 2006). In humans, defects in some of the NER components 
cause the genetic disorders xeroderma pigmentosum (XP), Cockayne 
syndrome (CS) or trichothiodystrophy (TTD) (de Boer and Hoeijmakers, 2000). 
XP patients exhibit more than 1000-fold incidence of sun-induced skin cancer, 
whereas CS and TTD patients are not predisposed to tumour development (de 
Boer and Hoeijmakers, 2000; Friedberg, 2001). XP is caused by mutations in 
one of eight genes (XPA - XPG and XPV) (Bootsma and Hoeijmakers, 1994). 
Unlike the other seven genes, XPV  gene is involved in TLS and not in NER 
(Ensch-Simon et al., 1998).
NER has been reconstituted in vitro with purified human proteins 
(Aboussekhra et al., 1995; Mu et al., 1996). The DNA lesion is recognised by 
the complex between XPC and hHR23B (Figure 1.1, step a) (Sugasawa et al., 
1998). hHR23B is the human homologue of S. cerevisiae NER protein Rad23
DNA lesion recognition
HHR23B
XPC
m
hHR23B
TFIIH
Binding of TFIIH, XPA, 
RPA and XPG
Binding of XPF/ERCC1
hHR23B
XPA XPC
TFIIH
RPA
hHR23B
TFIIH
DNA lesion excision
*
DNA synthesis 
and ligation
♦
FIGURE 1.1: Schematic representation of mammalian nucleotide 
excision repair
See the main text in Section 1.3 for detailed description.
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(Sugasawa et al., 1996). XPA, RPA, TFIIH and XPG are then recruited to the 
site of damage (Figure 1.1, step b) (Friedberg, 2001). XPA is able to confirm the 
presence of DNA damage by the recognition of an abnormal DNA structure 
(Buschta-Hedayat et al., 1999). TFIIH is a six subunit transcription factor 
required for initiation of RNA polymerase II transcription (Zurita and Merino,
2003). The TFIIH subunits XPB and XPD can unwind the duplex DNA on both 
sides of the lesion and create a bubble structure that can be stabilised by the 
single-strand binding protein RPA (Figure 1.1, step b) (Evans et al., 1997b). 
Following the binding of the XPF/ERCC1 complex, the damaged DNA strand is 
cleaved sequentially on the 3 ’-side of the lesion by XPG and on the 5 ’-side by 
XPF/ERCC1 (Figure 1.1, step c) (O'Donovan et al., 1994; Sijbers et al., 1996a). 
The double incision allows the release of an oligonucleotide approximately 30 nt 
long (Figure 1.1, step d) (Moggs et al., 1996). DNA integrity is then restored by 
DNA polymerase 6 or e and DNA ligase (Figure 1.1, step e) (Hindges and 
Hubscher, 1997; Mozzherin and Fisher, 1996).
1.4 HOMOLOGOUS RECOMBINATION REPAIR
HRR is responsible for the accurate repair of DNA lesions, such as ssDNA gaps 
or DSBs, which can be produced by DNA damaging agents such as UV and IR 
or can occur during DNA replication as a consequence of replication fork 
blockage or collapse (McGlynn and Lloyd, 2002b; Paques and Haber, 1999). 
Moreover, in eukaryotes DSBs are induced during meiosis by the endonuclease 
Spo11 in order to generate genetic diversity (Keeney et al., 1997). This section 
will concentrate on the repair of DSBs, whereas the repair of ssDNA gaps will 
be discussed in Section 1.5.
Several models have been suggested for DSB repair in eukaryotes. In the 
classical DSB repair model proposed in 1983 by Szostak et al. (Figure 1.2) 
(Szostak et al., 1983), DSBs are processed in order to generate 3 ’-ssDNA ends, 
which are required to initiate HRR. A possible candidate for the resection of 
DSBs ends is the MRE11/RAD50/NBS1 complex (Figure 1.2, step a) due to its 
reported nuclease activity on DNA ends (Pauli and Gellert, 1999). However, in 
vitro MRE11/RAD50/NBS1 produces only 5’-ssDNA ends and not 3 ’-ssDNA
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b. single end invasion
c. second end capture 
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d. dHJ formation
o
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FIGURE 1.2: General model of DSB repair as suggested by Szostak et 
al., 1983
Proteins involved in each step of the DSB repair model are indicated in 
blue. See the main text in Section 1.4 for detailed description. This figure
has been adapted from Hollingsworth and Brill, 2004.
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ends (Pauli and Gellert, 1998). It is possible that MRE11/RAD50/NBS1 in vivo 
could generate 3 ’-ssDNA ends by a yet unknown mechanism, or that other 
proteins are responsible for DSBs resection, such as the exonuclease EX01 
(Tsubouchi and Ogawa, 2000).
After DSB resection, the recombinase RAD51 assembles as a multimeric 
filament on the 3’-ssDNA ends, similar to its bacterial orthologue RecA (Ogawa 
et al., 1993; Yu et al., 2001). It is thought that RAD52 can interact with RAD51 
and favour the formation of the RAD51 filament by displacing RPA from the 3’- 
ssDNA end (New et al., 1998; Shen et al., 1996). In addition to RAD52, the 
tumour suppressor protein BRCA2 can interact with RAD51, as shown in vitro 
by direct binding of RAD51 to BRCA2 repeat motifs (BRC repeats) and in vivo 
by co-localisation of BRCA2 and RAD51 in nuclear foci after DNA damage 
(Tarsounas et al., 2004; Wong et al., 1997). BRCA2 is a 384 kDa protein whose 
inactivation predisposes to breast and ovarian cancer (Rahman and Stratton, 
1998). The observation that cells lacking BRCA2 are impaired in the formation 
of RAD51 foci after DNA damage (Yuan et al., 1999) has led to the proposal 
that BRCA2 might act as a scaffold to maintain RAD51 inactive while promoting 
RAD51 association to the processed DSBs after DNA damage (Davies et al., 
2001). It has been recently shown that the loss of Serine 3291 phosphorylation 
in response to IR stimulates the interaction between RAD51 and the C-terminus 
of BRCA2 (Esashi et al., 2005). It is therefore possible that C-terminus of 
BRCA2, which has a ssDNA binding domain, might be critical for depositing 
RAD51 monomers into the site of damage (Esashi et al., 2005).
Once the RAD51 filament has assembled, RAD51 promotes the invasion 
of a single 3-ssDNA end into the homologous DNA duplex (Baumann et al., 
1996; Sung, 1994). This process, which is referred to as single end invasion 
(SEI), leads to the formation of a structure known as D-loop (Figure 1.2, step b). 
It has been reported that RAD54 helps to stabilise the formation of D-loop 
structures obtained after SEI (Mazina and Mazin, 2004; Petukhova et al., 1998). 
This could be explained by the ability of RAD54, a member of the family of 
SWI2/SNF2 chromatin remodeling proteins, to induce negative supercoils into 
duplex DNA and transiently separate the DNA strands (Sigurdsson et al., 2002;
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Tan et al., 1999; Van Komen et al., 2000). RAD54-mediated strand separation 
could therefore promote the formation of D-loop by RAD51. Moreover, the ability 
of RAD54 to translocate along the DNA could help displace histones and 
facilitate the identification of homologous sequences (Ristic et al., 2001).
In the classical DNA recombination model proposed by Szostak et al., SEI 
is followed by the second end capture (Figure 1.2, step c). This could be 
promoted by RAD52, as suggested by its ability to favour single-strand 
annealing of complementary sequences in vitro (Mortensen et al., 1996). Both 
ends are then used as primers for DNA synthesis. The mechanism of DNA 
synthesis after RAD51-mediated strand invasion will be discussed in Section
1.5.
DNA ligation of the newly synthesised strands can lead to the formation of 
two contiguous four-way junctions, called Holliday junctions (HJs). This 
structure is referred to as double HJ (dHJ; Figure 1.2, step d). The existence of 
HJ intermediates formed by two DNA helices covalently linked (Lilley and White, 
2001) was initially proposed by Robin Holliday and then confirmed by electron- 
microscopic studies (Benbow et al., 1975; Doniger et al., 1973; Holliday, 1964; 
Thompson et al., 1975).
In bacteria, HJs are processed by the RuvABC complex (West, 1997). 
RuvA targets RuvB to the HJ and enables RuvB to assemble as symmetrical 
hexameric rings on the two opposite arms of the HJ (Parsons et al., 1995; 
Yamada et al., 2002). The DNA is then passed through the RuvB rings as a 
result of the translocase activity of RuvB. This allows branch migration of the HJ 
along the DNA strands (Tsaneva et al., 1992). In order to separate the two DNA 
strands connected by the HJ, the endonuclease RuvC binds the HJ as a dimer 
and promotes HJ resolution by introducing symmetrical nicks in strands of the 
same polarity (Ariyoshi et al., 1994; Bennett et al., 1993; Dunderdale et al., 
1991). The ligation of the nicked duplex products generated by HJ resolution 
can then restore genomic integrity.
The mechanism of HJ resolution in eukaryotes is still mysterious. No 
eukaryotic homologue with sequence similarity to the bacterial RuvABC 
resolvasome has been described (Liu et al., 2004). Nonetheless, HJ branch
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migration and resolution activities similar to those of RuvABC have been 
identified in mammalian cells (Constantinou et al., 2001). The resolvase 
associated with this activity has been named Resolvase A (Figure 1.2 , step e) 
(Constantinou et al., 2001), although its identity is still elusive. However, 
proteins of the RAD51 family, also known as RAD51 paralogs, have recently 
been associated with the HJ branch migration and resolution activity (Liu et al.,
2004). In mammals, five RAD51 paralogs, named RAD51B, RAD51C, RAD51D, 
XRCC3 and XRCC2, have been identified (Thacker, 2005). They are known to 
form two main complexes: one contains RAD51B, RAD51C, RAD51D and 
XRCC2 and the other consists of RAD51C and XRCC3 (Masson et al., 2001). It 
has been reported that extracts from mammalian cells deficient for RAD51C or 
XRCC3 have reduced levels of HJ resolution activity (Liu et al., 2004). 
Moreover, depletion of RAD51C causes loss of HJ branch migration and 
resolution activity that can be restored by addition of purified recombinant 
complexes containing RAD51C (Liu et al., 2004). It has not yet been determined 
whether the HJ can be resolved by RAD51C itself or by an endonuclease 
interacting with RAD51C.
As suggested by the DSB repair model in Figure 1.2, HJ resolvases could 
either cleave the crossed or the non-crossed strand of the HJ (step e). 
Depending on the orientation in which each of the two HJs of the dHJ is 
cleaved, different resolution product will be obtained. If the two crossed strands 
of the first HJ and the two non-crossed of the second HJ are nicked, then the 
arms that flank the dHJ will exchange DNA strands, generating a crossover 
(Figure 1.2, step e) (Paques and Haber, 1999). Instead, if the nicks are 
introduced in the same DNA strands in both the first and the second HJ, 
non-crossover products will be produced (Figure 1.2, step e) (Paques and 
Haber, 1999).
1.5 D na-D am ag e-T o leran ce  Mechanisms
As previously mentioned (Section 1.2), DNA-Damage-Tolerance Mechanisms 
are involved in ensuring DNA replication progression in the presence of DNA 
damage, such as UV lesions, SSBs and DSBs, or replication fork blocks. The
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mechanism involved in this process in bacteria and eukaryotes will be 
discussed.
DNA Replication Restart after UV Radiation
Re-priming of DNA Synthesis
In bacteria, the recovery of DNA replication after UV radiation has been 
extensively studied. DNA lesions are thought to affect DNA synthesis in a 
manner dependent upon the DNA strand in which they are located. Models for 
DNA replication propose that DNA synthesis is continuous in the leading-strand 
and discontinuous in the lagging-strand (Benkovic et al., 2001). Therefore, DNA 
lesions on the lagging-strand might be bypassed by re-priming DNA synthesis 
downstream of the lesion, whereas lesions of the leading-strand could block the 
progression of DNA synthesis, due to the inability of the DNA replication 
apparatus to re-prime DNA synthesis on the leading-strand (Higuchi et al.,
2003).
It has been reported that after UV radiation lagging-strand DNA synthesis 
can become transiently uncoupled from leading-strand synthesis and continue 
beyond the end of the leading-strand (Figure 1.3, step a) (Higuchi et al., 2003; 
Pages and Fuchs, 2003). This could generate ssDNA regions on the leading- 
strand for approximately 1 Kbp downstream of the DNA lesion before replication 
fork progression is blocked (Higuchi et al., 2003). According to the current 
model of continuous leading-strand synthesis, blocked leading-strand synthesis 
can exclusively be restarted from the exact position where it was interrupted, 
without leaving any discontinuities behind.
However, early work in E  coli showed that, following UV radiation of cells 
defective in the repair of UV lesions, DNA replication progression is continued 
and single-stranded DNA gaps are left opposite the UV lesions (Rupp and 
Howard-Flanders, 1968; Rupp et al., 1971). These observations support a 
discontinuous model of DNA replication in which DNA synthesis can be re­
primed downstream the DNA lesion in both the leading- and the lagging-strand 
(Wang, 2005). This could generate DNA gaps in both newly synthesised
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strands (Wang and Chen, 1992). Recent biochemical evidence supports the 
hypothesis that leading-strand DNA synthesis restarts downstream of DNA 
lesions (Figure 1.3, step b) (Heller and Marians, 2006). The primosomal protein 
PriC was reported to promote the loading of the DNA helicase DnaB on the 
lagging-strand, which could then coordinate the re-priming of the leading-strand 
by the primase DnaG (Heller and Marians, 2006). The re-initiation of the 
leading-strand would then generate ssDNA gaps (Figure 1.3, step b).
Similar mechanisms of DNA replication restart after UV radiation might be 
also present in eukaryotes. Recent experiments have suggested that UV- 
irradiated S. cerevisiae cells, which are defective in the NER factor Rad14, 
accumulate ssDNA gaps in both the leading- and the lagging-strand, due to 
DNA replication defects in copying DNA regions damaged by UV lesions (Lopes 
et al., 2006). Moreover, early studies indicate that mouse cells accumulate 
ssDNA gaps after UV radiation (Lehmann, 1972). However, there is currently no 
clear evidence whether in mammals DNA synthesis can be re-primed 
downstream of DNA lesions on both DNA strands.
Homologous Recombination Repair of ssDNA Gaps
In bacteria, ssDNA gaps are repaired at the end of DNA replication by a 
process called post-replication repair (Howard-Flanders and West, 1983). Post­
replication repair is dependent on the recombinase RecA, which promotes the 
pairing of gapped DNA with the corresponding homologous duplex (Cassuto et 
al., 1980; Cunningham et al., 1980; Shibata et al., 1979). RecA-mediated 
homologous pairing might be favored by the RecFOR complex, which is able to 
direct the loading of RecA into the ssDNA gap (Morimatsu and Kowalczykowski,
2003). Following homologous pairing, RecA promotes strand invasion of the 3 ’- 
end of the gapped DNA into the homologous duplex (Figure 1.3, step c) (West 
et al., 1982).
In a similar manner, RAD51 might induce the repair of ssDNA gaps in 
eukaryotes. It is known that during S phase RAD51 co-localises in nuclear foci 
together with the ssDNA binding protein RPA in mammalian cells (Tarsounas et 
al., 2003). Some of these foci might represent sites of repair of ssDNA gaps
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generated during DNA replication. HRR proteins, such as RAD52 and RAD54, 
might favour RAD51-mediated strand invasion, as described in Section 1.4 
(Figure 1.3, step c).
After DNA synthesis and ligation, dHJs could be formed (Figure 1.3, step 
d). As described in Section 1.4, HJs could be resolved by RuvABC or 
Resolvase A (with RAD51C/XRCC3) in bacteria or mammals, respectively 
(Figure 1.3, step e). In situations where the two HJs of the dHJ are resolved in 
different orientation, crossover products would be generated (Figure 1.3, step f).
Alternatively, it has recently been proposed that in mammals dHJs might 
be dissolved by the concerted action of the Bloom’s syndrome helicase BLM 
and the topoisomerase TOPOIIIa (Wu and Hickson, 2003) (Figure 1.3, step g). 
BLM, a member of the RecQ family of helicases, is indeed able to branch 
migrate in vitro two HJs in opposite directions and generate a catenated 
intermediate that can be released by TOPOIIIa (Wu and Hickson, 2003). A 
similar reaction might be performed also by the yeast RecQ helicases Sgs1 (S. 
cerevisiae) or Rqh1 (S. pombe) in complex with Top3 (Figure 1.3, step g). The 
dissolution of dHJs would then generate non-crossover products (Figure 1.3, 
step h) (Ira et al., 2003; Wu and Hickson, 2003). The absence of the dHJ 
dissolution pathway could lead to an increase in crossover products generated 
by the alternative dHJ resolution pathway. In agreement with this model, cell 
lines with BLM mutation have a hyper-recombination phenotype with 10-fold 
increase of sister chromatid exchanges (SCEs), which are indicative of 
crossover products (Chaganti et al., 1974).
Translesion Synthesis
In an alternative to leading-strand re-priming, DNA replication can progress 
through UV lesions by TLS (Figure 1.3, step I) (Friedberg, 2005). In bacteria, 
the TLS polymerase polV, whose subunits UmuC and UmuD are expressed 
after UV radiation (Kitagawa et al., 1985), is able to copy DNA templates with 
DNA lesions (Figure 1.3, step I) (Tang et al., 1999). However, polV, a member 
of the Y-family of DNA polymerases, has a lower fidelity than the replicative 
polymerase pollll, and can introduce mutations during DNA synthesis (Tang et
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al., 1999). It is indeed known that polV is responsible for the majority of UV 
radiation-induced mutagenesis (Kato and Shinoura, 1977).
In mammals, the main polymerase responsible for the bypass of UV 
lesions is the Y-family polymerase polri (Figure 1.3, step I) (Lehmann, 2005). 
Mutation of the POLH gene have been associated with the XP-V variant of the 
genetic disorder xeroderma pigmentosum (Section 1.3) (Johnson et al., 1999b; 
Masutani et al., 1999). The observation that poll interacts with polri (Kannouche 
et al., 2002) indicates that also poll might be involved in UV lesion bypass 
(Vaisman et al., 2003). It is known that both polri and poll interact with 
monoubiquitinated PCNA through a ubiquitin binding domain (Bienko et al., 
2005; Kannouche et al., 2004), which is required to promote the formation of 
polri and poll foci after UV radiation (Bienko et al., 2005). Therefore, polri and 
poll might be recruited to the site of damage by monoubiquitinated PCNA 
(Bienko et al., 2005; Kannouche et al., 2004). In the current polymerase switch 
model, PCNA is monoubiquitinated when the replication fork stalls at UV lesions 
present in the leading-strand (Figure 1.3, step a) (Kannouche et al., 2004; 
Lehmann, 2005). Under these conditions, monoubiquitinated PCNA 
preferentially binds polri (and possibly poll), which replaces the replicative 
polymerase polS and allows bypass of the UV lesion (Figure 1.3, step I) (Bienko 
et al., 2005; Kannouche et al., 2004). In addition, polri might be required to 
repair the ssDNA gaps left opposite to the UV lesion after the re-priming of 
leading-strand DNA synthesis (Figure 1.3, step k).
Recent reports have indicated a role for polri also during HRR (Kawamoto 
et al., 2006; Mcllwraith et al., 2005). It has been shown that in chicken DT40 cell 
lines polri is required for HRR during immunoglobulin diversification (Kawamoto 
et al., 2006). Moreover, RAD51 was shown to co-localise in nuclear foci with 
polri after UV radiation (Kannouche et al., 2001) and to stimulate the ability of 
polri to extend in vitro DNA structures mimicking D-loop recombination 
intermediates (Mcllwraith et al., 2005). It is therefore possible that in vivo polri 
might be directly involved both in TLS and HRR (Figure 1.2, step c; Figure 1.3, 
steps c, k and I).
C hapter  O ne 32
Fork Regression
In alternative to the mechanisms described above, UV lesions in the leading- 
strand could be bypassed by replication fork regression (McGlynn and Lloyd, 
2002a). In bacteria, the helicase RecG is able to induce replication fork 
regression by favoring the annealing of the leading- and lagging-strand and 
generating a HJ structure with ssDNA extension in one of the arms (Figure 1.3, 
step n) (McGlynn and Lloyd, 2000; McGlynn and Lloyd, 2001; Singleton et al.,
2001). This structure, also known as the “chicken foot”, could allow the restart of 
DNA synthesis of the blocked leading-strand using the homologous sequence 
of the lagging-strand as a template (Figure 1.3, step o) (McGlynn and Lloyd, 
2002b). The reset of the fork in its original position could then let DNA 
replication continue (Figure 1.3, step p).
Eukaryotic proteins able to promote fork regression have not yet been 
identified. Regressed forks have been visualized by electron-microscopy after 
HU treatment of S. cerevisiae cells defective in the replication checkpoint kinase 
Rad53 (Sogo et al., 2002). The absence of reversed fork structures in wild-type 
cells indicates that these structures might accumulate primarily under 
pathological conditions due to the absence of factors involved in the 
stabilisation of the replication fork (Lopes et al., 2006; Sogo et al., 2002).
DNA Replication Restart after Replication Fork Blockage or Collapse
As mentioned above, the possibility that DNA synthesis could be re-primed 
downstream of DNA damaged bases, such as UV lesions, suggests that DNA 
replication progression might be only partially affected by these lesions. Instead, 
DNA replication progression could be disrupted by SSBs, DSBs and replication 
fork blocks.
As indicated in Section 1.1, SSBs might be generated by CPT, reactive 
oxygen radicals or IR. During DNA synthesis, SSBs are converted into DSBs, 
which induce replication fork collapse (Figure 1.4, step a) (Kuzminov, 2001 b). 
The DSBs created by fork collapse are repaired by HRR. In bacteria, the DSB 
ends can be resected by the RecBCD complex, which generates a 3-end 
suitable for RecA-mediated strand invasion (Figure 1.4, steps b and c)
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(Anderson and Kowalczykowski, 1997; Kowalczykowski, 2000). The replication 
fork could then be re-established by RuvABC-induced resolution of the HJ 
formed after strand invasion (Figure 1.4, step d) (Cox et al., 2000; Kuzminov, 
2001a). Similar mechanisms of repair of collapsed replication forks might be 
present in eukaryotes, as described in Section 1.10.
DNA replication progression could be blocked by the presence of 
replication fork barriers (RFBs). RFBs are sites of blockage, either accidental or 
programmed (Lambert and Carr, 2005). Accidental RFBs can derive from 
defects in the replication machinery or from the collision of DNA replication fork 
with RNA transcription. In bacterial strains defective in components of the 
replication machinery, such as DnaB and Rep helicases or DNA polymerase III 
subunits, spontaneous fork regression could form HJs, which could be resolved 
by RuvABC (Figure 1.4, steps i, j and k) (Flores et al., 2001; Seigneur et al., 
1998). This would result in DSBs, which could be repaired by the RecBCD and 
RecA pathway (Figure 1.4, steps b, c and d) (Michel et al., 2004).
In E. coli, the collision of the replication fork with the transcription 
apparatus stalled at UV lesions has also been proposed to induce fork 
regression (Figure 1.4, step i) (McGlynn and Lloyd, 2000), which could be 
followed either by HJ resolution by RuvABC (Figure 1.4, steps j and k) or by fork 
reset once the UV lesion and the stalled RNA polymerase have been removed 
(Figure 1.4, step n). It has been suggested that RecG might be involved in fork 
regression or fork reset (Figure 1.4, steps i and n) (McGlynn and Lloyd, 2000). 
In S. cerevisiae, the collision between DNA replication and transcription 
apparatus can induce pausing of the replication fork (Prado and Aguilera, 
2005). Under these conditions, replication fork blockage has been associated 
with an increase in HRR.
In addition to accidental RFBs, DNA replication could be blocked by 
programmed RFBs. Examples of programmed RFBs are present in the rDNA 
loci of many species, from S. cerevisiae (Brewer and Fangman, 1988) to 
mammals (Gerber et al., 1997), and in the mating-type switching mat-1 locus of 
S. pombe (Dalgaard and Klar, 2001). Among programmed RFBs, the rDNA 
RFB of S. cerevisiae has been the most extensively studied. The function of the
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rDNA RFB is to ensure that DNA replication forks move in the same direction of 
RNA polymerase, therefore preventing the collision between DNA replication 
and transcriptional apparatus (Brewer and Fangman, 1988; Takeuchi et al.,
2003). It has been shown that replication forks stalled at rDNA RFBs are 
cleaved and successively repaired by HRR mechanisms (Burkhalter and Sogo,
2004). RFBs in the S. pombe mat-1 locus ensure that during the mating-type 
switching DNA replication occurs from the telomere to centromere direction 
(Dalgaard and Klar, 2001). This RFB is constituted by the replication termination 
sequence (RTS1) (Dalgaard and Klar, 2001).
Recently, programmed RFBs have been exploited as a tool to study 
blockage of DNA replication at specific chromosome loci. In S. pombe, it was 
shown that replication fork blockage at RTS 1 sequences located in an ectopic 
locus promotes extensive recombination (Ahn et al., 2005). In agreement with 
these data, HRR proteins were reported to form foci and to be required for cell 
survival in response to a replication fork stalled at the RTS1 site (Lambert et al.,
2005). Moreover, replication fork processing by HRR resulted in gross 
chromosomal rearrangements (Lambert et al., 2005). Taken together, these 
experiments indicate that the repair of replication forks blocked at RFBs is 
dependent on HRR and that this process can generate genomic instability. In 
contrast, replication forks stalled at ectopic S. cerevisiae rDNA RFBs were 
shown to be stable and to maintain an intact replisome, independently from 
replication checkpoint or HRR proteins (Calzada et al., 2005). However, as 
mentioned above, rDNA RFBs induce DSB formation when located in their 
native rDNA region (Burkhalter and Sogo, 2004). It is therefore possible that 
rDNA RFBs are not processed when introduced outside of the rDNA locus.
1.6 INTERSTRAND CROSS-LINK REPAIR
As mentioned above, ICLs represent particularly toxic lesions, because they 
tether both DNA strands together and prevent DNA strand unwinding, which is 
required for DNA replication and transcription. Due to the complexity of these 
lesions, ICLs are repaired by a concerted action of NER, HRR and TLS. Details 
of these pathways will be described for bacteria, yeast and vertebrates.
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Interstrand Cross-link Repair in Bacteria
In E  coli, the repair of ICLs induced by psoralen has been reconstituted in vitro 
(Berardini et al., 1999; Sladek et al., 1989; Van Houten et al., 1986). The NER 
UvrABC complex has been shown to generate nicks in one DNA strand on both 
sides of the ICL (Figure 1.5A, step 2) (Van Houten et al., 1986). The result is an 
11 bp oligonucleotide cross-linked to the other DNA strand (Van Houten et al., 
1986). The introduction of nicks is followed by the formation of a ssDNA gap on 
the 3 ’-side of the ICL due to the exonuclease activity of DNA polymerase I 
(Figure 1.5A, step 3) (Sladek et al., 1989). The ssDNA gap can then be repaired 
by HRR. RecA can promote strand invasion and displace the cross-linked 
oligonucleotide (Figure 1.5A, step 4) (Sladek et al., 1989). After HJ formation 
and resolution by RuvABC, UvrABC can introduce two additional nicks on both 
sides of the ICL on the DNA strand not previously cleaved (Figure 1.5A, step 5) 
(Sladek et al., 1989). This allows the release of the cross-linked oligonucleotide 
from DNA. DNA synthesis and ligation are then required to restore genomic 
integrity (Figure 1.5A, step 6). In the absence of HRR, the first incisions induced 
by UvrABC could be followed by TLS bypass of the ICL performed by DNA 
polymerase II (Figure 1.5B, steps 2 and 3) (Berardini et al., 1999). The ICL 
would then be removed after the second incisions by UvrABC (Figure 1.5B, 
steps 4 and 5).
Interstrand Cross-link Repair in Yeast
The mechanism of ICL repair between bacteria and yeast is similar, but in yeast 
more proteins participate in this pathway, in S. cerevisiae, ICL repair is thought 
to be performed by proteins involved in NER, HR and TLS (Dronkert and 
Kanaar, 2001). According to the phase of the cell cycle during which ICLs are 
generated, different ICL repair pathways might be activated, as described by 
the models represented in Figure 1.6. In G1, NER repair proteins can introduce 
nicks on both sides of the ICL (Figure 1.6A, steps 1 and 2). The NER proteins 
Radi, Radio, Rad2, Rad3 and Rad14 (orthologues of mammalian XPF, 
ERCC1, XPG, XPD and XPA, respectively) are thought to be involved in this 
step (Jachymczyk et al., 1981; McHugh et al., 1999; Miller et al., 1982). The
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FIGURE 1.5: Interstrand cross-link repair pathways in E. coli
See the main text in Section 1.6 for detailed description. This figure has 
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nuclease Pso2 has also been associated with the processing of the ICL, even 
though its function is still unclear (Barber et al., 2005). Once the nicks have 
been generated, it is thought that the TLS DNA polymerase £ may bypass the 
ICL (Figure 1.6A, step 3). Consistent with this proposal, mutants of DNA 
polymerase £ are particularly sensitive to cross-linking agents during stationary 
phase (McHugh et al., 2000). A second round of incisions generated on the 
second DNA strand by NER factors would then release the ICL from the DNA 
(Figure 1.6A, step 4). DNA synthesis and ligation can then repair the ssDNA 
gap (Figure 1.6A, step 5).
In G2, a similar repair pathway is thought to be employed (Figure 1.6C, 
steps 1-4) (Barber et al., 2005). However, the presence of the sister chromatid 
can also allow the repair of the ICL by HRR (Barber et al., 2005). After the 
introduction of incisions on both sides of the ICL (Figure 1.6D, step 1), Rad51 
could promote strand invasion, followed by DNA synthesis, dHJ formation and 
resolution (Figure 1.6D, steps 2-4).
In S phase, DNA replication blockage at ICLs could induce DSB formation 
by an as yet unknown mechanism (Figure 1.6B). It has been hypothesised that 
NER proteins could be involved in generating DSBs, but genetic observations 
suggest that this process is NER-independent (McHugh et al., 2000). As in the 
other cell cycle phases, NER factors are believed to introduce nicks on one side 
of the ICL in order to initiate ICL repair (Figure 1.6B, step 1) (Meniel et al., 
1997). NER cleavage could be followed by TLS bypass of the ICL by DNA 
polymerase £ (Figure 1.6B, step 2), followed by removal of the ICL by NER 
proteins and repair of the DSB mediated by HRR (Figure 1.6B, steps 3-4).
Fanconi Anemia and Interstrand Cross-link Repair in Vertebrates
Fanconi Anemia
In vertebrates, the repair of ICLs is dependent on the recently discovered 
proteins defective in the genetic syndrome Fanconi Anemia (FA) (Niedernhofer 
et al., 2005). FA is a rare autosomal recessive and X-linked disorder that affects 
less than 1 in 100,000 people (Fei et al., 2005). The clinical features of FA
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include early childhood skeletal abnormalities (thumb, arm, spine and hip 
abnormalities), cardiac, gastrointestinal and renal dysfunctions, abnormal skin 
pigmentation (also known as cafe au lait spots) (D'Andrea and Grompe, 2003). 
In addition, at an early age, FA patients develop pancytopenia due to apoptosis 
of hematopoietic progenitor cells. FA is also associated with an 800-fold 
increased risk of developing myelodysplasia and acute myeloid leukemia by the 
age of 14 (Alter, 2003; Kook, 2005). Moreover, the risk of developing solid 
tumours, such as head and neck, gynecological and gastrointestinal squamous 
cell carcinomas, is highly increased (Alter, 2003; Kook, 2005). The average 
survival of FA patients is 16 years, with bone marrow failure and cancer being 
the most common cause of death (Alter, 2003; Kook, 2005).
At a cellular level, the common FA diagnostic test is a hypersensitivity to 
cross-linking agents, such as MMC, diepoxybutane and cisplatin (Ishida and 
Buchwald, 1982). After treatment with cross-linking agents, FA cells show 
chromosome breaks and the formation of multiple radial structures (D'Andrea 
and Grompe, 2003). This can be attributed to the inability of FA cells to properly 
repair the DSBs generated by ICLs (Niedernhofer et al., 2005).
FA is characterized by genetic heterogeneity and it has been classified 
into 12 different complementation groups (FA-A, B, C, D1, D2, E, F, G, I, J, L 
and M) (Figure 1.7A) (Kennedy and D'Andrea, 2005; Niedernhofer et al., 2005). 
The classification is based on cell fusion experiments: cell lines that are not able 
to complement each other’s defect are assumed to be deficient in the same 
gene and therefore belong to the same complementation group. The FA genes 
have been named according to the complementation group in which they are 
defective. So far 11 FA genes have been cloned: the only gene not yet identified 
is FANC-I (Niedernhofer et al., 2005). The most common genes mutated in the 
FA patients are FANC-A, FANC-C and FANC-G, affecting 60%, 15% and 10% 
of FA patients, respectively (Figure 1.7A) (Kennedy and D'Andrea, 2005). 
Mutations in FANC-D1 or FANC-D2 are present in 10% of FA patients (5% for 
each of them), whereas defects in the other FA genes are rare (Figure 1.7A) 
(Kennedy and D'Andrea, 2005).
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A FANC-A 60%
B FANC-B Rare
C FANC-C 15%
D1 FANC-D1/BRCA2 5%
D2 FANC-D2 5%
E FANC-E Rare
F FANC-F Rare
G FANC-G 10%
I FANC-I Rare
J FANC-J/BRIP1 Rare
L FANC-L Rare
M FANC-M /HEF Rare
B
D2
ISPI
M / HEF
D2
 ^ D1/BRCA2
J/BRIP1
C hapter  O ne 44
Structure of the Fanconi Anemia Core Complex
Eight of the FA proteins (FANC-A, B, C, E, F, G, L and M) associate with each 
other to form the FA core complex (Figure 1.7B) (Kennedy and D'Andrea, 
2005). Loss of FA proteins, such as FANC-A, FANC-G or FANC-M, result in the 
instability of the FA core complex (Garcia-Higuera et al., 2000; Mosedale et al., 
2005). The association of FANC-A with FANC-G is believed to be one of the 
early steps in the assembly of the FA complex (Garcia-Higuera et al., 2000). 
The formation of the FANC-A/FANC-G complex is dependent on the FANC-G 
protein-protein interaction motifs called tetratricopeptide repeats (TPRs) (Blom 
et al., 2004). Moreover, FANC-A and FANC-G are known to stabilise each other 
by reciprocally extending their half-life (Garcia-Higuera et al., 2000). Once the 
complex is formed, FANC-C, FANC-E and FANC-F associate with FANC- 
A/FANC-G (de Winter et al., 2000). FANC-E interacts with FANC-C and is 
required for the nuclear accumulation of FANC-C (Medhurst et al., 2001; Pace 
et al., 2002; Taniguchi and D' Andrea, 2002), whereas FANC-F functions as an 
adaptor protein by mediating the assembly of FANC-A/FANC-G and FANC- 
C/FANC-E complexes (Leveille et al., 2004).
Two of the remaining proteins of the FA core complex, FANC-B and 
FANC-L, have been proposed to directly interact with each other (Meetei et al.,
2004). FANC-B, initially erroneously believed to be BRCA2, is the only FA gene 
on the X chromosome (Meetei et al., 2004). FANC-B mutations are therefore 
transmitted as an X-linked disease and cause the development of FA only in 
male patients, due to the presence of a single copy of the X chromosome in the 
male genome (Fei et al., 2005). FANC-B is required for FANC-A and FANC-L 
nuclear accumulation and is also involved in FANC-L stabilisation (de Winter et 
al., 2000; Meetei et al., 2004), probably through the binding to the FANC-L 
protein-protein interaction motifs known as WD40 repeats (Gurtan et al., 2006).
Requirement of the Fanconi Anemia Core Complex for FANC-D2 
Monoubiquitination
Under DNA damaging conditions, the FA core complex is required for the 
monoubiquitination of the FA protein FANC-D2 on Lysine 561 (Figure 1.7B)
C hapter  O ne 45
(Garcia-Higuera et al., 2001). Loss of any of the proteins of the FA core 
complex results in a lack of FANC-D2 monoubiquitination (Garcia-Higuera et al., 
2001; Meetei et al., 2003a; Meetei et al., 2004; Meetei et al., 2005; Taniguchi 
and D' Andrea, 2002). FANC-D2 monoubiquitination is believed to be the signal 
of the activation of the FA pathway (Garcia-Higuera et al., 2001). This 
modification is induced by a variety of DNA damaging agents, such as UV, IR, 
HU and cross-linking agents (Garcia-Higuera et al., 2001; Howlett et al., 2005), 
and it also occurs during normal S phase of the cell cycle (Taniguchi et al., 
2002). Therefore, the FA pathway appears to be activated in any condition of 
DNA stress, either caused by DNA replication or DNA damaging agents. 
However, the FA pathway is primarily required for ICL repair, as indicated by 
the exquisite sensitivity of FA cells to cross-linking agents, but not to UV, HU 
and IR (D'Andrea and Grompe, 2003).
The identification of the protein responsible for FANC-D2 
monoubiquitination has been controversial. The initial observation that BRCA1 
mutant cell lines have lower levels of FANC-D2 monoubiquitination, compared 
to the same cell lines complemented by the ectopic expression of BRCA1, 
raised the possibility that BRCA1 could be the E3 ubiquitin ligase for FANC-D2 
(Garcia-Higuera et al., 2001). BRCA1, whose inactivation predisposes 
individuals to the development of familial breast cancer (Easton et al., 2004), 
has been shown to have E3 ubiquitin ligase activity in complex with its partner 
protein BARD1 (Hashizume et al., 2001). The BRCA1/BARD1 complex 
monoubiquitinates FANC-D2 in vitro, but FANC-D2 monoubiquitination appears 
not to be affected by BRCA1 depletion (Vandenberg et al., 2003). The recent 
finding that FANC-L has an in vitro autoubiquitination activity dependent on its 
C-terminal RING-finger-like Plant HomeoDomain (PHD) led to the proposal that 
FANC-L is the E3 ubiquitin ligase for FANC-D2 (Meetei et al., 2003a). Although 
it has been reported that FANC-L deficient cell lines are defective in FANC-D2 
monoubiquitination, direct evidence of in vitro monoubiquitination of FANC-D2 
by FANC-L remains to be determined (Meetei et al., 2003a). It has been 
proposed that the entire FA core complex might be required for the in vitro 
monoubiquitination reaction (Fei et al., 2005). In particular, it is known that
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FANC-E directly interacts with FANC-D2 (Gordon et al., 2005; Pace et al.,
2002). Therefore, FANC-E might be necessary for the recruitment of FANC-D2 
to the FA core complex in order to be monoubiquitinated by FANC-L. Moreover, 
the role of FANC-I is still unknown. It was reported that cell lines mutated for 
FANC-I are defective for FANC-D2 monoubiquitination (Levitus et al., 2004), 
indicating that also FANC-I could be required for FANC-D2 monoubiquitination.
Following monoubiquitination, FANC-D2 associates with chromatin (Figure 
1.7B) (Garcia-Higuera et al., 2001; Montes de Oca et al., 2005). The exact 
mechanism by which monoubiquitinated FANC-D2 is targeted to chromatin is 
not yet known. It has recently been proposed that components of the FA core 
complex could be required for chromatin targeting of monoubiquitinated FANC- 
D2 (Matsushita et al., 2005). In particular, it was reported that a FANC-D2- 
monoubiquitin fusion protein could be targeted to chromatin in chicken cell lines 
defective for FANC-D2 but not for FANC-C, FANC-L and FANC-G (Matsushita 
et al., 2005). This raises the possibility that components of the FA core complex 
might be required to translocate monoubiquitinated FANC-D2 to chromatin 
(Matsushita et al., 2005).
Fanconi Anemia Pathway and Regulation of Homologous Recombination 
Repair
Monoubiquitinated FANC-D2 associated with chromatin co-localises in nuclear 
foci with the HRR proteins BRCA1 (Garcia-Higuera et al., 2001), BRCA2 (Wang 
et al., 2004) and RAD51 (Hussain et al., 2004). These observations led to the 
proposal that the FA pathway could be involved in HRR. Data in support of this 
hypothesis came from the identification of BRCA2 as the FA gene mutated in 
FANC-D1 patients (Howlett et al., 2002). In addition, FANC-D2 was shown to 
interact directly with BRCA2/FANC-D1 and to be required for the assembly of 
BRCA2/FANC-D1 foci after DNA damage (Hussain et al., 2004; Wang et al.,
2004). In fact, FANC-D2 and BRCA2/FANC-D1 are thought to form the FA 
complex that is directly involved in the repair of the ICL through HRR (Figure 
1.7B).
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Despite the connections between FA and HRR proteins, the role of the FA 
pathway in HRR remains unclear. Cells deficient in FANC-A (Yang et al., 2005), 
FANC-C (Hirano et al., 2005; Niedzwiedz et al., 2004), FANC-G (Yamamoto et 
al., 2003) and FANC-D2 (Houghtaling et al., 2005; Yamamoto et al., 2005) are 
defective in HRR. However, a recent report found that the HRR defects of 
FANC-A, FANC-G and FANC-D2 mutant cell lines (Nakanishi et al., 2005) are 
significantly milder than those observed in BRCA1 (Moynahan et al., 2001a; 
Westermark et al., 2003), BRCA2/FANC-D1 (Moynahan et al., 2001b) and 
RAD51 paralogs (Johnson et al., 1999a; Pierce et al., 1999) mutants. These 
results suggest a minor role of the FA core components in HRR, in contrast to 
that of BRCA2/FANC-D1 (Nakanishi et al., 2005; Yamamoto et al., 2003). In 
agreement with these conclusions, the formation of DNA damage-induced 
RAD51 foci, which are often considered a sign of HRR, was shown to be 
significantly impaired in BRCA2/FANC-D1 cell lines (Godthelp et al., 2002a) but 
not in FANC-D2 (Houghtaling et al., 2003; Ohashi et al., 2005; Yamamoto et al., 
2005) or FA core complex mutants (Godthelp et al., 2002a; Godthelp et al., 
2006; Yamamoto et al., 2003). Some studies, however, reported an attenuated 
and delayed formation of DNA damage-induced RAD51 foci in cells defective 
for FA core components (Digweed et al., 2002; Pichierri et al., 2002; Yang et al., 
2005).
BRCA2/FANC-D1 is thought to have a late role in the FA pathway, as 
confirmed by the normal FANC-D2 monoubiquitination in BRCA2/FANC-D1 
mutant cell lines (Siddique et al., 2001). Similar to BRCA2/FANC-D1, cell lines 
mutated in the newly identified FANC-J(Levitus et al., 2005; Levran et al., 2005) 
have normal FANC-D2 monoubiquitination levels (Bridge et al., 2005; Litman et 
al., 2005). It has been suggested that FANC-J might be part of the FA DNA 
repair complex, along with FANC-D2 and BRCA2/FANC-D1 (Figure 1.7B). 
FANC-J was previously known as BRIP1 (BRCA1 Interacting Protein 1) or 
BACH1 (BRCA1 Associated C-terminal Helicase 1) (Cantor et al., 2004). As 
suggested by its name, BRIP1/FANC-J interacts with BRCA1 and mutations in 
BRIP1 have been detected in patients with early-onset breast cancer (Cantor et 
al., 2004). BRIP1 /FANC-J is a member of the DEAH family of helicases with
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5’->3’ DNA unwinding activity on forked DNA structures (Cantor et al., 2004; 
Gupta et al., 2005). Mammalian cell lines depleted with small interfering RNAs 
(siRNAs) for BRIP1/FANC-J were shown to have HRR defects similar to cell 
lines depleted for BRCA1 (Litman et al., 2005). However, the opposite results 
were obtained for chicken cell lines defective for BRIP1/FANC-J, where chicken 
BRIP1/FANC-J appeared not to be required for HRR and to function 
independently of BRCA1 in the FA pathway of ICL repair (Bridge et al., 2005). It 
has been suggested that these differences are due to the distinct role played by 
BRCA1 in chicken and in mammals (Kennedy and D'Andrea, 2005). Cell lines 
mutant for chicken BRCA1 (Bridge et al., 2005), unlike cells defective in 
mammalian BRCA1 (Moynahan et al., 2001a), are indeed proficient in ICL 
repair.
Role of the Fanconi Anemia Pathway in Interstrand Cross-link Repair 
Studies in mammalian cells have demonstrated that processing of the ICL is 
more efficient in dividing cells and requires passage through S phase (De Silva 
et al., 2000; Rothfuss and Grompe, 2004). These observations led to the 
proposal that ICL repair might be activated by replication forks stalled at ICLs 
(Figure 1.8, step 2) (De Silva et al., 2000).
Stalled replication forks are known to activate the replication checkpoint, 
which is regulated primarily by the ATR (ATM and Rad3 Related) kinase 
(Osborn et al., 2002). Recent studies have implicated ATR in the activation of 
the FA pathway (Figure 1.8, centre) (Andreassen et al., 2004; Pichierri and 
Rosselli, 2004; Sobeck et al., 2006). Indeed, ATR was shown to be important 
for FANC-D2 monoubiquitination after IR and MMC treatment (Andreassen et 
al., 2004). The precise mechanism of ATR-dependent FANC-D2 
monoubiquitination has not been determined. It is known that FANC-D2 can be 
phosphorylated by ATR (Figure 1.8, centre) (Pichierri and Rosselli, 2004). It is 
therefore possible that FANC-D2 phosphorylation could be required for FANC- 
D2 to be monoubiquitinated by FANC-L (Niedernhofer et al., 2005).
The observation that FANC-D2 is monoubiquitinated during normal S 
phase, indicates a role for the FA pathway during unperturbed DNA replication
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(Taniguchi et al., 2002). Indeed, FANC-A and FANC-D2 associate to chromatin 
during DNA replication in an ATR-dependent manner and are required to 
prevent the accumulation of DSBs during DNA replication (Sobeck et al., 2006). 
In agreement with these data, treatment of FA cells with agents known to inhibit 
DNA polymerase, such as aphidicolin, results in increased chromosomal 
breakage at fragile sites, which are regions of the genome particularly 
susceptible to replication fork stalling and collapse (Howlett et al., 2005). It is 
therefore possible that the primary function of FA proteins is to coordinate the 
processing of stalled replication forks (Kennedy and D'Andrea, 2005).
In order to repair a replication fork stalled at an ICL, a DSB is generated by 
cleavage of the replication fork upstream of the lesion (Figure 1.8, step 3) (De 
Silva et al., 2000; Rothfuss and Grompe, 2004). The endonuclease responsible 
for the formation of ICL-induced DSBs has been proposed to be XPF/ERCC1, 
due to the ability of XPF/ERCC1 to cleave branched DNA structures (De Laat et 
al., 1998a). However, ICL-induced DSBs are efficiently generated in the 
absence of XPF or ERCC1 (De Silva et al., 2000; Niedernhofer et al., 2004). 
The identity of this nuclease is therefore still unknown.
Once formed, ICL-induced DSBs have been shown to co-localise with 
monoubiquitinated FANC-D2 (Kennedy and D'Andrea, 2005). The longer 
persistence of ICL-induced DSBs in FA cell lines suggest that FA proteins might 
be involved in ICL-induced DSB processing (Figure 1.8, step 4) (Rothfuss and 
Grompe, 2004). The exact mechanism by which the FA pathway might 
coordinate ICL-induced DSB processing is not yet characterised, but it has been 
proposed that FA proteins can recruit DNA repair factors to the ICL-induced 
DSBs (Kennedy and D'Andrea, 2005). The nuclear foci where 
monoubiquitinated FANC-D2, and presumably FA core components, co-localise 
with DNA repair proteins RAD51 (Hussain et al., 2004), BRCA2/FANC-D1 
(Wang et al., 2004), BRCA1 (Garcia-Higuera et al., 2001), NBS1/MRE11 
(Pichierri et al., 2002), RPA and PCNA (Howlett et al., 2005), could visually 
represent the sites of repair of ICL-induced DSBs.
In order to separate the two DNA strands, a second incision is required on 
the opposite side of the DSB. This reaction, also known as ICL unhooking, is
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likely to be performed by XPF/ERCC1 endonuclease (Figure 1.8, steps 5 and 
6). In fact, XPF/ERCC1 was shown to cleave on one side of an ICL located at 
forked DNA structures (Kuraoka et al., 2000). In support of the involvement of 
XPF/ERCC1 in ICL repair, cell lines deficient for XPF  or ERCC1, but not for 
other NER genes, are hypersensitive to cross-linking agents (Collins, 1993) and 
ERCC1'/m mice exhibit hematopoietic defects characteristic of FA (Prasher et al.,
2005). Moreover, XPF was shown to co-localise with FANC-A (Sridharan et al.,
2003) and FANC-D2 (Mace et al., 2005) after treatment with cross-linking 
agents.
In order to repair the gap left by the unhooking reaction, DNA synthesis is 
required. This is probably performed by TLS DNA polymerases that are able to 
bypass the residual cross-link adduct present on the opposite strand (Figure 
1.8, step 7). Evidence for a role of TLS in ICL repair came from experiments 
showing that chicken cell lines deficient for the TLS polymerases Rev1 or Rev3 
are hypersensitive to cross-linking agents (Niedzwiedz et al., 2004). The 
observations that Rev1 and Rev3 mutants are epistatic with FANC-C for cis- 
platin sensitivity and that Rev1 co-localises with FANC-D2 after DNA damage 
further suggests that the FA pathway and TLS are interconnected (Niedzwiedz 
et al., 2004). In addition, FA cell lines have been demonstrated to generate 
fewer rather than more mutations after cross-linking agents treatment 
(Papadopoulo et al., 1990a; Papadopoulo et al., 1990b). This correlates well 
with the hypothesis of defective TLS, which is an error-prone pathway, in the 
absence of FA proteins (Niedzwiedz et al., 2004).
After removal of the residual cross-link adduct by NER or by spontaneous 
hydrolysis (Figure 1.8, step 8), the DSB might be repaired by HRR (Figure 1.8, 
step 10). The involvement of HRR in ICL repair was initially suggested by the 
hypersensitivity of mutants for HRR proteins, such as BRCA1 (Yun et al., 2005) 
and RAD51 paralogs RAD51C (Godthelp et al., 2002b), RAD51D (Gruver et al.,
2005), XRCC2 and XRCC3 (Cui et al., 1999), to cross-linking agents. As 
previously mentioned, the identification of FANC-D1 as BRCA2 (Howlett et al., 
2002) and the colocalisation of FANC-D2 with HRR proteins have suggested a 
relationship between HRR and FA pathways (Kennedy and D'Andrea, 2005).
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However, the link between HRR and FA pathway might be restricted to the 
repair of a particular subset of DNA lesions, such as ICLs. In agreement with 
this, it was shown that chicken XRCC3 and FANC-C deletions are epistatic for 
c/s-platin sensitivity (Hirano et al., 2005), even though XRCC3 mutants have 
considerably higher defects in HRR than FANC-C mutants (Niedzwiedz et al.,
2004).
It has been proposed that BRIP1/FANC-J might participate during the 
repair of the ICL-induced DSB by HRR (Figure 1.8, step 10) (Litman et al.,
2005). The exact role of BRIP1/FANC-J is uncertain, but BRIP1/FANC-J could 
permit the efficient pairing of the invading strand with homologous DNA by 
unwinding non-productive D-loops formed by partial annealing of the invading 
strand with homeologous sequences. Consistent with this proposal, 
BRIP1/FANC-J is able to unwind D-loop structures in vitro (Gupta et al., 2005).
The replication fork could then be re-established by resolution of the HJ 
formed after RAD51-mediated strand invasion (Figure 1.8, step 11). 
Alternatively, BLM/TOPOIIIa complex could promote the dissolution of dHJs 
that might be generated (Figure 1.8, step 12) (Wu and Hickson, 2003). The 
identification of BLM and TOPOII la in a complex with FA core proteins is 
suggestive of a connection between BLM/TOPOIIIa and the FA pathway 
(Meetei et al., 2003b). Further studies have shown that FANC-D2 co-localises in 
nuclear foci with BLM after treatment with cross-linking agents and that the FA 
pathway is required for the efficient formation of BLM foci (Hirano et al., 2005; 
Pichierri et al., 2004). Altogether, these observations provide some evidence of 
the possible involvement of BLM/TOPOIIIa in ICL repair.
Once the ICL has been repaired, the deubiquitinating enzyme USP1 can 
inactivate the FA pathway by removing the ubiquitin moiety from FANC-D2 
(Figure 1.8, bottom centre) (Nijman et al., 2005). Moreover, it has been 
suggested that USP1 might be responsible for deubiquitinating FANC-D2 at the 
end of S phase after DNA replication (Nijman et al., 2005). This observation 
further supports the possible role of the FA pathway in the repair of stalled forks 
during an unperturbed cell cycle.
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III. Dna Repair Structure-Specific Nucleases
1.7 HOLLIDAY JUNCTION RESOLVASES
HJ resolvases are endonucleases that cleave HJs by introducing symmetrical 
nicks (Lilley and White, 2001). As described in Section 1.4, HJs are four-way 
junctions, in which two DNA double helices are covalently connected (Figure 
1.9A, panels 1 and 3). Four-way junctions can adopt different conformations. In 
the presence of cations, such as Mg2+, HJs assume an X-shape conformation 
with the DNA helices stacked antiparallel to each other (Figure 1.9A panel 4) 
(Duckett et al., 1988). In the absence of cations, the electrostatic repulsion 
between the DNA backbone of the helices induces the HJ to adopt an 
unstacked open planar structure (Figure 1.9A panel 4) (Clegg et al., 1994). This 
structure can be stabilised by the binding of HJ processing enzymes (Liu and 
West, 2004).
HJ resolvases have been identified in bacteriophage, bacteria and 
archaea (Sharpies, 2001). Examples are phage T4 endonuclease VII (Mizuuchi 
et al., 1982), E  coli RuvC and RusA (Dunderdale et al., 1991; Sharpies et al., 
1994), archaeal Hjc (Holliday junction cleavage) and Hje (Holliday junction 
endonuclease) (Komori et al., 1999; Kvaratskhelia and White, 2000). In 
eukaryotes, the mitochondrial HJ resolvases S. cerevisiae Cce1 and S. pombe 
Ydc2 have been identified (Evans and Kolodner, 1988; Symington and 
Kolodner, 1985; Whitby and Dixon, 1997; White and Lilley, 1997). Most of the 
HJ resolvases belong to two groups: the integrase superfamily or the nuclease 
superfamily (Figure 1.9B) (Lilley and White, 2000). RuvC, Cce1 and Ydc2 are 
part of integrase superfamily (Aravind et al., 2000; Ariyoshi et al., 1994; 
Ceschini et al., 2001), whereas Hjc and Hje belong to the nuclease superfamily 
(Middleton et al., 2004; Nishino et al., 2001). On the contrary, T4 endonuclease 
VII and RusA have evolved independently from these two groups (Figure 1.9B) 
(Raaijmakers et al., 1999; Rafferty et al., 2003). A more detailed description of 
RuvC will follow.
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RuvC
E. coli RuvC is the most extensively characterised HJ resolvase. RuvC is 
structurally similar to RNAse H1 (Ariyoshi et al., 1994) and HIV integrase (Dyda 
et al., 1994). This observation suggests a common catalytic mechanism 
between these proteins (Ariyoshi et al., 1994; Saito et al., 1995). The crystal 
structure of RuvC indicates that it binds HJ structures as a dimer, with the two 
monomers facing opposite directions (Ariyoshi et al., 1994). The binding of 
RuvC to the HJ promotes disruption of base pairing at the core of the junction 
(Bennett and West, 1995). Once the RuvC-HJ complex is formed, RuvC 
introduces two symmetrical nicks on DNA strands of like polarity (Figure 1.1 OA) 
(Bennett et al., 1993). These symmetrical nicks are induced at the specific 
sequences 5 ’- a/tT T |g/c -3’ near the crossover region (Shah et al., 1994). Each 
monomer of RuvC is responsible for the introduction of one of the two incisions, 
which occur independently from each other (Shah et al., 1997). The linear 
duplexes that are generated by RuvC contain nicks that are re-ligatable 
(Bennett et al., 1993).
RuvC’s HJ resolution activity is coordinated with HJ branch migration 
promoted by RuvAB (Section 1.4) (West, 1997). RuvC is thought to bind to the 
HJ held in an open planar conformation by RuvAB (Whitby et al., 1996). It has 
been proposed that RuvC might scan the HJ during RuvAB branch migration 
until a consensus sequence is identified (Whitby et al., 1996). This sequence 
would then trigger the cleavage of the HJ by RuvC.
1.8 FEN-1 FAMILY OF ENDONUCLEASES
Members of the FEN-1 (Flap ENdonuclease-1) family can be identified in all of 
the kingdoms of life (Lieber, 1997). In mammals, the FEN-1 family includes the 
endonucleases FEN-1 and XPG.
FEN-1 is a structure specific endonuclease that preferentially cleaves 5’- 
flap structures by nicking the dsDNA region adjacent to the 5’-ssDNA arm 
(Figure 1.1 OB) (Harrington and Lieber, 1994). A double flap structure, which has 
a 3’-single nucleotide tail in addition to the 5’-flap, has been suggested to be the 
preferred substrate of FEN-1 (Figure 1.10B) (Kao et al., 2002). The 5’-flap
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activity of FEN-1 is important for Okazaki fragment maturation during DNA 
replication (Hubscher and Seo, 2001). In the current model of Okazaki fragment 
processing, DNA extension synthesis catalysed by DNA polymerase 6 can 
displace the RNA primer of the downstream Okazaki fragment, thus creating a 
5’-flap that can be cleaved by FEN-1 (Henneke et al., 2003).
XPG is required during NER to nick the 3 ’-side of the damaged DNA 
strand (Section 1.3). Similar to FEN-1, XPG cleaves ssDNA/dsDNA junctions by 
introducing nicks on the dsDNA region near the 5’-ssDNA arm (Figure 1.10C) 
(Evans et al., 1997a; Hohl et al., 2003; O'Donovan et al., 1994). However, there 
are differences in the substrate specificity between XPG and FEN-1. Whereas 
XPG efficiently cleaves splayed arm and bubble structures (O'Donovan et al., 
1994), FEN-1 prefers 5 ’-flap structures (Figure 1.10, compare B and C) 
(Harrington and Lieber, 1994).
1.9 SLX ENDONUCLEASES
SLX (Synthetic Lethal of unknown function) genes have been identified in a 
genetic screen for mutations that are lethal in combination with sgsl (Mullen et 
al., 2001). This screen led to the isolation of six SLX genes: SLX1, SLX2, SLX3, 
SLX4, SLX5 and SLX8. Genetic and biochemical analyses have shown that 
these proteins form three heterodimeric complexes: Slx1/Slx4, Slx2/Slx3 and 
Slx5/Slx8 (Mullen et al., 2001). Slx2 and Slx3, which correspond to Mms4 and 
Mus81, will be discussed in Section 1.10.
Slx1 is an endonuclease that contains an N-terminal UvrC-lntron-type 
(URI) nuclease domain (Aravind and Koonin, 2001). The endonuclease activity 
of Slx1 can be significantly stimulated by the interaction of Slx1 with Slx4 
(Coulon et al., 2004; Fricke and Brill, 2003). Slx1/Slx4 has been shown to 
cleave 5'-flap, splayed arm and replication fork structures more efficiently than 
HJs (Figure 1.10D) (Fricke and Brill, 2003). 5'-flap structures are nicked by 
Slx1/Slx4 on the ssDNA strand precisely at the junction between ssDNA and 
dsDNA. Therefore the resulting cleavage products can be religated by DNA 
ligase (Fricke and Brill, 2003). In contrast, the HJ cleavage products are not
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religatable. Unlike classical HJ resolvases, Slx1/Slx4 does not introduce 
symmetrical nicks at the crossover of the junction (Fricke and Brill, 2003).
Yeast cells deficient for SLX1 or SLX4 do not exhibit any obvious 
phenotype after treatment with DNA damaging agents (Mullen et al., 2001). 
However, S. cerevisiae slx4 mutants containing a temperature-sensitive allele of 
SGS1 are defective in rDNA replication (Kaliraman and Brill, 2002). Similar 
results were obtained in S. pombe for slx1 or rqhl mutants (Coulon et al.,
2004). However, no defects in bulk DNA replication have been detected in the 
absence of SGS1 or SLX4 (Kaliraman and Brill, 2002). These data indicate that 
Slx1/Slx4 might be specifically required during rDNA replication.
The observation that slx1 or slx4 are synthetic lethal with sgsl(rqhl) or 
top3 (Coulon et al., 2004; Mullen et al., 2001), suggests that Slx1/Slx4 and 
Sgs1(Rqh1)/Top3 might provide alternative pathways to process stalled 
replication forks at rDNA RFBs (Coulon et al., 2006; Fricke and Brill, 2003). It 
has been proposed that converging replication forks at RFBs could be either 
cleaved by Slx1/Slx4 or dissolved by Sgs1(Rqh1)/Top3 (Coulon et al., 2006; 
Fricke and Brill, 2003). The absence of both Sgs1(Rqh1) and Slx1/Slx4 could 
prevent stalled fork processing and completion of rDNA replication and 
therefore be incompatible with cell survival.
In contrast to Slx1/Slx4 and Slx2/Slx3, neither Slx5 nor Slx8 contain known 
nuclease domains. Instead, both Slx5 and Slx8 contain RING finger domains 
(Mullen et al., 2001), which have been identified in ubiquitin or SUMO E3 
ligases (Jackson, 2001). It has recently been reported that S. cerevisiae slx5 or 
six8 mutants are synthetic lethal with SUMO conjugating enzymes (Wang et al.,
2005). This has raised the possibility that Slx5 and Slx8 might be SUMO E3 
ligases. However, no activity has yet been reported for the Slx5/Slx8 complex.
Among the SLX genes, SLX5 and SLX8 have been recently shown to be 
particularly critical for the suppression of spontaneous gross chromosomal 
rearrangements, such as translocations, large deletions and loss of 
chromosomal arms (Zhang et al., 2006). However, the mechanism by which 
Slx5 and Slx8 ensure genomic stability is still unknown and no clear explanation 
is available for the synthetic lethality of six5 or slx8 with sgsl mutants.
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1.10 MUS81 FAMILY OF ENDONUCLEASES
The MUS81 family derives its name from the endonuclease MUS81, initially 
identified in yeast (Boddy et al., 2000; Interthal and Heyer, 2000). Members of 
this family can be found both in archaea and in eukaryotes (Nishino et al.,
2006). The single archaeal member of the MUS81 family has been named XPF 
in Aeropyrum pernix (or Sulfolobus solfataricus) and Hef in Pyrococcus furiosus 
(Figure 1.11). In S. pombe, four MUS81 family proteins are known: Mus81, 
Eme1, Rad16 and Swi10. The S. cerevisiae orthologues of Eme1, Rad16 and 
Swi10 are Mms4, Radi and Radio, respectively. Rad16(Rad1) and Swi10 
(Radio) correspond to human XPF and ERCC1, respectively.
Proteins of the MUS81 family are characterised by the presence of the 
ERCC4 nuclease domain (Enzlin and Scharer, 2002), which is structurally 
related to the nuclease domain of type II restriction endonucleases (Nishino et 
al., 2003). Indeed, the catalytic motif of the ERCC4 domain, ERKX3D, with an 
extension at the N-terminal GDXn (GDXnERKX3D), is similar to the sequence 
PDXn(D/E)XK required for restriction endonuclease activity. Interestingly, some 
MUS81 family proteins, such as Eme1(Mms4), Swi10(Rad10) and ERCC1 
contain an inactive ERCC4 domain, due to the absence of the catalytic motif 
ERKX3D (Figure 1.11) (Aravind et al., 1999). The characteristics of the MUS81 
family proteins will be described in following sections.
Archaeal MUS81 Family Proteins
P. furiosus Hef was the first archaeal member of the MUS81 family identified. In 
the initial report, Hef was discovered as a stimulatory factor of the nuclease 
activity of the HJ resolvase Hjc (Komori et al., 2002). In addition to the ERCC4 
nuclease domain, Hef contains a DEAH helicase domain typical of DNA/RNA 
helicases of the superfamily II (SF2) (Figure 1.11) (Nishino et al., 2005b). SF2 
helicases, which also include RecG and RecQ (Bernstein et al., 2003; Singleton 
et al., 2001), are characterised by the presence of seven helicase motifs (l-la-ll- 
lll-IV-V-VI) (Singleton and Wigley, 2002). Motifs I and II contain the conserved 
Walker A and B sequences typical of ATPases (Walker et al., 1982).
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FIGURE 1.11: Evolutionary relationship of the MUS81 family of proteins
The MUS81 family of proteins in Pyrococcus furiosus, A eropyrum  pernix, 
Schizosaccharom yces pom be  and Homo sapiens are represented. Sulfolo- 
bus solfataricus XPF has the same domain organisation of Aeropyrum  pern ix  
XPF. S a cch a ro m yce s  c e re v is ia e  orthologues of S ch izo sa cch a ro m yce s  
pom be  proteins are shown in brackets. ERCC4 nuclease domains (red), HhH 
motifs (dark violet), DEAH helicase domains (blue) are indicated with boxes. 
Inactive ERCC4 and DEAH domains are indicated with red and blue cross­
es, respectively.
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In vitro experiments using truncated mutant proteins have shown that the 
C-terminal fragment of Hef containing the ERCC4 nuclease domain exhibits 
preferential cleavage of 3 ’-flap and replication fork substrates (Figure 1.1 OE) 
(Komori et al., 2002), whereas the N-terminal DEAH domain is able to unwind 
replication fork structures and HJs (Komori et al., 2004). It has been reported 
that the Hef DEAH helicase domain stimulates the Hef nuclease activity on 
mobile replication fork substrates (Komori et al., 2004). In particular, the Hef 
helicase domain can regress replication forks with lagging strand gaps, 
therefore forming “chicken foot” structures, which could be cleaved by the 
ERCC4 nuclease domain (Figure 1.10E). In addition, the Hef helicase domain 
could reset replication forks that have regressed to form HJs after replication 
fork blockage (Figure 1.4, step I and Figure 1.10E). The Hef ERCC4 nuclease 
domain could then cleave the reset replication fork (Figure 1.4, step h and 
Figure 1.10E). Alternatively, regressed replication forks that have formed HJs 
could be processed by the HJ resolvase Hjc (Figure 1.4, step k). Taken 
together, these observations suggest that the helicase activity of the DEAH 
domain of Hef cooperates with the ERCC4 nuclease domain in the processing 
of blocked replication forks (Komori et al., 2004).
In crenarchaea, such as A. pernix and S. solfataricus, the MUS81 family 
proteins do not contain the DEAH helicase domain (Figure 1.11) (White, 2003). 
The observation that S. solfataricus XPF is active only in complex with the 
sliding clamp PCNA (Roberts et al., 2003), has suggested that PCNA could be 
functionally equivalent to the DEAH helicase domain of P. furiosus Hef (Roberts 
et al., 2003). S. solfataricus XPF preferentially cleaves 3’-flap, replication fork, 
nicked HJ and D-loop structures, with splayed arm structures and intact HJs 
processed 10- and 100-fold less efficiently, respectively (Figure 1.1 OF) (Roberts 
and White, 2005).
Archaeal proteins of the MUS81 family form homodimers in order to be 
active (Komori et al., 2002). In P. furiosus, the dimerisation of the Hef protein is 
mediated by the ERCC4 nuclease domain and the two adjacent Helix hairpin 
Helix (HhH) motifs (Figure 1.11) (Nishino et al., 2003; Nishino et al., 2005a). 
The HhH motifs are commonly found in DNA repair proteins and are thought to
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be important for DNA substrate recognition (Doherty et al., 1996). It has been 
proposed that the HhH motifs of P. furiosus Hef form a bridge between the 
duplex arms of the fork structure allowing the ERCC4 nuclease domain to bind 
and cleave near the centre of the fork (Nishino et al., 2005a). Although P. 
furiosus Hef homodimer has two ERCC4 nuclease domains, one is sufficient to 
have a fully active complex (Nishino et al., 2005a). A similar model has been 
suggested for A. pernixXPF (Figure 1.12) (Newman et al., 2005).
XPF and ERCC1
Structural Organisation of XPF and ERCC1
In contrast to the archaeal members of the MUS81 family, mammalian XPF 
does not homodimerise, but forms a heterodimer with ERCC1 (Sijbers et al., 
1996a). The interaction between XPF and ERCC1 is mediated by their C- 
terminal regions (De Laat et al., 1998b), which contain the two HhH motifs 
(Figure 1.11) (Gaillard and Wood, 2001). The similarity between the C-termini of 
XPF and ERCC1 had suggested that ERCC1 might have derived by gene 
duplication of the 3 ’-region of XPF  (Aravind et al., 1999; Gaillard and Wood,
2001). The crystal structure of the complex between the C-termini of XPF and 
ERCC1 showed that the interaction between XPF and ERCC1 is mediated by 
hydrophobic contacts between the HhH motifs of XPF and ERCC1 (Tripsianes 
et al., 2005). In particular, Phe894 of XPF and Phe293 of ERCC1 (Figure 1.13A, 
green amino acid residues) interact with hydrophobic pockets formed by the 
HhH motifs of ERCC1 and XPF, respectively. The importance of Phe293 of 
ERCC1 is indicated by the observation that Phe293 is required for the stability 
and function of XPF/ERCC1 complex (De Laat et al., 1998b; Sijbers et al., 
1996b).
The XPF/ERCC1 complex functions as an endonuclease that preferentially 
cleaves splayed arm, 3 ’-flap and bubble structures on dsDNA regions near the 
transition between dsDNA and ssDNA (Figure 1.10G) (De Laat et al., 1998a). 
The critical residues for endonuclease activity reside in the ERCC4 domain of 
XPF (Enzlin and Scharer, 2002), whereas they are absent in the ERCC4
FIGURE 1.12: Structural model of Aeropyrum pernix XPF bound to a 
3'-flap substrate
A. Crystal structure of the nuclease domains and the HhH motifs of 
Aeropyrum pernix XPF dimeric complex bound to DNA. The nuclease 
domain and the HhH motifs of the XPF monomer A are in blue and green, 
respectively, whereas the corresponding domains of the XPF monomer B 
are in light blue and yellow. A schematic model of XPF interacting with a 3'- 
flap structure is shown on the right. The interaction of XPF with site I of the 
3'-flap was determined by crystal log raphic data, whereas the binding of 
XPF to the site II is modelled. Taken from Newman et al., 2005.
B. Representation of the catalytically active (red) and inactive (green) 
subunits of A. pernix XPF dimeric complex. The DNA strand that is cleaved 
by XPF is indicated by a black line, which continues into the active site of 
XPF and beyond (dashed black and red lines). Note that the active XPF 
monomer is in contact with the DNA strand to be cleaved. Taken from 
Newman et al., 2005.
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domain of ERCC1, which is inactive (Figure 1.11) (Aravind et al., 1999). 
Therefore, as observed with archaeal Hef and XPF proteins, a single active 
ERCC4 domain is sufficient for endonuclease activity.
Recent data indicate that ERCC1 is required to target XPF to DNA 
(Tripsianes et al., 2005). In particular, the residues Gly276 and Gly278, which 
form a classical GhG hairpin in the second HhH motif of ERCC1 (Figure 1.13A), 
are involved in DNA binding (Figure 1.13B). In contrast, the HhH motifs of XPF, 
which do not contain classical GhG hairpins (Figure 1.13A), fail to interact with 
DNA (Figure 1.13B). Altogether, these observations support a model in which 
DNA binding and nuclease activities are located in different subunits of the 
XPF/ERCC1 complex (Tripsianes et al., 2005).
In addition to the ERCC4 nuclease domain and the HhH motifs, XPF and 
its yeast orthologues Radi (S. cerevisiae) or Rad16 (S. pombe) have a helicase 
domain similar to the DEAH domain of P. furiosus Hef (Figure 1.11). However, 
this domain is predicted to be inactive, due to mutations in the catalytic DEAH 
motif (Aravind et al., 1999; Sgouros et al., 1999). On the contrary, in S. 
cerevisiae the helicase Mph1 has a functional DEAH domain related to P. 
furiosus Hef (Scheller et al., 2000). In vitro experiments have shown that Mph1 
has 3 ’ 5 ’ helicase activity (Prakash et al., 2005). In vivo, mph1 mutants are
sensitive to MMS or CPT and have a mutator phenotype that is dependent on 
the error-prone TLS polymerases (Scheller et al., 2000). This observation 
indicates that Mph1 might provide an error-free pathway that is alternative to 
TLS (Schurer et al., 2004). In particular, the hyper-recombination phenotype of 
mph1 sgsl compared to the single mutants suggests that Mph1 might act in an 
anti-recombinogenic pathway independent of Sgs1 (Schurer et al., 2004).
In Vivo Functions of XPF/ERCC1
As described in Section 1.3, XPF/ERCC1 is required during NER to nick the 5 ’- 
side of the damaged DNA strand. The concerted action of XPF/ERCC1 and 
XPG, which cleaves the 3’-side of the damaged DNA strand, is responsible for 
the release of an oligonucleotide containing the DNA lesion (Figure 1.1).
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Mutations in XPF  have been identified in XP patients of the 
complementation group F (Section 1.3) (Sijbers et al., 1996a). However, no 
complementation groups of XP patients are defective for ERCC1 (Cleaver,
2005). This could be a result of the apparent requirement of ERCC1 for 
postnatal survival, as suggested by the death of ERCC1'A mice 3 weeks after 
birth (Weeda et al., 1997). Similar results obtained for XPFA mice indicate that 
XPF is also necessary for postnatal survival (Tian et al., 2004). Therefore, 
mutations of XPF  might be compatible with mammalian development 
exclusively when the XPF activity is only partially affected. Indeed, XPF patients 
have XPF  hypomorphic mutations that do not completely eliminate XPF function 
(Matsumura et al., 1998). As a consequence, individuals with XPF  mutations 
show mild symptoms of photosensitivity, compared to XP patients of other 
complementation groups (Kondo et al., 1989).
X P F a or ERCC1'/m mice have a distinct phenotype from XPAV~ or XPC A 
mice, which develop normally (de Vries et al., 1995; Nakane et al., 1995; Sands 
et al., 1995). This indicates that XPF/ERCC1 complex has an additional function 
outside NER. As described in Section 1.6, the hypersensitivity of X PFA or 
ERCC1'a cells to cross-linking agents indicates that XPF/ERCC1 might be 
involved in ICL repair (Niedernhofer et al., 2004; Prasher et al., 2005; Tian et 
al., 2004; Weeda et al., 1997). Biochemical studies have proposed that 
XPF/ERCC1 could be responsible for ICL unhooking (Section 1.6 and Figure 
1.8).
Besides their role in NER and ICL repair, XPF and ERCC1 have been 
associated with HRR. In particular, ERCC1 is dispensable for general repair of 
DSBs (Adair et al., 2000), but is essential in ES cells for a particular subset of 
HRR, such as targeted gene replacement (Adair et al., 2000; Niedernhofer et 
al., 2001). In addition to a role in gene targeting, XPF/ERCC1 has been 
implicated in HRR during meiosis. In Drosophila melanogaster, MEI-9, which is 
the orthologue of XPF, is required for NER, ICL repair and meiotic 
recombination (Yildiz et al., 2004). It has been shown that mei-9 mutants exhibit 
90-95% decrease of the number of crossover products and extensive
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chromosomal non-disjunctions (Baker and Carpenter, 1972). These 
observations indicate that MEI-9 might be involved in HJ resolution (Yildiz et al., 
2004). It has been reported that MEI-9 has two different partners, MUS312 and 
ERCC1 (Yildiz et al., 2002). MUS312, a protein identified exclusively in D. 
melanogaster, is required for the formation of crossover products (Yildiz et al.,
2002), whereas ERCC1 is only partially involved in meiotic recombination 
(Radford et al., 2005). It is not known whether MEI-9/MUS312 complex is able 
to generate crossovers by cleaving HJs (Yildiz et al., 2002). In mouse, XPF and 
ERCC1 are highly expressed in testis and ERCC1 is required for normal 
spermatogenesis and oogenesis (Hsia et al., 2003; Shannon et al., 1999). 
However, no direct evidence of a role for XPF or ERCC1 in meiotic 
recombination has been obtained.
MUS81
Structural Organisation of MUS81 and its Partner Protein 
Mus81 was initially identified as an interactor of the HRR protein Rad54 in S. 
cerevisiae (Interthal and Heyer, 2000) and the replication checkpoint kinase 
Cds1 in S. pombe (Boddy et al., 2000). The human MUS81 orthologue was 
subsequently found based on a homology search (Chen et al., 2001). Both 
yeast and human MUS81, similar to A. pernix and S. solfataricus XPF, do not 
contain the helicase DEAH domain (Figure 1.11). Moreover, the analysis of the 
MUS81 sequence has suggested that, different from the other member of the 
family, the C-terminal two HhH motifs are separated, with a HhH motif at the N- 
terminus and the other at the C-terminus of MUS81 (Figure 1.11) (Interthal and 
Heyer, 2000). Knowing that the HhH motifs cooperate in promoting DNA binding 
in the archaeal MUS81 family proteins, it is possible that the 2 HhH motifs of 
MUS81 might be in close proximity in the MUS81 three-dimentional structure.
Yeast Mus81 forms a heterodimer with Mms4 in S. cerevisiae (Mullen et 
al., 2001) and Eme1 in S. pombe (Boddy et al., 2001). Both Mms4 and Eme1, 
like Radio and Swi10, contain in their C-termini a ERCC4 domain, which is 
inactive due to the absence of the catalytic motif ERKX3D, and a single HhH
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motif (Figure 1.11). The observation that the C-terminal regions of Mus81 and 
Eme1(Mms4) are required for the formation of the Mus81/Eme1(Mms4) 
complex, suggests that, similar to the archaeal MUS81 family proteins (Nishino 
et al., 2003; Nishino et al., 2005a), the ERCC4 domain and the HhH motifs 
might be responsible for the interaction between Mus81 and Eme1(Mms4) 
(Boddy et al., 2001; Fu and Xiao, 2003). The formation of the heterodimeric 
complex is necessary for the endonuclease activity of Mus81/Eme1(Mms4) 
(Boddy et al., 2001; Kaliraman et al., 2001), both during meiosis and mitosis.
Role of MUS81 in Meiosis
Initial experiments in S. pombe showed that mus81 or eme 1 mutants exhibit 
very pronounced meiotic defects consistent with problems with the processing 
of recombination intermediates, and that this phenotype could be at least 
partially rescued by the expression of the RusA HJ resolvase (Boddy et al., 
2001). These studies raised the possibility that Mus81/Eme1 possessed HJ 
resolution activity, a proposal that was supported by in vitro studies with 
Mus81/Eme1 protein (Boddy et al., 2001). However, the ability of Mus81/Eme1 
to cleave HJs was subsequently shown to be considerably lower than that 
observed with other DNA substrates such as 3 ’-flaps and replication fork 
structures (Figure 1.10H) (Boddy et al., 2001; Doe et al., 2002; Whitby et al., 
2003). The recent in vitro observation that Mus81/Eme1 efficiently cleaves D- 
loops and nicked HJs (Figure 1.1 OH) (Gaillard et al., 2003; Osman et al., 2003) 
led to the suggestion that D-loops and nicked HJs might be the substrates 
cleaved by Mus81/Eme1 in vivo during meiosis (Osman et al., 2003). In the 
current model, Mus81/Eme1 is proposed to nick the D-loop structure formed by 
strand invasion and the unligated HJ generated after second end capture 
(Figure 1.14, steps 3c and 5c). By this mechanism, Mus81 would generate 
crossover products, without resolving intact HJs (Figure 1.14, step 6c). This 
model is in agreement with the observation that S. pombe mus81 cells have 
defects in generating crossover products, whereas non-crossovers are 
unaffected by the absence of Mus81 (Osman et al., 2003; Smith et al., 2003). 
Therefore, the extensive meiotic defect of mus81 or em el mutants (Boddy et
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al., 2001; Osman et al., 2003) indicates that Mus81 is responsible for the major 
pathway that leads to meiotic crossover products in S. pombe (Figure 1.14) 
(Hollingsworth and Brill, 2004).
In S. cerevisiae, however, the mild crossover defects of mus81 and mms4 
cells has suggested the presence of an alternative Mus81-independent pathway 
for the generation of crossovers (de los Santos et al., 2003; de los Santos et al., 
2001). It has been proposed that in S. cerevisiae meiotic crossover products 
can be generated either by the Mus81 pathway or by the Msh4-Msh5 pathway 
(Figure 1.14) (Hollingsworth and Brill, 2004), as indicated by the observation 
that mms4 msh5 and mus81 msh5 mutants exhibit a more pronounced meiotic 
defect than the single mutants (de los Santos et al., 2003; de los Santos et al., 
2001). Msh4 and Msh5 are thought to promote dHJ formation by stabilising 
recombination intermediates through the formation of a sliding clamp around the 
homologous DNA strands (Figure 1.14, step 3a) (Whitby, 2005). Following 
extension of the heteroduplex region catalysed by the helicase Mer3 (Figure 
1.14, step 4a), Msh4-Msh5 in conjunction with the mismatch repair Mlh1-Mlh3 
complex may facilitate the resolution of dHJs by the HJ resolvase (Figure 1.14, 
step 6a) (Whitby, 2005). The crossovers generated by the Msh4-Msh5 pathway 
are subjected to interference (Figure 1.14, step 7a) (de los Santos et al., 2003), 
a phenomenon by which crossovers are prevented to be near one another and 
are evenly distributed throughout the genome (Hollingsworth and Brill, 2004; 
Whitby, 2005). In contrast, crossovers formed by the Mus81 pathway are not 
regulated by interference (Figure 1.14, step 6c) (de los Santos et al., 2003). 
Whereas in S. cerevisiae crossovers result from both the interference- 
dependent Msh4-Msh5 pathway and the interference-independent Mus81 
pathway, in C. eiegans crossovers are exclusively generated by the 
interference-dependent Msh4-Msh5 pathway (Figure 1.14) (Hollingsworth and 
Brill, 2004).
In mammals, as observed with C. eiegans, crossovers might be formed 
only by the interference-dependent MSH4-MSH5 pathway (Figure 1.14) 
(Whitby, 2005). Indeed, MSH4'A and MSH5f' mice are infertile (de Vries et al.,
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1999; Edelmann et al., 1999; Kneitz et al., 2000), whereas MUS81'/mmice do not 
exhibit any meiotic defects (Dendouga et al., 2005; McPherson et al., 2004). 
Altogether, these observations suggest that mammalian MUS81 might function 
exclusively during mitosis.
Mus81 and Replication Fork Cleavage in Yeast
In vivo studies have shown that yeast mus81 mutants are sensitive to DNA 
damaging agents that cause replicative damage, such as UV, HU, MMS or CPT 
(Bastin-Shanower et al., 2003; Boddy et al., 2000; Doe et al., 2002; Interthal 
and Heyer, 2000). In contrast, mus81 mutants do not show defects in DSB 
repair, as indicated by the normal growth after IR (Boddy et al., 2000; Interthal 
and Heyer, 2000). In agreement with a role for Mus81 during DNA replication, 
yeast Mus81/Eme1(Mms4) was shown to efficiently cleave replication fork and 
3’-flap substrates in vitro (Doe et al., 2002; Kaliraman et al., 2001; Whitby et al.,
2003). Taken together, these observations suggest that Mus81 might be 
involved during DNA replication in repairing blocked or collapsed replication 
forks.
Consistent with this proposal, MUS81 and MMS4 were identified in a 
screen for S. cerevisiae genes that are synthetic lethal in combination with sgsl 
(Mullen et al., 2001). Similarly, S. pombe rqhl mus81 cells proved to be inviable 
(Doe et al., 2002). These data indicate that Mus81 and the RecQ helicase 
Sgs1(Rqh1) might act on alternative pathways in the repair of replicative 
damage. In S. pombe, Rqh1 is required for the stabilisation of the replication 
fork, as indicated by the formation of DSBs in replication forks blocked at the 
RTS1 RFB in the absence of Rqh1 (Ahn et al., 2005). RecQ helicases could 
maintain fork integrity by resetting replication forks that have regressed at DNA 
replication blocks (Figure 1.4, step n) (Doe et al., 2000; Karow et al., 2000). 
This could allow DNA replication restart when the block has been removed 
(Figure 1.4, step n). In the absence of RecQ helicases, Mus81/Eme1 could be 
required in order to cleave blocked replication forks (Figure 1.4, step h). 
Mus81/Eme1 cleavage activity might be favoured by helicases that could reset 
replication forks that have regressed (Figure 1.4, step I), similar to the
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mechanism described for the helicase and nuclease domain of P. furiosus Hef 
(Komori et al., 2004). As a consequence of Mus81/Eme1 cleavage, DNA 
replication could restart after the DSBs are repaired by HRR (Figure 1.4, steps 
b-f). However, the observation that DSBs at the RTS1 RFB are not detected in 
wild-type cells (Ahn et al., 2005) indicates that, in physiological conditions, 
replication fork cleavage might not represent the primary mechanism of 
replication fork restart after replication fork blockage.
Replication fork breakage might be deleterious, as it could induce genomic 
rearrangements (Kai et al., 2005; Lambert et al., 2005). It has been proposed 
that, in order to avoid replication fork cleavage when replication forks stall 
because of HU-induced dNTP depletion, S. pombe Mus81 might dissociate from 
the chromatin after being phosphorylated in a Cds1-dependent manner (Kai et 
al., 2005). Following Mus81 release from the chromatin, replication fork 
progression could resume once dNTP levels are restored. These observations 
may indicate that Mus81 is not a critical factor for survival after HU treatment. In 
contrast, Mus81 might be required when DNA replication progression is 
compromised by mutations of replicative genes (Kai et al., 2005). In these 
mutants, Mus81 is only partially phosphorylated, due to moderate activation of 
Cds1, and remains associated to chromatin. In the proposed model, chromatin- 
associated Mus81 could promote the cleavage of blocked replication forks in 
order to restart DNA replication. As a consequence, chromosomal deletions 
might be generated by inaccurate DSB repair. These chromosomal 
rearrangements are the price that replication mutants might have to pay in order 
to complete DNA replication and survive. Taken together, these experiments 
suggest that Cds1 might restrict Mus81 activity to situations in which it is 
required for cell survival (Kai et al., 2005). The absence of checkpoint kinases is 
predicted to result in hyperactivation of Mus81. It is possible that the replication 
fork collapse observed in S. cerevisiae rad53 strains after HU and MMS 
treatment (Lopes et al., 2001; Tercero and Diffley, 2001) could be partly due to 
abnormal activation of Mus81.
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Mus81 and the Repair of ssDNA Gaps and DSBs during DNA Replication in 
Yeast
In addition to replication fork breakage, Mus81/Eme1(Mms4) could promote the 
cleavage of HRR intermediates generated by the repair of ssDNA gaps during 
DNA replication (Figure 1.3) (Fabre et al., 2002). As an alternative to dHJ 
formation, the yeast Srs2 helicase could promote the synthesis dependent 
strand annealing (SDSA) pathway by disassembling the Rad51 filament and 
therefore dissociating the D-loop intermediate (Figure 1.3, step i) (Ira et al., 
2003; Krejci et al., 2003; Veaute et al., 2003). In case DNA synthesis extends 
over the length of the ssDNA gap, 3 ’-flap structures would be generated when 
the displaced invading strand re-anneals to the original DNA filament (Figure 
1.3, step i). These 3’-flap structures could be efficiently cleaved by Mus81/ 
Eme1(Mms4) (Figure 1.3, step j) (Fabre et al., 2002), as indicated by in vitro 
experiments (Kaliraman et al., 2001; Whitby et al., 2003). The involvement of 
Mus81 in the Srs2-dependent SDSA pathway has been suggested by the 
epistatic relationship between srs2 and mus81 after UV radiation (Doe and 
Whitby, 2004).
Mus81 and Srs2, instead, do not appear to function in the same pathway 
in the repair of replication forks collapsed at CPT-induced SSBs, as indicated by 
the hypersensitivity to CPT of mus81 srs2 cells compared to either mus81 or 
srs2 mutants (Doe and Whitby, 2004). The exquisite sensitivity of mus81 to 
CPT indicates that Mus81 has an important role in repairing collapsed forks 
(Bastin-Shanower et al., 2003; Doe et al., 2002; Kai et al., 2005). In S. pombe 
collapsed forks can be repaired by mechansims dependent or independent of 
Rhp51 (S. pombe Rad51 orthologue) (Doe et al., 2004). Mus81 has been 
shown to function in the Rhp51-independent pathway, while Srs2 belongs to the 
Rhp51-dependent pathway (Doe et al., 2004; Doe and Whitby, 2004). It has 
been proposed that Mus81/Eme1 might restart the collapsed fork by cleaving a 
D-loop formed by Rad22 (S. pombe Rad52 orthologue) (Figure 1.4, steps e and 
f) (Doe et al., 2004). Instead, the repair of the collapsed fork by Srs2 might 
involve the formation of a D-loop by Rhp51 and subsequent HJ resolution
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(Figure 1.4, steps c and d) (Doe and Whitby, 2004). The differences between 
the two mechanisms are not yet defined.
MUS81 and Genomic Integrity in Mammals
In mammals, MUS8V/m mouse embryo fibroblasts (MEFs) and M U S 8 T human 
colon cancer HCT116 cell lines exhibit proliferation defects, due to the activation 
of the checkpoint kinases CHK1 and CHK2 and subsequent delay of the cell 
cycle (Dendouga et al., 2005; Hiyama et al., 2006). Consistent with the 
hypothesis that the checkpoint might be activated by spontaneous generation of 
DNA damage, MUS8Vf' MEFs accumulate chromosomal aberrations, including 
breaks, fusions, triradials (Dendouga et al., 2005). Other studies have reported 
equal numbers of chromosome abnormalities in both MUS81+/' and MUS8T/m 
activated T cells or MUS81+/' and MUS8V/_ HCT116 cell lines (Hiyama et al., 
2006; McPherson et al., 2004). Therefore inactivation of a single copy of 
MUS81 appears to be sufficient to cause genomic instability (McPherson et al.,
2004).
According to these data, MUS81+/' and MUS81'A mice were reported to 
develop tumours, in particular non-Hodgkin’s lymphomas, during the first year of 
life (McPherson et al., 2004). On the contrary, a second study demonstrated 
that MUS81+/' and MUS81V' mice are healthy and viable during the first 15 
months of life (Dendouga et al., 2005). The basis of this discrepancy is not 
clear. Although similar mouse strains were used in both studies, the distinct 
phenotypes might be due to different disruption strategy of the MUS81 gene. 
Future experiments are required to test whether MUS81 is a tumour suppressor 
gene.
MUS81 plays a role during normal DNA replication, as indicated by 
MUS81 accumulation during unperturbed S phase (Gao et al., 2003). The 
majority of MUS81 protein during normal conditions is retained in the nucleoli, 
where the repetitive rDNA is located (Gao et al., 2003). Following UV radiation, 
MUS81 is recruited to the site of UV lesions (Gao et al., 2003). Similarly, in HU-
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treated cells, MUS81 has been reported to co-localise in nuclear foci with BLM 
and RAD51 (Zhang et al., 2005). The interaction between MUS81 and BLM has 
been confirmed in vitro (Zhang et al., 2005).
Despite being recruited to site of replicative damage after HU treatment 
and UV radiation, mammalian MUS81 appears to be required exclusively for 
recovery from treatment with cross-linking agents, as indicated by the 
hypersensitivity of MUS8V/' cells to MMC and c/s-platin, but not to HU, UV and 
IR (Dendouga et al., 2005; Hiyama et al., 2006; McPherson et al., 2004). 
Moreover, in contrast to yeast mus81 cells, no sensitivity to CPT has been 
observed for mammalian MUS81'A cells (Dendouga et al., 2005). These data 
indicate that the primary role of mammalian MUS81 could be in ICL repair.
It has been proposed that MUS81 might promote the formation of 
crossover products during mitosis (Blais et al., 2004). In fact, depletion of 
MUS81 in human somatic cells was reported to induce a two-fold reduction of 
mitotic recombination. Similar to yeast cells, this recombination defect could be 
rescued by overexpression of RusA (Blais et al., 2004). However, human 
somatic cells possess the unknown Resolvase A, which is distinct from MUS81 
(Constantinou et al., 2002) and it has been shown to be associated with the 
RAD51 paralogs RAD51C and XRCC3 (Section 1.4) (Liu et al., 2004). It is 
therefore possible that Resolvase A might be primarily responsible for crossover 
formation in mitosis (and also in meiosis).
Taken together, these data suggest that mammalian MUS81 is required 
for the maintanance of genomic stability, during both normal cell growth and 
after treatment with cross-linking agents. Characterisation of the biochemical 
properties of human MUS81 has been hampered by the lack of obvious human 
orthologues of S. pombe Eme1 or S. cerevisiae Mms4.
In the work described in this thesis, we report the identification of two 
human othologues of S. pombe Eme1, which we named human EME1 and 
EME2. We showed that EME1 and EME2 interact with MUS81 and are novel 
members of the MUS81 family. The biochemical properties of MUS81/EME1 
and MUS81/EME2 complexes have been characterised. Moreover, we have
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identified two more human members of the MUS81 family, which we have 
called HEF and HIP. We demonstrate that HEF and HIP form a complex both in 
vitro and in vivo. Consistent with the recent identification of HEF as FANC-M, 
we show that HIP is a novel member of the Fanconi Anemia core complex.
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Materials and Methods
I. Enzymes A nd Reagents
2.1 Enzymes
Enzymes were purchased from the following companies:
New England Biolabs Inc. (NEB): restriction enzymes, T4 polynucleotide 
kinase, T4 DNA ligase 
Sigma Aldrich: Proteinase K
2.2 REAGENTS
Reagents were obtained from Sigma or BDH unless indicated otherwise. Other 
materials were obtained as follows: radiolabelled reagents, ECL western 
blotting detection reagents, GST-sepharose 4 Fast Flow, HiPrep 16/60 
Sephracryl S-200 HR gel filtration column, HiTrap chelating and Heparin 
columns, Thrombin (Amersham); Talon metal affinity resin (BD bioscience); 
Bradford reagent, bromophenol blue, xylene cyanol, ammonium persulfate and 
30% acrylamide solution (Biorad); ethidium bromide (International 
Biotechnologies Inc.); Cellfectin, Mark 12 Unstained Standard, NuPAGE 4-12%  
Bis-Tris gradient gels, SeeBlue Plus2 Pre-Stained Standard, ProQuest HeLa 
Cell cDNA library, ProQuest Human Fetal Brain cDNA library and Superscript 
Human Testis cDNA library (Invitrogen); Biomax MR and X-Omat films (Kodak); 
urea (MP Biomedicals); 10x BugBuster (Novagen); Imject Maleimide Activated 
KeyHole Limpet Hemocyanin (KLH), ImmunoPure gentle Ag/Ab elution buffer, 
Snakeskin dialysis bag and SulfoLink kit (Pierce); Nickel-NTA Agarose 
(Qiagen); complete EDTA-free protease inhibitor cocktail (Roche); anti-ERCC1 
FL-297 polyclonal antibody (Santa Cruz); BA85 cellulose-nitrate membrane 
(Schleicher and Schuell); anti-FLAG M2 mouse monoclonal antibody and anti- 
FLAG M2 Affinity Gel Resin (Sigma).
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2.3 BUFFERS AND SOLUTIONS
2.3.1 MEDIA AND PROTEIN BUFFERS 
Blocking buffer: 4% (w/v) milk in PBS
Coomassie blue staining solution: 40% (v/v) methanol, 10% (v/v) glacial 
acetic acid, 0.1% (w/v) Coomassie brilliant blue
Denaturing lysis buffer: 100 mM sodium phosphate pH 7.0, 10% (v/v) 
glycerol, 8 M urea
Destaining solution: 40% (v/v) methanol, 10% (v/v) glacial acetic acid 
Developing solution: 2% (w/v) sodium carbonate, 0.04% (v/v) formaldehyde 
FLAG buffer: 50 mM Tris-HCI pH 7.5, 10% (v/v) glycerol, 0.1% (v/v) NP40, 0.5 
mM EDTA
GST buffer: 50 mM Tris-HCI pH 7.5, 10% (v/v) glycerol, 0.5% (v/v) triton X-100, 
500 mM KCI, 1 mM DTT, 1 mM EDTA
Heparin buffer: 50 mM Tris-HCI pH 7.5, 10% (v/v) glycerol, 0.1% (v/v) triton X- 
100, 1 mM EDTA, 1 mM DTT
Insect cell medium: Grace’s medium supplemented with 3.3 g/l TC-yeastolate,
3.3 g/l TC-lactalbumin, 10% (v/v) heat inactivated fetal calf serum and 1% (v/v) 
antibiotic/antimycotic solution
Luria broth: 1% (w/v) bactotryptone, 0.5% (w/v) yeast extract, 0.05% (w/v) 
NaCI
Lysis buffer: 50 mM Tris-HCI pH 7.5, 10% (v/v) glycerol, 0.5 mM EDTA 
Nickel buffer: 50 mM Tris-HCI pH 7.5, 10% (v/v) glycerol, 0.5% (v/v) triton, 500 
mM KCI, 1 mM p-mercaptoethanol
PBS: 140 mM NaCI, 3.4 mM KCI, 10 mM Na2HP04, 18 mM KH2PO4 
Phosphate buffer: 50 mM sodium phosphate pH 7.0, 0.01% (v/v) NP40 and 
10% (v/v) glycerol
SDS gel buffer A (2x): 750 mM Tris-NaOH (pH 8.8), 0.2% (w/v) SDS 
SDS gel buffer B (2x): 250 mM Tris-HCI (pH 6.8), 0.2% (w/v) SDS 
SDS sample buffer (4x): 125 mM Tris-HCI (pH 6.8), 10% (v/v) glycerol, 2% 
(w/v) SDS, 0.01% (w/v) bromphenol blue,10% (v/v) p-mercaptoethanol
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Storage buffer: phosphate buffer containing 0.1 M NaCI, 1 mM DTT and 0.5 
mM EDTA
SDS gel running buffer: 25 mM Tris base, 190 mM glycine, 1 mg/ml SDS 
SulfoLink coupling buffer: 50 mM Tris-NaOH (pH 8.5), 5 mM EDTA 
SulfoLink wash buffer: 1 M NaCI, 0.05% NaN3 
Transfer buffer: 25 mM Tris base, 190 mM glycine, 20% (v/v) methanol
2.3.2 DNA BUFFERS:
Formamide loading buffer: 80% (v/v) deionised formamide, 89 mM Tris base, 
89 mM boric acid, 2 mM EDTA, 0.2% (w/v) bromophenol blue, 0.2% (w/v) 
xylene cyanol
Sample loading buffer (5x): 50 mM Tris-HCI (pH 8.0), 50 % (v/v) glycerol, 1 
mg/ml bromophenol blue
Stains-all solution: 20% (v/v) isopropanol, 10% (v/v) formamide, 0.01% (w/v) 
Stains-all
TAE buffer: 40 mM Tris base, 1.1% (v/v) glacial acetic acid, 1mM EDTA
TBE buffer: 89 mM Tris base, 89 mM boric acid, 2 mM EDTA
TE: 10 mM Tris-HCI (pH 8.0), 1 mM EDTA
TNM buffer: 10 mM Tris-HCI (pH 8.0), 50 mM NaCI, 10 mM MgCI2
2.3.3 Enzyme b u ffe rs :
Cleavage buffer: 60 mM sodium phosphate (pH 7.4), 5 mM MgCl2, 1 mM DTT, 
100 ng/ml BSA
Stop buffer (5x): 2% (w/v) SDS, 10 mg/ml Proteinase K
2.4 Ba c t e r ia l  St r a in s
E  coli competent cells XL1-Blue cells (Stratagene) were used for DNA cloning. 
E  coli competent cells DH10BAC (Invitrogen), which contain a baculovirus 
shuttle vector, also known as bacmid, were used to generate recombinant 
baculovirus DNA, as described in Section 2.23.
E. coli competent cells BL21-CodonPlus (DE3)-RIL (Stratagene), BL21- 
CodonPlus (DE3)-PR (Stratagene) and E  coli STL5827 BL21-(DE3)-Exol'
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Endol' were used for protein expression. E  coli STL5827 BL21-(DE3)-Exol‘ 
Endol' strain was a gift of Bob Lloyd.
2.5 DNA OLIGONUCLEOTIDES 
TABLE 2.1: List of DNA oligonucleotides
1 )  5 c a t c a t g c c a t g g c t c a c c a t c a c c a c c a t c a c c a t c a t c a c c a c g g c g g c c t g g a a g t t c t g t t c c a g g g
GCCCCATATG TCGCATGGTGGTGGAAAGGAGGTCT3
2 )  5’c a t a t a a g a a t g c g g c c g c g c t a g c g g t a c c t t a c t t g t c a t c g t c g t c c t t g t a g t c t c c t c c g g g c c c c
TGGAACAGAACTTCCAGTATATCAGATTTCAGTCTATCTTGGTTAAGATCATTTG3
3) 5 c a t a t a a g a a t g c g g c c g c g c t a g c g g t a c c t t a t t t t t c g a a c t g c g g g t g g c t c c a a g c g c t g g g c c c c
TGGAACAGAACTTCCAGTATATCAGATTTCAGTCTATCTTGGTTAAGATCATTTG3
4) 5 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCATATGAGCGGACGGCAAAGA3’
5) 5 CATCATCCGCTCGAGTTATTTACCATCCCTATAGGAAA3
6 )  5 CATGGGAATTCATCGATGGTACCAAGCTTC3
7) 5 g g a a t t c c a t a t g g c t c t a a a g a a g t c a t c a c c c 3
8 )  5 c a t c c c a a g c t t t c a g t c a g c a c t a t c t a a a g a g a g 3
9) 5 g g g g a c a a g t t t g t a c a a a a a a g c a g g c t t c c a t a t g g c g c g g g t t g g a c 3 
10 
11 
12
13
14
15
16
17
18
19
20 
21 
22
23
24
25
26
27
28
29
30
5 g g g g a c c a c t t t g t a c a a g a a a g c t g g g t a a a g c t t t c a g g a g c c c a g g t c c a g 3
5 GG AATTCCATATGG ACCCTGGGAAGGAC3
5 c a t c c c a a g c t t t c a g g g t a c t t t c a a g a a g g g 3
5 g g g g a c a a g t t t g t a c a a a a a a g c a g g c t t c c a t a t g g a a a a g a a c c c c c c t g 3
5 g g g g a c c a c t t t g t a c a a g a a a g c t g g g t a a a g c t t t c a c c t g g g c t g t g t g a a g 3
5 c a t c a t g a a t t c t g g a t c c a t g g a a a a g a a c c c c c c t g 3
5 c a t c a t g g a t c c g c g g c c g c t c a c c t g g g c t g t g t g a a g 3
5 ATGGCGCGGGTTGGAC3
5 TCAGGAGCCCAGGTCCA3’
5 g g g g a c a a g t t t g t a c a a a a a a g c a g g c t t c c a t a t g g g a t c c t t a g c a a a g c a g a g c a a a c a g a 3
5 g g g g a c c a c t t t g t a c a a g a a a g c t g g g t a g c g g c c g c c t c g a g t t a t a t a t c a g a t t t c a g t c t a t c t t 3’
5 CATGAATTCTAATGGCGGCCCCGGTCCG3
5 c a t g g a t c c c t c g a g t c a g g t c a a g g g g c c g t a g c 3
5’c a t c g g a a t t c t a c a a c g c t a t c t c a c t g c t t t g 3
5’c a t c a t c c g c t c g a g t c a c t t t t t c c c t t t t c c t t t t g 3’
5’g g g g a c a a g t t t g t a c a a a a a a g c a g g c t t c a t g g c t c t a a a g a a g t c a t c a c c c 3
5 g g g g a c c a c t t t g t a c a a g a a a g c t g g g t a t c a g t c a g c a c t a t c t a a a g a g a g 3
5 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCATATGCCCACAGCAGGGCTG3 
5 GGGGACCACTTTGTACAAGAAAGCTGGGTAAAGCTTTCAGGAGCCCAGGTCCAGC3
5 g g g g a c a a g t t t g t a c a a a a a a g c a g g c t t c a t g g c g g c c c c g g t c c g 3
5 g g g g a c c a c t t t g t a c a a g a a a g c t g g g t a t c a g g t c a a g g g g c c g t a g c 3
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2.6 PLASMIDS
TABLE 2.2: List of plasmids constructed
PLASMID DESCRIPTION
PDEST8-iohisHEF Gateway vector for baculovirus expression 
generated by Gateway recombination 
between pDEST8 (Invitrogen) and pENTR4- 
iohisHEF
PDEST8-iohisHEFflag Gateway vector for baculovirus expression 
generated by Gateway recombination 
between pDEST8 (Invitrogen) and pENTR4-
iohisHEFflag
PDEST8-iohisHEFstrep Gateway vector for baculovirus expression 
generated by Gateway recombination 
between pDEST8 (Invitrogen) and pENTR4- 
iohisHEFstrep
pDEST 1 5-gstMUS81 Gateway vector for E. coli expression 
generated by Gateway recombination 
between pDEST15 (Invitrogen) and p221- 
MUS81
pDEST 1 7-hisEME1 Gateway vector for E. coli expression 
generated by Gateway recombination 
between pDEST17 (Invitrogen) and p221- 
EME1
pDEST 1 7-hisMUS81 Gateway vector for E. coli expression 
generated by Gateway recombination 
between pDEST17 (Invitrogen) and p221- 
MUS81
pENTR4-1 OHIS-FLAG Gateway entry vector obtained by inserting 
into the Nco I and Not I sites of pENTR4 
(Invitrogen) a PCR fragment (amplified with
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DNA oligonucleotides 1 and 2 described in 
Table 2.1) coding for amino acids 1859-2048 
of HEF in frame with a N-terminus 10HIS tag 
and a C-terminus FLAG tag (Figure 5.3)
pENTR4-1 OHIS-STREP Gateway entry vector obtained by inserting 
into the Nco I and Not I sites of pENTR4 
(Invitrogen) a PCR fragment (amplified with 
DNA oligonucleotides 1 and 3 described in 
Table 2.1) coding for amino acids 1859-2048 
of HEF in frame with a N-terminus 10HIS tag 
and a C-terminus Strep tag
pENTR4-iomsHEF Gateway entry vector obtained by cloning 
HEF (Nco I and Not I cut from pET16b-HEF) 
into the Nco I and Not I sites of pENTR4 
(Invitrogen)
PENTR4-iohisHEFflag Gateway entry vector obtained by inserting a 
fragment coding for amino acids 1-2018 of 
HEF from pET16b-HEF (Nde I and Bgl II 
digested) into the Nde I and Bgl II sites of 
pENTR4-1 OHIS-FLAG (Figure 5.3)
PENTR4- iohisHEFstrep Gateway entry vector obtained by inserting a 
fragment coding for amino acids 1-2018 of 
HEF from pET16b-HEF (Nde I and Bgl II 
digested) into the Nde I and Bgl II sites of 
pENTR4-1 OHIS-STREP
pET16b-HEF E. coli expression vector generated by 
cloning HEF from Origene clone TC125463 
(Sac II and Not I digested) into the Sac II and 
Not I sites of pET 16b- HEF.,.^
pET 16b-HEF ^ ggg E  coli expression vector generated by 
cloning a fragment coding for amino acids 1- 
669 of HEF (PCR amplified from the IMAGE
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clone 5270515 with DNA oligonucleotides 4 
and 5 described in Table 2.1) into the Nde I 
and Xho I sites of pET16b (Novagen). The 
Not I site was introduced before Xho I
pET21d-linker E  coli expression vector generated by 
introducing a polylinker (DNA oligonucleotide 
6 described in Table 2.1) into the Nco I and 
Xho I sites (Figure 3.4) of pET21 (Novagen)
pET21d-MUS81/HisEME1 Bicistronic vector for E  coli expression 
constructed by inserting an EcoR \-Hind III 
fragment encoding MUS81/hisEME1 from 
pGex-GSTMUS81/HisEME1 into the EcoR I 
and Hindi III sites of pET21d-linker (Figure 
3.4)
pET21d-MUS81/HisEME2 Bicistronic vector for E. coli expression 
constructed by inserting an EcoR \-Hind III 
fragment encoding MUS81/hisEME2 from 
pGex-GSTMUS81/HisEME2 into the EcoR I 
and Hind III sites of pET21d-linker
pET28-EME1 E. coli expression vector generated by 
cloning EME1 (PCR amplified from IMAGE 
clone 2899969 with DNA oligonucleotides 7 
and 8 described in Table 2.1) into the Nde I 
and Hind III of pET28 (Novagen)
pET28-EME2 E  coli expression vector generated by 
cloning EME2 (PCR amplified from pGEMT- 
EME2_HeLa with DNA oligonucleotides 9 
and 10 described in Table 2.1) into the Nde I 
and Hind III of pET28 (Novagen)
pET28-ERCCl E. coli expression vector generated by 
cloning ERCC1 (PCR amplified from 
Invitrogen SUPERSCRIPT Human testis
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cDNA library with DNA oligonucleotides 11 
and 12 described in Table 2.1) into the Nde I 
and Hind III of pET28 (Novagen)
pET28-HIP E. coli expression vector generated by 
cloning HIP (PCR amplified from the IMAGE 
clone 3609326 with DNA oligonucleotides 13 
and 14 described in Table 2.1) into the Nde I 
and Hind III of pET28 (Novagen)
pFAST-BAC-DUAL-
iohisH EFflag/H IP
Bicistronic vector for baculovirus expression 
generated by cloning HIP (PCR amplified 
from IMAGE clone 3609326 with DNA 
oligonucleotides 15 and 16 described in 
Table 2.1) into the BarrM I and Not I sites of 
pFAST-BAC-DUAL (Invitrogen), followed by 
the insertion of HEF (Nco I and Kpn I cut from 
PENTR4-iohisHEFflag) into the Nco I and 
Kpn I sites (Figure 5.5).
pGEMT-EME2_HeLa Cloning vector constructed by inserting 
EME2_HeLa (PCR amplified from Invitrogen 
ProQuest HeLa Cell cDNA library with DNA 
oligonucleotides 17 and 18 described in 
Table 2.1) into TT overhangs of pGEMT 
(Promega)
pGEMT-EME2_testis Cloning vector constructed by inserting 
EME2_testis (PCR amplified from Invitrogen 
Superscript Human Testis cDNA library with 
DNA oligonucleotides 17 and 18 described in 
Table 2.1) into TT overhangs of pGEMT 
(Promega)
pGex-BICIS-HIS Bicistronic vector for E. coli co-expression of 
one GST-tagged and one HIS-tagged protein 
(Figure 3.2). Gift from Frank Uhlmann
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(CRUK, LIF)
pGex-GSTHEF 1727-2048 Bicistronic vector for E  coli expression 
constructed by cloning HEF1727_2048 (fragment 
coding for amino acids 1727-2048 of HEF, 
PCR amplified from Origene clone TC125463 
with DNA oligonucleotides 19 and 20 
described in Table 2.1) into the BamH I and 
Xho I sites of pGex-BICIS-HIS
pGex-GSTHEF 1727-2048  ^
hisEMEI
Bicistronic vector for E  coli expression 
generated by cloning EME1 (Nde I and Not I 
cut from pET28-EME1) into the Nde I and Not 
I sites of pGex-GSTHEF1727_2048
pGex-GSTHEF 1727-2048  ^
hisEME2
Bicistronic vector for E  coli expression 
generated by cloning EME2 (Nde I and Not I 
cut from pET28-EME2) into the Nde I and Not 
I sites of pGex-GSTHEF1727_2048
pGex-GSTHEF 1727-2048  ^
hisERCCI
Bicistronic vector for E  coli expression 
generated by cloning ERCC1 (Nde I and Not I 
cut from pET28-ERCC1) into the Nde I and 
Not I sites of pGex-GSTHEF!727.2048
pGex-GSTHEF1727.2048/ hisHIP Bicistronic vector for E  coli expression 
generated by cloning HIP (Nde I and Not I cut 
from pET28-HIP) into the Nde I and Not I 
sites of pGex-GSTHEF1727_2048
pGex-GSTMUS81 Bicistronic vector for E  coli expression 
constructed by cloning MUS81 (PCR 
amplified from the IMAGE clone 4135990 
with DNA oligonucleotides 21 and 22 
described in Table 2.1) into the EcoR I and 
Xho I sites of pGEX-BICIS-HIS (Figure 3.2)
pGex-GSTMUS81 /hisEMEI Bicistronic vector for E  coli expression
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generated by cloning EME1 (PCR amplified 
from the IMAGE clone 2899969 with DNA 
oligonucleotides 7 and 8 described in Table 
2.1) into the Nde I and Hind III sites of pGex- 
gstMUS81 (Figure 3.2)
pGex-GSTMUS81 /hisEME2 Bicistronic vector for E  coli expression 
generated by cloning EME2 (Nde I and Hind 
III cut from pET28-EME2) into the Nde I and 
Hind III sites of pGex-GSTMUS81
pGex-GSTMUS81/
HisEME2_predicted
Bicistronic vector for E  coli expression 
generated by cloning EME2_predicted (Nde I 
and Hind III cut from p221-EME2_predicted) 
into the Nde I and Hind III sites of pGex- 
gstMUS81
pGex-GSTMUS81 /hisERCCI Bicistronic vector for E. coli expression 
generated by cloning ERCC1 (Nde I and Not I 
cut from pET28-ERCC1) into the Nde I and 
Not I sites of pGex-GSTMUS81
pGex-GSTMUS81/HisHIP Bicistronic vector for E. coli expression 
generated by cloning HIP (Nde I and Not I cut 
from pET28-HIP) into the Nde I and Not I 
sites of pGex-GSTMUS81
pGex-GSTXPF606.905 Bicistronic vector for E  coli expression 
constructed by cloning XPFg^gog (fragment 
coding for amino acids 606-905 of XPF, PCR 
amplified from Invitrogen SUPERSCRIPT 
human testis cDNA library with DNA 
oligonucleotides 23 and 24 described in 
Table 2.1) into the EcoR I and Xho I sites of 
pGEX-BICIS-HIS
pGex-GSTXPF606_905/HisEME1 Bicistronic vector for E. coli expression 
generated by cloning EME1 (Nde I and Not I
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cut from pET28-EME1) into the Nde I and Not 
I sites of pGex- gstXPF606_905
pGex-GSTXPF606_905/HisEME2 Bicistronic vector for E. coli expression 
generated by cloning EME2 (Nde I and Not I 
cut from pET28-EME2) into the Nde I and Not 
I sites of pGex- GSTXPF606.905
pGex-GSTXPF606.905/
hisER C C I
Bicistronic vector for E. coli expression 
generated by cloning ERCC1 (Nde I and Not I 
cut from pET28-ERCC1) into the Nde I and 
Not I sites of pGex- GSTXPF606.905
pGex-GSTXPF606.905/
hisHIP
Bicistronic vector for E. coli expression 
generated by cloning HIP (Nde I and Not I cut 
from pET28-HIP) into the Nde I and Not I 
sites of pGex- GSTXPFgQg.905
p221-EME1 Gateway entry vector obtained by inserting 
through Gateway recombination EME1 (PCR 
amplified from the IMAGE clone 2899969 
with DNA oligonucleotides 25 and 26 
described in Table 2.1) into p221 (Invitrogen)
p221 -EME2_predicted Gateway entry vector obtained by inserting 
through Gateway recombination 
EME2_predicted (PCR amplified from the 
cDNA # AK074080 with DNA 
oligonucleotides 27 and 28 described in 
Table 2.1) into p221 (Invitrogen)
p221-MUS81 Gateway entry vector obtained by inserting 
through Gateway recombination MUS81 
(PCR amplified from the IMAGE clone 
4135990 with DNA oligonucleotides 29 and 
30 described in Table 2.1) into p221 
(Invitrogen)
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II. G el Electrophoresis
2.7 SDS-PAGE
Gels were prepared according to the Laemmli procedure (Laemmli, 1970). 
Running gels typically contained 10 or 12% polyacrylamide, supplied as a 30% 
stock (29:1 acrylamide : bisacrylamide ratio; Section 2.2) and 1x SDS gel buffer 
A (Section 2.3.1). Stacking gels contained 4% polyacrylamide and 1x SDS gel 
buffer B (Section 2.3.1). Polymerisation was induced by addition of 0.1% (w/v) 
ammonium persulfate and 0.1% (v/v) TEMED. Protein samples were prepared 
by adding 1/3 volume of SDS sample buffer (4x; Section 2.3.1) and were boiled 
for 3 minutes before gel loading. Gel electrophoresis was performed in SDS gel 
running buffer (Section 2.3.1) at 150 V for 90 minutes (Mini PROTEAN II) or 200 
V for 2 hours (20 x 12 cm Cambridge gel apparatus). Proteins were visualized 
by western blotting, Coomassie blue staining or silver staining (Sections 2.18,
2.19 and 2.22).
2.8 A g a ro s e  G e l E le c tro p h o re s is
Gels were prepared in ANACHEM Mini Cell gel trays and contained 0.8-1%  
(w/v) agarose in TAE buffer (Section 2.3.2). Approximately 1/4 volume sample 
loading buffer (5x; Section 2.3.2) was added to samples and gels were run in 
TAE at 7 V/cm. DNA samples were visualised by staining with 0.5 jxg/ml 
ethidium bromide (Sharp et al., 1973). Stained gels were imaged and 
photographed using a digital camera on a BIORAD GelDoc 2000 setup.
2.9 NEUTRAL PAGE
Gels were prepared using a BIORAD PROTEAN II gel apparatus or Cambridge 
gel apparatus and contained 10% polyacrylamide (acrylamide/bisacrylamide 
19:1) in TBE buffer (Section 2.3.2). Samples were supplemented with sample 
loading buffer (5x) and gels were run in TBE at 150 V for 2 hours. Gels were 
dried onto 3MM filter paper (Whatman) and ^P-labelled DNA was detected by 
autoradiography (Section 2.11).
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2.10 DENATURING PAGE
Gels were prepared in a BIORAD Sequi-Gen nucleic acid sequencing apparatus 
(21 x 50 cm) and contained 7 M urea and 10% polyacrylamide (acrylamide/bis- 
acrylamide 19:1) in TBE buffer. Samples were resuspended in formamide 
loading buffer (Section 2.3.2) and boiled for 3 minutes before gel loading. Gels 
were preheated to 50°C, and run in TBE buffer for 2 hours at 65 W. Gels were 
dried onto 3MM filter paper (Whatman) and ^P-labelled DNA was detected by 
autoradiography (Section 2.11).
2.11 AUTORADIOGRAPHY
Dried agarose or polyacrylamide gels were exposed to Biomax MR films 
(Section 2.2). Intensifying screens were used at -80°C when necessary. Films 
were developed using an IGP Compact2 X-ray film processor.
2.12 PHOSPHORIMAGER ANALYSIS
Dried gels plates were exposed to Molecular Dynamics storage phosphor 
screens up to 12 hours. Screens were analysed on a Molecular Dynamics 
Phosphorlmager (model 425E) and ImageQuant software.
III. G eneral M ethods of D na Manipulation
2.13 DNA CONCENTRATION DETERMINATION
DNA concentrations were determined by measuring the absorbance at 260 nm 
using quartz cuvettes and a UltroSpec 2000 Spectrophotometer (Pharmacia). 
Calculations were based on the assumption that the absorbance at 260 nm 
equals 1 (A260=1) for a solution of 36 ^g/ml single-stranded or 50 i^g/ml duplex 
DNA.
2.14 SOLVENT EXTRACTION
Samples were mixed with an equal volume of solvent, mixed thoroughly and the
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phases were separated by low speed centrifugation. The aqueous phase was 
retained for further processing. Solvents used were phenol and chloroform 
(supplemented with 1/25 volume of isoamyl alcohol).
2.15 ETHANOL PRECIPITATION
DNA samples were mixed with 1/10 volume of 3 M sodium acetate (pH 7.0) and
2.6 volumes of ethanol. After 30 minutes in dry ice, precipitated DNA was 
collected by centrifugation. The DNA pellet was washed with 70% ethanol, air- 
dried and resuspended in TE buffer (pH 8.0; Section 2.3.2).
IV. G eneral M ethods of Protein 
Manipulation
2.16 PROTEIN CONCENTRATION DETERMINATION
Protein concentrations were determined by the Bradford method (Bradford, 
1976). The Bradford reagent was diluted 5-fold with ddH20  and 5 to 10 \i\ of 
protein were added. The colour was allowed to develop for 10 minutes at room 
temperature. The absorbance at 595 nm was then measured and it was 
compared to a standard curve obtained with known concentrations of BSA.
2.17 MOLECULAR WEIGHT STANDARDS
Molecular weight Mark 12 Unstained Standard and SeeBlue Plus2 Pre-Stained 
Standard were used (Section 2.2). Mark 12 Unstained Standard contains 
myosin (200 kDa), p-galactosidase (116 kDa), phosphorylase (97 kDa), BSA 
(66 kDa), glutamic dehydrogenase (55 kDa), lactate dehydrogenase (36 kDa), 
carbonic anhydrase (31 kDa), tripsin inhibitor (21 kDa) and lysozyme (14 kDa). 
SeeBlue Plus2 Pre-Stained Standard was used as a guideline for SDS-PAGE 
and western blotting. Approximate molecular weights are: myosin (250 kDa), 
phosphorylase (148 kDa), BSA (98 kDa), glutamic dehydrogenase (64 kDa),
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alcohol dehydrogenase (50 kDa), carbonic anhydrase (36 kDa) and myoglobin 
red (30 kDa).
2.18 C o o m a s s ie  b l u e  s t a in in g
After SDS-PAGE, gels were soaked overnight in Coomassie blue staining 
solution (Section 2.3.1). Gels were then destained with 5-6 washes in 
destaining solution (Section 2.3.1) and subsequently dried between two sheets 
of cellophane with GelAir Dryer (Biorad).
2.19 S i lv e r  S ta in in g
Silver staining was performed as described (Shevchenko et al., 1996). After 
electrophoresis, gels were fixed overnight in 100 ml 40% (v/v) ethanol and 10% 
(v/v) acetic acid. Gels were then soaked for 10 minutes in 100 ml 50% (v/v) 
methanol and for 10 minutes in 100 ml ddH20 . Gels were sensitised by 1 
minute incubation in 100 ml 0.02% (w/v) sodium thiosulfate and, after 2 washes 
with ddH20 , were incubated in 50 ml 0.1 % (w/v) silver nitrate for 20 minutes at 
4°C. Gels were subsequently rinsed in ddH20  and developed in 50 ml 
developing solution (Section 2.3.1). Incubation was continued until the bands 
had reached the desired intensity. After discarding the developing solution, gels 
were stored in 1% (v/v) acetic acid at 4°C until they were dried between two 
sheets of cellophane with GelAir Dryer.
2.20 G e n e ra tio n  o f  m o n o c lo n a l and p o ly c lo n a l  A ntibodies
a) Mouse Monoclonal Antibodies
Recombinant hisMUS81 and hisEM E I were purified under denaturing 
conditions from E. coli (Sections 2.27 and 2.29). Four protein aliquots (50 ^g 
each) were diluted to 300 1^ with PBS to immunise mice (two per antigen). Mice 
test bleeds received after 3 months were assayed by western blotting (Section 
2.22) on hisMUS81 or hisE M E I and on HeLa extract. Spleen tissue was then 
removed from mice showing positive by western blotting, and hybridoma cells 
were generated from single antibody producing cells. The hybridomas were 
then screened by western blotting on hisMUS81 or hisEM EI and on HeLa
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extract, positive clones were expanded, and antibodies were purified using 
affinity chromatography. Anti-MUS81 antibody was designated MTA30 2G10 
and anti-EME1 antibody MTA31 7H2.
b) Rabbit Polyclonal Antibodies
Synthetic peptides for EME2 (amino acids 271-290) and HIP (amino acids 16- 
34) were generated. Peptides (1 mg) were cross-linked to 2 mg of Imject 
Maleimide Activated KeyHole Limpet Hemocyanin (KLH; Section 2.2) for 4 
hours at room temperature. Conjugated peptides-KLH were dialysed against 83 
mM sodium phosphate pH 7.0 and 450 mM NaCI for 1 hour at 4°C, aliquoted 
(200 fig  for the first aliquot, 100 fig  for 5 aliquots), and injected into a single 
rabbit. Test bleeds were assayed by western blotting against hisEME2 or 
hisHIP, and against HeLa extract. The final bleed was then used as a stock 
antibody. Anti-EME2271_290 antibody was designated SWE57 and anti-HIP16_34 
SWE92.
Recombinant hisHIP and GSTHEFi727.2048 were purified from E. coli 
(Sections 2.34 and 2.35, respectively). Six aliquots of 300 fig hisHIP or 
gstH E F1727.2048 were used to immunise one rabbit. The final bleed was used as 
stock antibody. Anti-GSTHEF^^.^g and anti-HisHIP antibodies were designated 
SWE98 and SWE94, respectively.
2.21 PURIFICATION OF POLYCLONAL ANTIBODIES
SWE57 anti-EME2 polyclonal antibody was purified using SulfoLink kit (Section 
2.2). EME2 peptide (amino acids 271-290; 5 mg) was dissolved in SulfoLink 
coupling buffer (Section 2.3.1). Peptide solution was added to a pre-packed 
column containing SulfoLink resin that immobilises any peptide containing 
cystein sulfhydryl groups (-SH). The column was then sealed and rotated 
overnight at 4°C. EME2 peptide was then dripped through the column followed 
by 8 ml wash with coupling buffer and L-cysteine (15.8 mg) to block non-specific 
binding to the resin. After adding 12 ml of SulfoLink wash buffer (Section 2.3.1), 
15 ml of SWE57 serum was loaded on the column. The flow-through was
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reloaded to the column 2 more times. The remaining flow-through (5 ml) was 
mixed with SulfoLink column resin overnight and applied to the column followed 
by 12 ml wash with coupling buffer. Bound antibody was eluted from the resin 
with 8 x 1 ml fractions of ImmunoPure gentle Ag/Ab elution buffer (Section 2.2). 
Fractions with highest OD280 readings were stored at -20°C and used for 
western blotting.
2.22 WESTERN BLOTTING
Protein samples were subjected to SDS-PAGE as described in Section 2.7 and 
transferred onto BA85 cellulose-nitrate membrane in transfer buffer (Section
2.3.1) at 100 V for 2 hours. Membranes were then incubated in blocking buffer 
for 30 minutes, followed by the addition of primary antibody diluted in blocking 
buffer. Primary antibodies used were: mouse monoclonal anti-MUS81 MTA30 
2G10 (1:1000), anti-EME1 MTA31 7H2 (1:1000) and anti-FLAG (1:1000; 
Section 2.2) or rabbit polyclonal purified anti-EME2 SWE57 (1:500), anti-HIP 
SWE92 and SWE94 (1:500), anti-GSTHEF1727_2048 SWE98 (1:500), anti-GST 
(1:1000) and anti-ERCC1 FL-297 (1:1000; Section 2.2). The anti-GST antibody 
was a gift of Tim Hunt. Incubation with the primary antibody was continued 
overnight and then membranes were washed 3 times with 0.05% Tween and 
PBS. Peroxidase-conjugated goat anti-mouse (for MTA30, MTA31 and anti- 
FLAG) or swine anti-rabbit (for purified SWE57, SWE92, SWE93, SWE98 and 
anti-GST) secondary antibody was then diluted 1:5000 in blocking buffer. After 
one hour incubation with secondary antibody, the blots were washed three 
times with 0.05% Tween and PBS. Following application of ECL western 
blotting detection reagents (Section 2.2) membranes were exposed to X-Omat 
film (Section 2.2) for 1 to 10 minutes.
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V. Baculovirus  and Insect  C ells
2.23 BACULOVIRUS PRODUCTION
E  co//DH10BAC cells (Section 2.4) were transformed with p DEST8- iohisHEF, 
PDEST8-iohisHEFflag, p DEST8- iohisHEFstrep or pFAST-BAC-DUAL-ioHisHEF 
flag/H IP (Section 2.6). Recombinant bacmids were generated by transposing a 
DNA fragment flanked by Transposon 7 (Tn7) sites (containing iohisHEF, 
iohisHEFflag, iohisHEFstrep or iohisHEFflag/H IP) into the mini Tn7 
attachment sites of the bacmid DNA. Clones were grown on LB plates with 
kanamycin (50 ng/ml), tetracycline (10 pg/ml), gentamicin (7 ^g/ml), IPTG (40 
ng/ml) and X-gal (100 ng/ml). Successful transposition generated white colonies 
(due to the disruption of the lacZgene in the bacmid DNA). DNA extracted from 
white colonies was amplified with one DNA primer annealing to the bacmid DNA 
and one to the HEF gene in order to verify the recombination of iohisHEF, 
iohisHEFflag, iohisHEFstrep or iohisHEFflag/H IP  into the bacmid DNA.
2.24 TRANSFECTION OF INSECT CELLS
Spodoptera frugiperda Sf9 cells were grown on 6 well plates (1 x 106 cells per 
well) with complete insect cell medium (Section 2.3.1). Bacmid DNA for 
iohisHEF, iohisHEFflag, iohisHEFstrep or iohisHEFflag/H IP (5 \ig) and lipid 
reagent Cellfectin (6 |xl; Section 2.2) were diluted separately in 100 \i\ of insect 
cell medium without serum. The 2 solutions were mixed and left 20 minutes at 
room temperature. The transfection solution, containing bacmid DNA and 
Cellfectin, was then added to Sf9 cells incubated in medium without serum. 
After 6 hours 2 ml of medium with serum were added. Cell medium containing 
baculovirus particles released from the insect cells was collected after 5 days 
(P1 viral stock).
2.25 AMPLIFICATION OF BACULOVIRUS
P1 stock (0.5 ml, approximately 1 x 106 plaque forming units or pfu) was used to 
infect a medium flask containing 20 ml of Sf9 cells (1 x 106 cells/ml). The
C hapter  T w o 100
medium was then collected after 7 days (P2 viral stock). P2 stock (2 ml) was 
amplified by infecting a large flask containing 100 ml of Sf9 cells (1 x 106 
cells/ml) and the medium was collected after 7 days (P3 viral stock). P3 stock 
was tested for protein expression by western blotting using antibodies raised 
against HEF and the FLAG tag (for iohisHEF, iohisHEFflag and 
iohisHEFstrep).
VI. Protein Purification
2.26 PURIFICATION OF hisMUS81
pDEST17-HisMUS81 (Section 2.6) was grown at 30°C in E. coli BL21- 
CodonPlus (DE3)-PR in LB medium supplemented of ampicillin (50 i^g/ml) to an 
ODgoo = 1, and expression was induced by addition of 10 IPTG. Growth was 
then continued for a further 3 hours. Cultures (1 litre) were collected by 
centrifugation and the pellet was resuspended in 50 ml of phosphate buffer 
(Section 2.3.1) containing 0.1 M NaCI and 1 tablet of complete EDTA-free 
protease inhibitor cocktail (Section 2.2). The cells were then lysed using a 
French press. The mixture was centrifuged for 1 hour at 35,000 rpm in a 
Beckman 45 Ti rotor, and the clear supernatant was loaded on a 5 ml 
phosphocellulose column equilibrated with the same buffer. Proteins were 
eluted using a 50 ml gradient of phosphate buffer containing 0.1 -  1.0 M NaCI 
and identified by SDS-PAGE. Peak fractions of hisMUS81 were pooled 
(approximately 40 ml) and mixed with 0.5 ml of Talon metal affinity resin 
(Section 2.2). After 2 hours at 4°C, the beads were washed with 5 ml of 
phosphate buffer containing 0.5 M NaCI and 25 mM imidazole. Bound proteins 
were then eluted with 4 x 0.5 ml washes with the same buffer containing 0.5 M 
imidazole. Eluted proteins were identified by SDS-PAGE, pooled and dialysed 
for 2 hours against 4 litres of storage buffer (Section 2.3.1) and frozen in 25 i^l 
aliquots at-80°C . The final hisMUS81 yield was 210 ng.
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2.27 PURIFICATION OF DENATURED hisMUS81
pDEST17-HisMUS81 (Section 2.6) was grown at 37°C in E  coli BL21- 
CodonPlus (DE3)-PR to an O D ^  = 0.6, and expression was induced by 
addition of 1 mM IPTG. Growth was then continued for a further 4 hours. 
Cultures (1 litre) were collected by centrifugation and resuspended in 20 ml of 
denaturing lysis buffer (Section 2.3.1). The cell lysate was sonicated 3 x 30 
seconds using a Soniprep 150 sonicator (Jencons) and then stirred at room 
temperature for 4 hours. After centrifugation for 1 hour at 35,000 rpm in a 
Beckman 70 Ti rotor, the cleared supernatant was collected and incubated with 
Talon metal affinity resin (1 ml) for 2 hours at room temperature. Bound 
hisMUS81 was eluted with SDS sample buffer and run on a single well 10% 
SDS-PAGE gel for 2 hours at 150 V in a Cambridge apparatus. Strips 
corresponding to both ends of the gel were cut and stained with Coomassie 
blue to visualise hisMUS81. After destaining, the strips were aligned to the 
unstained gel and the portion of the unstained gel matching with the position of 
hisMUS81 was cut into small pieces. hisMUS81 was then electro-eluted from 
the gel into a Snakeskin dialysis bag (Section 2.2) for 2 hours at 100 V in SDS 
gel running buffer with the addition of transfer buffer (0.5x). Eluted hisMUS81 
was divided in 50 \ig aliquots and used for mice immunisation (Section 2.20).
2.28 PURIFICATION OF hisEMEI
pDEST17-HisEME1 (Section 2.6) was grown at 30°C in E. coli BL21-CodonPlus 
(DE3)-PR in LB medium supplemented of ampicillin (50 p-g/ml) to an O D ^  = 1, 
and expression was induced by addition of 10 pM IPTG. Purification of hisEM E I 
was performed according to the protocol described in Section 2.26 for 
hisM US81. The final hisE M E I yield was 130 [xg.
2.29 PURIFICATION OF DENATURED hisEMEI
pDEST17-HisEME1 (Section 2.6) was grown at 37°C in E  coli BL21-CodonPlus 
(DE3J-PR to an O D ^  = 0.6, and expression was induced by addition of 1 mM 
IPTG. Growth was then continued for a further 4 hours. Purification of hisEM EI
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was performed according to the protocol described in Section 2.27 for 
hisMUS81 . Electro-eluted hisE M E I was divided in 50 p,g aliquots and used for 
mice imunisation (Section 2.20).
2.30 Pu r if ic a t io n  o f  &stmus8i
E. coli BL21-CodonPlus (DE3)-PR carrying p DEST15-gstMUS81 (Section 2.6; 
1 litre) were grown at 30°C to an an O D ^  = 1 and induced with 10 jaM IPTG for 
3 hours. Cell pellets were resuspended in 50 ml of phosphate buffer (Section
2.3.1) containing 0.1 M NaCI, 1 tablet of complete EDTA-free protease inhibitor 
cocktail and 1 mM DTT and lysed using a French press. Following high speed 
centrifugation, as described in Section 2.26, the supernatant was loaded on a 5 
ml phosphocellulose column and eluted using a 50 ml 0.1 -  1.0 M NaCI gradient 
in the same buffer. Peak fractions were identified by SDS-PAGE, pooled, and 
incubated with 0.5 ml of GST-sepharose 4 Fast Flow beads (Section 2.2) for 2 
hours at 4°C. The beads were washed with 5 ml of phosphate buffer containing 
0.3 M NaCI, and 1 mM DTT, and bound proteins were eluted with 4 washes of 
0.5 ml of the same buffer containing 20 mM glutathione. Proteins were identified 
by SDS-PAGE, pooled and dialysed for 2 hours against 4 litres of storage buffer 
and frozen in 25 y\ aliquots at -80°C. The final yield of gstMUS81 was 260 \ig.
2.31 PURIFICATION OF MUS81/hisEME1
E  coli BL21-CodonPlus (DE3)-PR carrying pET21d-MUS81/hisE M E I (Section 
2.6; 4 litres) were grown at 30°C to an an O D ^  = 1 and induced with 10 p,M 
IPTG for 3 hours. Cell pellet was resuspended in 100 ml of phosphate buffer 
(Section 2.3.1) containing 0.5 M NaCI and 2 tablets of complete EDTA-free 
protease inhibitor cocktail and lysed using a French press. After high speed 
centrifugation, the supernatant was loaded on a 10 ml phosphocellulose column 
and eluted using 100 ml 0.5 -  1.5 M NaCI gradient in the same buffer. Peak 
fractions were supplemented with 1.5 ml of Talon metal affinity resin and 
incubated for 2 hours at 4°C. The beads were then washed with 10 ml of 
phosphate buffer containing 50 mM imidazole and eluted with 4 x 1.5 ml of 
buffer containing 0.5 M imidazole. Proteins were identified by SDS-PAGE,
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pooled and dialysed for 2 hours against 4 litres of storage buffer and frozen in 
25 \i\ aliquots at -80  °C. The final yield of MUS81/hisEM EI was 215 p,g.
2.32 PURIFICATION OF MUS81/hisEME2
E. coli BL21 -CodonPlus (DE3)-PR carrying pET21d-MUS81/HisEME2 (Section 
2.6; 4 litres) were grown at 30°C to an an ODgoo = 1 and induced with 10 
IPTG for 3 hours. Purification of M US81/hisEME2 was performed according to 
the protocol described for MUS81 /hisEM EI in Section 2.31. The final yield of 
M U S81/hisEM E2 was 175 ^g.
2.33 PURIFICATION OF hisHIP
E  coli BL21-CodonPlus (DE3)-RIL carrying pET28-HisHIP (Section 2.6) were 
grown at 30°C to an O D ^  = 0.6 and were induced with 1 mM IPTG for 5 hours. 
The cell pellet (1 litre) was lysed in 10 ml Nickel buffer (Section 2.3.1) with the 
addition of 5 mM imidazole and 1/2 tablet of complete EDTA-free protease 
inhibitor cocktail. Cell lysate was supplemented with 1 ml of BugBuster (10x; 
Section 2.2) and 100mg of lysozyme. The mixture was incubated at 4°C for 3 
hours under constant agitation and then centrifuged for 1 hour at 35,000 rpm in 
a Beckman 70.1 Ti rotor. The clear supernatant was loaded onto a 1 ml HiTrap 
chelating column (Section 2.2) pre-charged with 0.1 M NiS04. After 20 column 
volumes (CV) wash with Nickel buffer containing 50 mM imidazole, the bound 
protein was eluted with 20 x 1 ml fractions of Nickel buffer containing 0.05 M -  1 
M imidazole gradient. Peak fractions of hisHIP were then pooled, diluted 1:10 in 
Heparin buffer (Section 2.3.1) containing 100 mM KCI and were loaded onto a 
1ml HiTrap Heparin column (Section 2.2). The column was washed with 20 CV 
of Heparin buffer with 200 mM KCI and hisHIP was eluted with 15 ml of Heparin 
buffer containing 1 M KCI. Eluted protein was identified by SDS-PAGE, pooled, 
dialysed for 2 hours against 4 litres of Heparin buffer with 200 mM KCI and 
frozen in 250 pJ aliquots at -80°C. The final yield of hisHIP was 1.5 mg.
2.34 PURIFICATION OF DENATURED hisHIP
E  coli BL21-CodonPlus (DE3)-RIL carrying pET28-HisHIP (1 litre) were grown
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at 30°C to an O D ^  = 0.6 and were induced with 1 mM IPTG for 5 hours. Cell 
pellet was lysed and clear supernatant was subjected to Nickel chromatography 
as indicated in Section 2.33. Peak fractions containing hisHIP were pooled and 
run on a single well 10% SDS-PAGE gel for 2 hours at 150 V in a Cambridge 
apparatus. hisHIP was then cut from the gel as described for hisMUS81 
(Section 2.27). Electro-elution was performed overnight using a Biotrap 
apparatus at 100 V in SDS gel running buffer with the addition of transfer buffer 
(0.5x). Eluted hisHIP was divided in 300 \ig aliquots and used for rabbit 
immunisation (Section 2.20).
2.35 PURIFICATION OF DENATURED gstHEF1727.2048
E. coli BL21-CodonPlus (DE3)-RIL carrying pGex-GSTHEF1727_2048/HisHIP 
(Section 2.6) were grown at 37°C to an O D ^  = 0.6 and induced with 50 
IPTG for 4 hours. For this experiment, the pGex-GSTHEF1727_2048/HisHIP plasmid 
was preferred to pGex-GSTHEF1727.2048 because of the higher solubility of 
gstH E F1727.2048 when in complex with hisHIP. The cell pellet (1 litre) was lysed 
in 20 ml GST buffer (Section 2.3.1) supplemented with 1 tablet of complete 
EDTA-free protease inhibitor cocktail, 2 ml of 10x BugBuster and 200 mg of 
lysozyme. The mixture was incubated at 4°C for 2 hours under agitation and 
centrifuged 1 hour at 35,000 rpm in a Beckman 70 Ti rotor. The clear 
supernatant was mixed with 0.5 ml of GST-sepharose 4 Fast Flow beads for 2 
hours at 4°C. Bound proteins were eluted with SDS sample buffer and were run 
on a single well 10% SDS-PAGE gel for 2 hours at 150 V in a Cambridge 
apparatus. gstH EF1727_2048 was then cut from the gel as described for 
hisMUS81 (Section 2.27). Electro-elution was performed as indicated for hisHIP 
in Section 2.34. The eluted gstH EF1727_2048 was divided in 300 \ig aliquots and 
used for rabbit immunisation (Section 2.20).
2.36 PURIFICATION OF iohisHEFflag
High Five cells (2 litres) were infected with 100 ml iohisHEFflag P3 viral stock 
(Section 2.25). High Five cells were preferred to Sf9 cells because of a higher
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expression level of iohisHEFflag. After 2 days of infection, cells were harvested 
and the cell pellet was resuspended in 6 ml of FLAG buffer (Section 2.3.1) 
supplemented with 1 tablet of complete EDTA free protease inhibitor cocktail. 
Cells were kept in ice for 10 minutes, and 6 ml of FLAG buffer containing 500 
mM KCI was added (the final KCI concentration was 250 mM). The cell mixture 
was then lysed with an “A” pestel (40 strokes) and sonicated 2 x 30 seconds 
using a Soniprep 150 sonicator. The whole cell extract was centrifuged for 1 
hour at 35,000 rpm in a Beckman 70 Ti rotor. The supernatant was collected 
and the pellet resuspended in 20 ml of FLAG buffer containing 500 mM KCI 
(supplemented with 1 tablet of complete EDTA-free protease inhibitor cocktail) 
to extract proteins bound to chromatin. Chromatin extraction was performed at 
4°C for 1 hour under constant agitation. After centrifugation, the supernatant 
from the chromatin extract was collected and pooled with the supernatant from 
the whole cell extract (the final KCI concentration in the extract was 
approximately 300 mM). Anti-FLAG M2 Affinity Gel Resin (750 p.l; Section 2.2) 
was mixed with the pooled supernatant overnight at 4°C. After washing with 5 x 
20 ml of FLAG buffer containing 300 mM KCI, proteins were released from 
beads with 5 x 750 pi elutions of FLAG buffer (without EDTA) supplemented 
with 0.5 mg/ml FLAG peptide (amino acid sequence DYKDDDDK). Each 
elution was continued for 1 hour under constant agitation. Peak fractions of 
iohisHEFflag were pooled and diluted 1:10 in Nickel buffer (Section 2.3.1) 
containing 5 mM imidazole. Pooled fractions were incubated with Nickel-NTA 
Agarose (300 pi; Section 2.2) overnight at 4°C and then poured into a Biorad 10 
ml disposable column. After 50 CV wash with Nickel buffer containing 30 mM 
imidazole, bound iohisH EFflag was eluted with 10 x 300 pi of Nickel buffer 
containing 0.5 M imidazole. Proteins were identified by western blotting against 
HEF (Section 2.22). Peak fractions were pooled, run on a NuPAGE 4-12% Bis- 
Tris gradient gel (Section 2.2) and silver stained (Section 2.19).
2.37 PURIFICATION OF iohisHEFflag/HIP
High Five cells (2 litres) were infected with 100 ml iohisHEFflag/H IP P3 viral 
stock (Section 2.25). Purification of -iohisHEFflag/H IP  was performed according
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to the protocol for the purification of ioh isH E Fflag  (Section 2.36). Proteins were 
identified by western blotting against HEF and HIP (Section 2.22). Peak 
fractions were pooled, run on a NuPAGE 4-12% Bis-Tris gradient gel and silver 
stained (Section 2.19).
2.38 Pu r if ic a t io n  o f  h e f1727.2048/hip
E. coli BL21-CodonPlus (DE3)-PR or E  CO//STL5827 BL21-(DE3)-Exol' Endol* 
carrying pGex-GSTHEF1727.2048/HisHIP (Section 2.6) were grown at 30°C to an 
an ODgoo = 0.6 and induced with 0.1 mM IPTG for 5 hours. The cell pellet (1 
litre) was lysed in 10 ml GST buffer (Section 2.3.1) supplemented with 1/2 tablet 
of complete EDTA-free protease inhibitor cocktail, 1 ml of 10x BugBuster and 
100 mg of lysozyme. The mixture was incubated at 4°C for 2 hours under 
agitation and centrifuged 1 hour at 35,000 rpm in a Beckman 70 Ti rotor. The 
clear supernatant was mixed with 0.5 ml of GST-sepharose 4 Fast Flow beads 
for 2 hours at 4°C. The beads were washed 6 x 10 ml washes with GST buffer 
and 2 x 10 ml with PBS. Proteins were eluted from the GST beads by the 
addition of 450 l^ of PBS with 50 units of Thrombin (Section 2.2). The cleavage 
reaction was incubated for 4 hours at 4°C. Two additional elutions were 
performed as before. Eluted fractions were pooled and injected onto a HiPrep 
16/60 Sephracryl S-200 HR gel filtration column (Section 2.2) equilibrated in 
GST buffer. Following the injection of the pooled fractions (1.5 ml) at 0.5 ml/min, 
120 ml (1 CV) of GST buffer were loaded on the column at 0.5 ml/min. The first 
40 fractions (2 ml each) were collected. Proteins were identified by SDS-PAGE, 
pooled and dialysed for 2 hours against 4 litres of storage buffer and frozen in 
200 \i\ aliquots at -80°C. The final protein yield was 120 from E. coli BL21-
CodonPlus (DE3)-PR or 50 fxg from E. coliSTL5827 BL21-(DE3)- Endol’ Exol'.
2.39 CO-PRECIPITATION ASSAYS FOR gstMUS81 /hisEMEI AND 
gstMUS81/hisEME2
E  coli BL21 -CodonPlus (DE3)-PR carrying pGex-GSTMUS81/hisEM E I or pGex- 
gstM U S81/hisEME2 (Section 2.6) were grown at 30°C to an an O D ^  = 1 and
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induced with 10 p,M IPTG for 3 hours. A cell-free extract (50 ml), prepared in 
phosphate buffer (Section 2.3.1) containing 0.5 M NaCI, was incubated with 0.5 
ml of beads (either GST-sepharose 4 Fast Flow or Talon metal affinity resin) for 
2 hours at 4°C and eluted with 4 x 0.5 ml of the same buffer supplemented 20 
mM glutathione or 0.5 M imidazole, respectively.
2.40 GST PULL-DOWNS FOR MUS81 FAMILY PROTEINS
E. coli BL21-CodonPlus (DE3)-RIL (100 ml) carrying pGex-GSTXPFgQg. 
905/hisEMEI, pGex-GSTXPF606_905/HisEME2, pGex-GSTXPF606_905/HisHIP, pGex- 
gstXPF606_905/hisERCC1 , pGex-GSTHEF1727.2048/HlsEME1 > pGex-GSTHEF1727_ 
2048/hisEME2, pGex-GSTHEF1727.2048/HisHIP, pGex-GSTHEF1727_2048/HisERCCl, 
pGex-GSTMUS81/hisE M E I, pGex-GSTMUS81/HisEME2, pGex-GSTMUS81/ 
hisHIP or pGex-GSTMUS81/HisERCC1 (Section 2.6) were grown at 37°C to an 
ODgoo = 0.3 and induced with 50 ^M IPTG for 7 hours at 25°C. Cell pellets were 
resuspended in 10 ml GST buffer (Section 2.3.1) supplemented with 1/2 tablet 
of complete EDTA-free protease inhibitor cocktail, 1 ml of 10x BugBuster and 
100 mg of lysozyme. The mixture was incubated for 2 hours at 4°C under 
agitation and then centrifuged for 30 minutes at 35,000 rpm in a Beckman 70.1 
Ti rotor. The supernatant was mixed with 200 \i\ GST-sepharose 4 Fast Flow 
beads. After 2 hours at 4°C, the beads were washed with 5 x 10 ml GST buffer, 
transferred to Eppendorf tubes and washed twice with PBS. The beads (50 \i\) 
were resuspended in SDS sample buffer and aliquots were run on a 10% SDS- 
PAGE gel to visualise protein complexes. The remaining beads were stored at 
-20°C.
2.41 MAMMALIAN CELL EXTRACT FRACTIONATION
Mammalian cell extracts were prepared from HeLa S3 cells and were a gift from 
Yilun Liu (Liu et al., 2004). Peak MonoQ fractions with either 3 ’-flap or Holliday 
junction resolution activity were used as positive controls in cleavage assays 
(Section 2.45). The fraction partially purified from HeLa having Holliday junction 
resolution activity was designated Resolvase A fraction (due to the presence of
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the unidentified Resolvase A (Constantinou et al., 2002)) and the 3 ’-flap fraction 
was called MUS81 fraction (because it contains MUS81). The Resolvase A 
fraction and the MUS81 fraction used in the experiments described in Chapter 3 
were a gift from Angelos Constantinou and were purified as described 
(Constantinou et al., 2002). The Resolvase A fraction and the MUS81 fraction 
used in the experiments described in Chapters 4 and 5 were a gift from Yilun 
Liu and were purified as described (Liu et al., 2004).
Small scale cell extracts were prepared from HeLa S3 cells (50 ml at 1 x 
106 cells/ml). The cell pellet was resuspended in one volume of lysis buffer 
(Section 2.3.1) in the presence of complete EDTA-free protease inhibitor 
cocktail, left on ice for 10 min and lysed by the addition of 0.1% NP40. The cell 
lysate was then vortexed for 30 sec and 0.5 volume of lysis buffer containing 
0.5 M KCI was added. After 30 min incubation at 4°C, cell mixture was 
centrifuged for 10 min at 14,000 rpm. The supernatant was retained and the 
pellet was resuspended in 2 volumes of lysis buffer containing 0.5 M KCI to 
extract nuclear proteins. After 1 hour at 4°C under agitation, nuclear extract was 
centrifuged for 10 min at 14,000 rpm and the supernatant was mixed with whole 
cell extract supernatant. The pooled supernatant (10 nl) was then used for 
western blotting using antibodies against EME2, HEF and HIP (Section 2.22).
VII. Preparation  of Dna S ubstrates  and  
C leavage  A ssays
2.42 G e l P u rif ic a tio n  o f  O lig o n u c le o tid e s
Oligonucleotides were purchased from SIGMA-Genosys. The dried pellet was 
resuspended in TE buffer to give a final concentration of 1 mg/ml. 
Approximately 100 ng of oligonucleotide was loaded on a 15% polyacrylamide 
denaturing gel that was run at 400 V for 2 hours. The gel was then stained 
using Stains-all solution (Section 2.3.2) for 15 minutes and destained in water 
for 20 minutes. The oligonucleotide bands were excised from the gel, cut in
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small pieces, and soaked in 1 ml of TE buffer overnight. After spinning down the 
gel particles, the supernatant was removed and ethanol precipitated (Section 
2.15). The DNA pellet was resuspended in 100 \i\ of TE buffer and the 
oligonucleotide concentration was determined by spectrophotometry (Section 
2.13).
2.43 s ’-^p -end  L a b e llin g  o f  O lig o n u c le o tid e s
Reactions contained 200 ng oligonucleotide, 20 |iCi [y-32P] ATP and 10 units of 
T4 polynucleotide kinase in NEB T4 polynucleotide kinase buffer. After 
incubation for 45 minutes at 37°C, reactions were stopped by the addition of 
EDTA to 25 mM.
2.44 OLIGONUCLEOTIDE SUBSTRATE PREPARATION
Labelled oligonucleotides were boiled and annealed overnight with appropriate 
combinations of unlabelled oligonucleotides to generate the DNA substrates 
required (Table 2.3) for the biochemical assays. Annealed substrates were run 
on 10% polyacrylamide gels for 2 hours at 200 V. The gels were exposed to 
Biomax MR film and the 32P-labelled DNA bands were cut from the gel. The 
substrates were electro-eluted from the gel at 100 V for 2 hours using a Biotrap 
apparatus (Schleicher & Schuell). The eluted DNA substrates were dialysed for 
2 hours against TNM buffer (Section 2.3.2), divided in 50 \i\ aliquots and stored 
at -20°C.
2.45 C le a v a g e  a s s a y
Reactions (20 \x\) contained 5’-32P-labelled substrate (approximately 3 ng) in 
cleavage buffer (Section 2.3.3). Reactions were initiated by the addition of 
various concentrations of human hisMUS81, hisE M E I, M U S81/hisEME1, 
M US81/hisEM E2 or HEF1727.2048/HIP. Murine haEM E I or flagM U S81/haEME1 
were also tested for activity. Following incubation for 30 minutes at 37°C, the 
cleavage reactions were stopped and samples deproteinized by 15 min
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incubation in the presence of stop buffer (5x; Section 2.3.3). In time course 
experiments, reactions started by MUS81 /hisEMEI or MUS81/hisEME2 were 
stopped and deproteinised after 3 min, 10 min or 30 min. Labelled DNA 
products were analysed by electrophoresis through 10% neutral polyacrylamide 
gels followed by autoradiography (Section 2.11).
In order to visualise the cleavage pattern produced by MUS81 /hisEMEI 
and MUS81/hisEME2, cleavage reactions were performed in 10 \i\ volume. 
Aliquots (5 jaI) were resuspendend in formamide loading buffer (Section 2.3.2) 
and analysed by denaturing PAGE (Section 2.10) followed by autoradiography 
(Section 2.11).
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SUBSTRATE OLIGONUCLEOTIDES
*
\
(XOI) 5' GACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACATCTTTGCCCACCTGCAGGTTCACCC3
Splayed
arm
NX
3 ’-flap
(X 0 1 ) 5 GACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACATCTTTGCCCACCTGCAGGTTCACCC3 
(X 03  1/2) ^  CATGGAGCTGTCTAGAGGATCCGACTATCGA3
(X04) ATCGATAGTCGGATCCTCTAGACAGCTCCATGTAGCAAGGCACTGGTAGAATTCGGCAGCGT3
. _________/ /: r> 
Replication
fork
(X 0 1 ) s GACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACATCTTTGCCCACCTGCAGGTTCACCC3 
(X 03  1/2) s CATGGAGCTGTCTAGAGGATCCGACTATCGA
(X 0 4 ) ATCGATAGTCGGATCCTCTAGACAGCTCCATGTAGCAAGGCACTGGTAGAATTCGGCAGCGT3
*
nr
Static HJ
( X 0 3 ) AACGGCATAAAGCTTGACGATTACAACAGATCATGGAGCTGTCTAGAGGATCCGACTATCGA
(X 04) ATCGATAGTCGGATCCTCTAGACAGCTCCATGTAGCAAGGCACTGGTAGAATTCGGCAGCGT'
*
Mo Dile HJ
TABLE 2.3: Oligonucleotide sequences of synthetic DNA substrates
Identical colours indicate DNA strands in the substrates and their corresponding 
sequences. Complementary sequences are highlighted by the same colours. 
Note that splayed arm, 3-flap, replication fork and static HJ have 
oligonucleotides X0.1 and X0.4 in common. 32P label is indicated by an asterisk 
on each DNA structure.
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Identification and 
Characterisation of Human EME1
I. Identification  of a Human O rthologue of
S. pombe EME1
The endonuclease Mus81 was initially identified in yeast (Boddy et al., 2000; 
Interthal and Heyer, 2000). A human MUS81 orthologue was subsequently 
found by database searches for human proteins similar to yeast Mus81 (Chen 
et al., 2001). Yeast Mus81 is active in the presence of a partner protein, called 
Eme1 in S. pombe and Mms4 in S. cerevisiae (Boddy et al., 2001; Kaliraman et 
al., 2001). No human orthologues of S. pombe Eme1 and S. cerevisiae Mms4 
have yet been reported. This could be due to the high divergence of Mus81 
partners in eukaryotes, as suggested by the minimal similarity between S. 
pombe Eme1 and S. cerevisiae Mms4. As shown in Appendix 1, Figure 1, S. 
pombe Eme1 and S. cerevisiae Mms4 share only 15% and 19% of identical and 
similar residues, respectively.
In order to identify a partner for human MUS81, a search of the National 
Center for Biotechnology Information (NCBI) database was performed. PSI- 
BLAST (Position Specific Iterated - Basic Local Alignment Search Tool) 
software was utilised to identify similarities between proteins. PSI-BLAST 
searches of the NCBI database to identify a human orthologue of S. cerevisiae 
Mms4 were unsuccessful, but similar attempts to identify a human orthologue of 
S. pombe Eme1 proved to be fruitful. Among the sequences similar to S. pombe 
Eme1, we observed S. cerevisiae Mms4 and a Neurospora crassa Mms4/Eme1 
orthologue (NCBI # CAD21209), as previously reported {Mullen, 2001 #7193; 
Boddy, 2001 #7592}. Additionally, one human protein was identified which we 
designated EME1 (NCBI # BC016470). Human EME1 is a weak homologue of
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S. pombe Eme1, since it exhibits just 17% identity and 26% similarity to S. 
pombe Eme1 (Figure 3.1) (Ciccia et al., 2003).
Human EME1 is a 583 amino acid protein with a molecular weight of 65 
kDa. The EME1 gene is located on chromosome 17. In the NCBI database 
there is a second version of the gene (NCBI # AK055926) that encodes a 
protein that is 13 amino acids shorter (residues 372 to 384 are missing). It is 
possible that these are two tissue-specific splicing variants, as the long version 
of EME1 was cloned from choriocarcinoma cell cDNA whereas the shorter 
variant was isolated from neuroblastoma cells. EME1 cloned from HeLa cell 
cDNA library corresponds to the shorter isoform of EME1 (Blais et al., 2004). A 
third EME1 splice variant has been retrieved from the ATCC database. This 
EME1 isoform is 42 amino acid shorter than the long EME1 splice variant (Blais 
et al., 2004).
EME1 is conserved among all eukaryotes (Appendix 1, Figure 2): 
orthologues for human EME1 could be found in Canis familiaris (NCBI # 
XPJ548199), Mus musculus (NCBI # AAH89459), Rattus norvegicus (NCBI # 
XP_220879), Gallus gallus (NCBI #XP_420107), Danio rerio (NCBI # 
XP_707096), Ustilago maydis (NCBI # XP_761348) and Arabidopsis thaliana 
(NCBI #AAP21264).
II. Interaction  of Human Em ei with Mussi
In order to test the possible interaction between human EME1 and MUS81, a 
bicistronic vector containing MUS81 and the long isoform of EME1 was 
constructed (Figure 3.2). MUS81 and EME1 were cloned in the vector pGex- 
BICIS-HIS (Section 2.6) to co-express GSTMUS81 and hisEMEI in E. coli BL21- 
CodonPlus (DE3)-PR. Following expression of the two proteins, GST-sepharose 
beads were used in pull-down assays carried out with cell-free extracts 
containing GSTMUS81 and hisEMEI (Section 2.39). We observed that the GST 
beads pulled out both GSTMUS81 and hisEMEI (Figure 3.3, lane c), as 
determined by SDS-PAGE followed by Coomassie blue staining. Similarly,
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FIGURE 3.1: Sequence alignment between H. sapiens EME1 and S. 
pombe Eme1
Identical and similar residues are indicated in filled and unfilled red boxes, 
respectively. Sequence alignments were carried out using ClustalW.
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FIGURE 3.2: Construction of the bacterial bicistronic vector pGex- 
gstMUS81/hisEME1
Human MUS81 was amplified by PCR and cloned into the EcoR I and Xho 
I sites of pGex-BICIS-HIS (Section 2.6). Human EME1 was cloned by 
PCR and inserted into the Nde I and Hind III sites of a pGex-BICIS-HIS 
containing MUS81. MUS81 is represented by a violet arrow, EME1 by a 
red arrow. GST tag (GST), 6HIS tag (6HIS), ribosomal binding sites 
(RBS), Ampicillin resistance (Amp) and Lad  repressor gene (Lacl) are
indicated.
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FIGURE 3.3: Interaction of human MUS81 with EME1
Cell-free extracts were prepared from E. coli carrying the bicistronic vector 
pGex-GSTMUS81/hisEMEI (lane b; Section 2.6), and pull-down assays 
were carried out using GST-sepharose (lane c) or Talon (lane d) beads. 
Marker proteins gstMUS81 (lane e) and hisEMEI (lane f) were purified as 
described in Sections 2.30 and 2.28, respectively. Proteins were separated 
by 10% SDS-PAGE and the gel was stained with Coomassie blue.
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incubation of histidine-binding Talon beads with the extract led to the co­
precipitation of both gstMUS81 and hisEMEI (lane d). As expected, extracts 
prepared from E  coli expressing only one of the two proteins (either gstMUS81 
or hisEMEI) showed only single bands in the respective pull-downs (lanes e 
and f). Furthermore, interactions between MUS81 and EME1 were verified in 
Talon pull-downs from extracts prepared from E. coli carrying a bicistronic 
vector containing untagged MUS81 and hisEMEI (data not shown). We 
conclude that the gene identified here as human EME1 encodes the 
mammalian orthologue of S. pombe Eme1 and that human EME1 makes a 
stable complex with MUS81 protein.
III. Purification  of M u ssi/hisEm ei Complex
To purify the complex between MUS81 and EME1, the bacterial bicistronic 
expression vector pET21d-MUS81/hisEMEI was constructed (Figure 3.4). E. 
coli BL21-CodonPlus (DE3)-PR carrying pET21d-MUS81/HisEME1 were 
induced for 3 hours at 30°C with 10 i^M IPTG. Following induction, a high level 
of expression of MUS81 and hisEMEI was observed (Figure 3.5, lane c), but 
most of the over-expressed protein was found to be insoluble and precipitated 
during high-speed centrifugation. The clear supernatant (lane d) was loaded on 
a 10 ml phosphocellulose column and MUS81/hisEMEI complex was eluted 
with 0.5 -  1.5 M NaCI gradient. Peak fractions for MUS81/hisEME1 were 
pooled (lane e) and mixed with 1.5 ml of Talon beads for 2 hours at 4°C. The 
complex was then eluted from the beads with 0.5 M imidazole (lane f), dialysed 
and stored in aliquots at -80°C.
IV. S ubstrate  S pecificity of Human Mu s si/  
hisEm e i C om plex
As previously reported, recombinant S. cerevisiae Mus81/Mms4 and S. pombe
Nco I
Xho I
A/co I Xho I
MUS81
p E T21d -M U S 81 /H isE M E 1
FIGURE 3.4: Construction of the bacterial bicistronic vector pET21d- 
MUS81/hisEME1
A linker containing EcoR I and Hind III sites was inserted into the Nco I and 
Xho I sites of pET21d (Section 2.6). An EcoR l-H/'nd III fragment encoding 
MUS81/hisEMEI was cloned from pGEX-gstMUS81 /hisEMEI into the 
EcoR I and Hind III sites of pET21d-linker. MUS81 is represented by a vio­
let arrow, EME1 by a red arrow. 6HIS tag (6HIS), linker, Ampicillin resis­
tance (Amp) and Lac! repressor gene (Lacl) are indicated.
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FIGURE 3.5: Purification of MUS81/hisEME1 complex
MUS81/hisEM EI was purified following over-expression in E. coli cells car­
rying pET21d-MUS81/hisEM EI (Section 2.31). Lane a, marker proteins; 
lanes b and c, total cellular proteins before and after 3 hours induction with 
IPTG; lane d, supernatant (Sup) after high-speed spin; lanes e and f, frac­
tions eluted from phosphocellulose and Talon beads. Proteins were 
analysed by 10% SDS-PAGE and visualised by Coomassie blue staining.
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Mus81/Eme1 were shown to preferentially cleave flap and fork structures 
compared to HJ (Doe et al., 2002; Kaliraman et al., 2001; Whitby et al., 2003). 
The same substrate specificity for flap and fork structures was described for a 
fraction partially purified from HeLa cells containing MUS81 (Section 2.41) 
(Constantinou et al., 2002).
In order to determine the substrate specificities of human 
MUS81/hisEME1 complex, a series of branched DNA substrates was 
generated by annealing partially complementary oligonucleotides. These 
included splayed arm, 3 ’-flap, replication fork and Holliday junction (HJ) 
structures (Figure 3.6), each of which was 5’-32P-end labelled in the strand 
common (X0.1) to all substrates (Table 2.3). The HJ used contained an 
immobile crossover, therefore it is called static HJ. Using equal amounts of 
protein, we observed that the 3 ’-flap (lane j) and the replication fork (lane o) 
substrates were cut by MUS81/hisEME1. In contrast, very little cleavage was 
observed with the splayed arm (lane e) or static HJ (lane t) substrates. Purified 
MUS81/hisEME1 complex exhibited the same substrate specificity as the 
MUS81 fraction from HeLa (compare lanes g with j, I with o, and q with t) and 
that of purified S. cerevisiae Mus81/Mms4 and S. pombe Mus81/Eme1 (Doe et 
al., 2002; Kaliraman et al., 2001; Whitby et al., 2003). When the levels of 
cleavage of flap and fork structures by MUS81/hisEMEI were quantified by 
phosphorimaging, we observed that the flap and fork substrates were cut with a 
similar efficiency, and that the specific activity of the nuclease with these 
substrates was approximately 75x greater than that observed with the synthetic 
HJ (Figure 3.7).
Whereas purified MUS81 /HISEME1 exhibited flap and fork endonuclease 
activity, neither hisEMEI (Figure 3.6, lanes c, h, m and r) nor hisMUS81 (lanes 
d, i, n and s) alone exhibited nuclease activity. We conclude that human 
MUS81/EME1, like its yeast orthologues, is functional as a heterodimer. To 
date, attempts to reconstitute nuclease activity by mixing separately purified 
recombinant hisEMEI and HISMUS81 subunits have not been successful (data 
not shown).
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FIGURE 3.6: Substrate specificity of human MUS81/hisEME1 endonu­
clease
Reactions contained the indicated 32P-labelled substrates (approx 3 ng) 
and purified hisEMEI (15 ng), hisMUS81 (15 ng) or MUS81/hisEMEI (30 
ng)(Sections 2.28, 2.26 and 2.31, respectively). A MUS81-containing frac­
tion prepared from HeLa cell-free extracts was used as a positive control 
(Section 2.41). Reactions were incubated at 37°C for 30 min (Section 
2.45). DNA products were analysed by neutral PAGE followed by autora­
diography. 32P-labels are indicated with asterisks.
3'-flap
Replication fork 
Static HJ
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Protein amount (ng)
FIGURE 3.7: Quantification of the cleavage efficiency with the fork, 
flap and Holliday junction substrates
Reactions were carried out as described in Fig. 3.6 using purified 
MUS81/h isEME1 and 32P-labelled 3'-flap, replication fork and static 
Holliday junction (XO) substrates. The reaction products were separated 
by PAGE and the amount of cleavage quantified by phosphorimaging 
(Section 2.12). Cleavage is expressed as a percentage relative to that 
observed with the replication fork substrate. The data presented is an 
average of 5 independent experiments.
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V. Human Mu ssi/hisEm e i and Holliday  
Junctions
Initial studies on MUS81 showed that pull-downs for S. pombe TAP-tagged 
Mus81 and immunoprecipitates for human MUS81 were capable of cleaving 
HJs (Boddy et al., 2001; Chen et al., 2001). This raised the possibility that 
MUS81 was a HJ resolvase.
In the experiments described above (Figure 3.6), MUS81/hisEME1 activity 
was assayed on HJs that contain an immobile crossover. In order to test 
whether the presence of a mobile crossover in the HJ could affect 
MUS81/HISEME1 cleavage activity, we compared the cleavage efficiency of 
MUS81/hisEME1 between static and mobile HJs (containing a 26 bp 
homologous core (X26) through which the junction is freely able to branch 
migrate). We observed that the mobile junction served as a better substrate for 
MUS81/HISEME1, and was cut with an efficiency that was approximately 6-fold 
greater than the static junction (Figure 3.8, compare lanes b and c with g and 
h). Similar results were obtained with the partially purified MUS81 fraction from 
HeLa cells (lanes d and i). In contrast to recombinant MUS81/hisEME1 or the 
HeLa MUS81 fraction, fractionated extracts from HeLa cells enriched for the 
human HJ Resolvase A (Constantinou et al., 2002) cleaved static and mobile 
junctions equally and efficiently (lanes e and j).
Taken together, these results show that the endonuclease activity of 
MUS81/EME1 complex is specifically targeted to flap/fork structures. Although 
MUS81/EME1 is relatively inactive on HJs, the efficiency of cleavage can be 
enhanced by inclusion of homologous sequences. Previously, using chemical 
probes that could detect the formation of transient regions of single-stranded 
DNA, it was observed that mobile junctions exhibit a transient single-stranded 
character suggestive of base-pair breathing (West, 1995). We therefore suggest 
that the ability of MUS81/EME1 to cut four-way junctions is likely to be due to 
the recognition of transient flap structures that are formed as the junction 
undergoes spontaneous thermal denaturation. Consistent with this proposal, it 
was shown that cleavage of Holliday junctions by MUS81 fractions prepared
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+  Resolvase A fraction (HeLa)
FIGURE 3.8: Comparison of human MUS81/hisEME1 activity on static 
and mobile Holliday junctions
Reactions contained 32P-labelled synthetic Holliday junction (approx 3 ng) 
and purified MUS81/hisEME1 complex (Section 2.31). MUS81-containing 
fraction and Resolvase A (0.5 ^l), both partially purified from HeLa cell- 
free extracts, were used as controls (Section 2.41). Reactions were incu­
bated at 37°C for 30 min (Section 2.45). DNA products were analysed by 
neutral PAGE followed by autoradiography. 32P-labels are indicated with 
asterisks. Complementary DNA strands in the homologous core of the 
mobile HJ are represented in red or grey (Table 2.3).
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from HeLa extracts occurred at the 5 ’-side of the substrate and that the nicks 
were introduced without symmetry leading to the formation of non-ligatable 
products (Constantinou et al., 2002). We conclude that HJ cleavage by 
MUS81/EME1 is a secondary effect of its flap activity, rather than the sign of a 
classical HJ resolvase.
VI. A c tiv ity  o f  M. muscuius flagMussi/haEmei
Complex
In order to investigate whether EME1 function was conserved in other 
mammalian species, we established a collaboration with Razq Hakem (Ontario 
Cancer Institute, Canada), who had cloned the M. muscuius EME1 gene 
(Abraham et al., 2003). Murine EME1 is a 570 amino acids protein with 66% 
identity to human EME1 (Appendix 1, Figure 2). haEMEI and flagMUS81 were 
expressed by in vitro translation using rabbit reticulocyte extracts and were 
shown to interact after pull-downs with anti-HA and anti-FLAG antibodies from 
the in vitro translation mixtures (Abraham et al., 2003). To test whether murine 
flagMUS81/haEMEI had similar substrate specificity to human 
MUS81/hisEME1, we assayed the activity of haEMEI or flagMUS81 /haEMEI, 
both pulled-down with anti-HA beads from in vitro translation reactions. We 
found that flagMUS81 /haEMEI cleaved 3’-flap (Figure 3.9, lane h) and 
replication fork substrates efficiently (data not shown). In contrast, little or no 
cleavage was observed for the static HJ (lane I). A MUS81 fraction from HeLa 
(Section 2.41) was used as a positive control.
From this experiment we can conclude that murine MUS81/EME1 
preferentially cleaves the same substrates as yeast Mus81/Eme1(Mms4) and 
human MUS81/EME1. It is therefore likely that the MUS81/EME1 substrate 
specificity is conserved among all eukaryotic species.
The work described in this chapter has been published (Abraham et al., 2003; 
Ciccia et al., 2003).
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FIGURE 3.9: Substrate specificity of murine flagMUS81/haEME1 endo­
nuclease
Reactions contained a variety of 32P-labelled substrates (approx 3 ng) and 
murine haEMEI immunocomplex or murine flagMUS81 /haEMEI immuno- 
complex, as indicated. Both haEMEI and murine flagMUS81 /haEMEI were 
obtained by in vitro translation reaction in reticulocyte extracts followed by 
immunoprecipitation with anti-HA antibody (Abraham et al., 2003). A human 
MUS81-containing fraction prepared from HeLa cell-free extracts was used 
as a positive control (Section 2.41). Reactions were incubated at 37°C for 30 
min (Section 2.45). DNA products were analysed by neutral PAGE followed 
by autoradiography. 32P-labels are indicated with asterisks.
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Identification and 
Characterisation of Human EME2
I. Identification  of a S econd Partner  of 
Human Mussi
In addition to EME1, the initial PSI-BLAST search for proteins similar to S. 
pombe Eme1, revealed a second human EME1 homologue which we therefore 
designated EME2 (NCBI # XM_113869) (Ciccia et al., 2003). The EME2 gene, 
which is located on chromosome 16, was predicted to encode a 245 amino acid 
protein with a molecular weight of 26 kDa. For reasons indicated blow, we have 
re-named EME2 described in (Ciccia et al., 2003) as EME2_predicted 
(Appendix 1, Figure 3). EME2_predicted was PCR amplified from the human 
cDNA # AK074080 using DNA oligonucleotides 27 and 28 (Table 2.1). In order 
to test whether EME2_predicted interacts with MUS81, the bicistronic vector 
pGex-GSTMUS81/HisEME2_predicted was constructed (Section 2.6). Purification 
of GSTMUS81/HisEME2_predicted proved to be unsuccessful because the two 
proteins failed to form a stable complex (data not shown).
Further attempts to clone a different EME2 splice variant were carried out 
according to the Genscan prediction NT_037887.92 (NCBI # NP_001010865) 
that subsequently replaced the EME2_predicted record in the NCBI database. 
DNA oligonucleotides 17 and 18 (Table 2.1) corresponding to the 5 ’ and 3 ’ ends 
of the Genscan prediction NT_037887.92, here designated EME2_genescan, 
were used in a PCR amplification reaction from a ProQuest HeLa Cell cDNA 
library (Section 2.2). The PCR clone obtained from the ProQuest HeLa Cell 
cDNA library encodes a 379 amino acid protein, designated EME2_HeLa, with 
a molecular weight of 41 kDa (Appendix 1, Figure 3). Alignment between 
EME2_HeLa and EME2_predicted (Appendix 1, Figure 3) revealed that the C-
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terminal region of EME2_HeLa (amino acids 189-379) is identical to the C- 
terminus of EME2_predicted (amino acids 57-245). EME2_HeLa and 
EME2_predicted differ in their N-terminal regions, since EME2_HeLa is 134 
amino acids longer than EME2_predicted (Appendix 1, Figure 3). Sequence 
alignment between EME2_HeLa and EME2_genscan showed that EME2_HeLa 
is 65 amino acids shorter than EME2_genscan (Appendix 1, Figure 4). Both the 
N- and C-termini of EME2_HeLa and EME2_genscan are identical, but 
EME2_genscan has three additional regions (amino acids 193-236, 267-273 
and 312-325) that are not present in EME2_HeLa (Appendix 1, Figure 4). This 
is probably due to an inaccurate prediction of exons and introns by the Genscan 
software.
To verify whether EME2 cDNA had tissue-specific splice variants, 
additional PCR amplifications with DNA oligonucleotides 17 and 18 (Table 2.1) 
were performed from the ProQuest Human Fetal Brain and Superscript Human 
Testis cDNA libraries (Section 2.2). The PCR clone obtained from the ProQuest 
Human Fetal Brain cDNA library encodes for a protein identical to EME2_HeLa 
(data not shown). The PCR clone obtained from the Superscript Human Testis 
cDNA library, instead, encodes for a protein, designated EME2_testis, that is 
slightly different from EME2_HeLa. Although EME2_testis cDNA is longer than 
EME2_HeLa cDNA (1322 bp for EME2_testis cDNA and 1140 bp for 
EME2_HeLa cDNA), EME2_testis results in a protein that is 76 amino acids 
shorter than EME2_HeLa. This is due to a stop codon present at nucleotides 
910-912 of EME2_testis cDNA. The N-terminus of EME2_testis (amino acids 1- 
190) is identical to the N-terminus of EME2_HeLa (Appendix 1, Figure 5), but 
an unspliced intron between nucleotides 570 and 753 of the EME2_testis cDNA 
altered the protein sequence of the C-terminus of EME2_testis compared to 
EME2_HeLa.
EME2_HeLa is 39% identical and 23% similar to human EME1, with the C- 
terminal regions being the most conserved (Figure 4.1). On the other hand, 
EME2_testis is only 20% identical and 26% similar to human EME1 because it 
has lost the similarity with the C-terminus of EME1 (Appendix 1, Figure 6). To 
determine whether the human EME1 and EME2_HeLa C-terminal sequences
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FIGURE 4.1: Sequence alignment between H. sa p ie n s  EME1 and H. 
s a p ie n s  EME2_HeLa
Sequence alignments were carried out as described in Figure 3.1.
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were conserved in other proteins, a PSI-BLAST search was initiated using the 
last 160 amino acids of EME1 and EME2_HeLa. Remarkably, a close match 
was identified with human MUS81 protein. Alignment of MUS81, EME1 and 
EME2_HeLa confirmed that these three proteins have a conserved C-terminal 
region (Figure 4.2). Previously, it was shown that S. pombe Eme1 and S. 
cerevisiae Mms4 interact with Mus81 via their C-terminal regions (Boddy et al., 
2001; Fu and Xiao, 2003). From our sequence alignments, it appears likely that 
human MUS81 might interact with EME1 and EME2_HeLa via C-terminal 
contacts. The human MUS81 C-terminus contains the ERCC4 nuclease domain 
and a HhH motif (Figure 1.11) (Interthal and Heyer, 2000). As previously 
reported, the ERCC4 domain and the HhH motifs were shown to be necessary 
for the dimerisation of P. furiosus Hef (Nishino et al., 2003; Nishino et al., 
2005a).
In order to test whether EME1 and EME2_HeLa had an ERCC4 domain, 
we performed bioinformatic searches using the PHYRE (Protein 
Homology/analogY Recognition Engine) server developed by the Structural 
Bioinformatics Group at Imperial College of London. The PHYRE server 
predicts the structure of proteins based on sequence similarity with previously 
determined crystal structures. In the case of EME1 and EME2_HeLa, PHYRE 
identified similarities with the crystal structure of A. pernix XPF (Newman et al., 
2005). As previously reported, A. pernix XPF has an ERCC4 domain (Figure 
1.11). Therefore EME1 and EME2_HeLa appear to have the ERCC4 nuclease 
domain. However, as in the case of ERCC1, they have acquired mutations in 
the catalytic motif. When EME1 and EME2_HeLa were aligned with MUS81, it 
was apparent that they do not contain the ERKX3D catalytic motif (Figure 4.2, 
compare amino acids 333-339 of MUS81 with the corresponding amino acids of 
EME1 and EME2_HeLa). The PHYRE server also predicted the presence of a 
single HhH motif in human EME1 and EME2_HeLa, as also reported for MUS81 
(Interthal and Heyer, 2000).
As described previously, EME2_predicted was unable to form a stable 
complex with MUS81, even though it is identical to EME2_Hela for the C- 
terminal 190 amino acids (Appendix 1, Figure 3). Based on the database
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FIGURE 4.2: Sequence alignment of H. sapiens EME1, H. sapiens 
EME2_HeLa and H. sapiens MUS81
Sequence alignments were carried out as described using ClustalW.
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searches performed with the PHYRE server, the last 190 amino acids contain a 
truncated ERCC4 domain. The PHYRE server aligned the last 214 amino acids 
of EME2_HeLa with the ERCC4 domain of A. pernix XPF. It is therefore 
possible that the absence of a complete ERCC4 domain could prevent the 
interaction between EME2_predicted and MUS81. Another possible explanation 
is that other regions of EME2_HeLa, apart from the C-terminal region, might 
also be required for the interaction with MUS81. It was previously reported that 
a mutation in the N-terminal region of Mms4 (Gly173Arg) abrogates the 
interaction between Mms4 and Mus81, even though the C-terminal 94 amino 
acids of Mms4 are sufficient by themselves for the interaction with Mus81 (Fu 
and Xiao, 2003). Based on all of these considerations, we predict that 
EME2_testis will not be able to interact with MUS81 due to the lack of the C- 
terminal region containing the ERCC4 domain and the HhH motif. For this 
reason we focused our attention only on EME2_HeLa, which we have re­
designated simply EME2.
While EME1 is conserved among all eukaryotes (Appendix 1, Figure 2), 
EME2 orthologues can be found only in vertebrates, like Rattus norvegicus, Pan 
troglodytes, Bos taurus, Mus muscuius and Gallus gallus. As shown by 
sequence alignments, EME2 orthologues are highly conserved in their C- 
terminal region (Appendix 1, Figure 7). This emphasises the importance of the 
C-terminal regions for the function of EME2.
II. Interaction  of Human Eme2 with  Mussi
In order to test whether EME2 interacted with MUS81, the bicistronic vector 
pGex-MUS81/HisEME2 was constructed as described in Section 2.6. Cell-free 
extracts were prepared from E  co//'BL21-CodonPlus (DE3)-PR carrying pGex- 
gstMUS81/hisEME2 as indicated in Section 2.39 and pull-downs were 
performed either with GST-sepharose beads or Talon beads. We observed that 
GST-sepharose beads pulled-down both gstMUS81 and hisEME2, as 
determined by SDS-PAGE followed by Coomassie blue staining (Figure 4.3, 
lane b). In addition, gstMUS81 co-precipitated with hisEME2 when the cell-free
c
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FIGURE 4.3: Interaction of human MUS81 with EME2
Cell-free extracts were prepared from E. coli carrying the bicistronic vector 
pGex-GSTMUS81/HisEME2 (Section 2.6), and pull-down assays were car­
ried out using GST-sepharose (lane b) or Talon (lane c) beads (Section 
2.39). Proteins were separated by 10% SDS-PAGE and visualised by 
staining with Coomassie blue.
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extracts were mixed with Talon beads (Figure 4.3, lane c). This experiment 
indicates that MUS81 and EME2 form a stable complex. At the present time, we 
have not found another EME2 splice variant that can interact with MUS81. As 
mentioned above, EME2_predicted was not able to stably interact with MUS81 
following co-expression in E  coli. We have not tested whether EME2_testis can 
interact with MUS81, but we argue that EME2_testis is unlikely to bind MUS81 
due to the absence of the C-terminus containing the ERCC4 domain and the 
HhH motif (Appendix 1, Figure 5). It is therefore possible that in vivo there might 
be some EME2 splice variants that are incapable of interacting with MUS81. 
Further investigation is still necessary to understand whether these splice 
variants might have a MUS81-independent role.
In conclusion, we were able to identify EME2 as a second partner protein 
for MUS81. In humans, therefore, the MUS81 family contains two MUS81 
partner proteins (EME1 and EME2), while in yeast a single protein (Eme1 or 
Mms4) is able to interact with Mus81 (Figure 4.4). A comparison between 
MUS81/EME1 and MUS81/EME2 complexes is required to understand the 
possibly diverse role that EME1 and EME2 could play in vivo.
III. C omparison  of the A ctivities  of Human
MUS81/hisEME1 AND MUS81/hisEME2 COMPLEXES
In order to test whether the MUS81/EME2 complex was active, the bicistronic 
vector pET21d-MUS81/HisEME2 was constructed (Section 2.6). 
MUS81/hisEME2 was purified from E  coli BL21-CodonPlus (DE3)-PR carrying 
pET21 d-MUS81 /hisEME2 by phosphocellulose and Talon column 
chromatography, as described in Section 2.32. MUS81/hisEME2 complex was 
incubated with 3’-flap and replication fork substrates (Figure 4.5) that were 
prepared by annealing partially complementary oligonucleotides (Table 2.3). 
Both substrates contained a common 5’-32P labelled oligonucleotide (X0.1). We 
observed that MUS81/hisEME2 cleaved both the 3-flap and replication fork 
substrates with similar efficiency (compare lane b with lane d). MUS81/hisEME1
Mus81 1 I 572
S. pombe 
(S. cerevisiae)
Eme1 (Mms4) 
Rad16 (R a d i) 
Swi10 (Rad10)
E R p C 4 | H  738
1 892
1 | |  252
M US81
EME1
H. sapiens
EM E2
XPF
1 I |  551
|  583
! EREC4 |  379
d) * h I I 905
ERCC1 1 E I 297
FIGURE 4.4: Comparison of yeast and human MUS81 family of proteins
The MUS81 family of proteins in S. pombe and H. sapiens are represented. 
S. cerevisiae orthologues of S. pombe proteins are shown in brackets. Novel 
human proteins of the MUS81 family are highlighted by red boxes. H. sapi­
ens EME2 corresponds to H. sapiens EME2_HeLa (Figure 4.1). ERCC4 
nuclease domains (red), HhH motifs (dark violet) and DEAH helicase 
domains (blue) are indicated with boxes. Inactive ERCC4 and DEAH 
domains are indicated with red and blue crosses, respectively.
3'-flap
Replication
fork
M U S 81/hisEM E2
a b c d
FIGURE 4.5: MUS81/hisEME2 activity on 3'-flap and replication fork 
structures
Reactions contained 32P-labelled synthetic substrates (approx 3 ng of 3'- 
flap or replication fork) and purified MUS81/hisEME2 complex (10 nM; 
lanes b and d). MUS81/hisEME2 was purified as described in Section 
2.32. Reactions were incubated at 37°C for 30 min (Section 2.45). DNA 
products were analysed by neutral PAGE followed by autoradiography. 
32P-labels are indicated with asterisks.
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also showed equal cleavage efficiency of 3 ’-flap and replication fork substrates 
(Figure 3.7).
In order to test the substrate specificity of MUS81/hisEME2, its activity was 
compared on replication fork, mobile HJ (X26) and static HJ (XO) structures 
(Figure 4.6A). Time-course experiments revealed that MUS81/hisEME2 cleaved 
replication forks more efficiently than HJs (compare lane c with g and k), as 
previously shown for MUS81/hisEME1 (Figure 3.6, compare lanes o and t). 
Phosphorimaging analysis indicated a 12-fold difference between the cleavage 
of replication forks and the cleavage of HJs by MUS81/hisEME2 (Figure 4.6B). 
Similar results were obtained when MUS81/hisEME2 activity was compared on 
3’-flap and HJs (data not shown). We previously quantified the difference of 
cleavage between 3’-flap/fork structures and HJs to be approximately 75-fold for 
MUS81/HISEME1 (Figure 3.7). These results show that the specificity for 3 ’- 
flap/fork structures is higher for MUS81/HISEME1 than for MUS81/hisEME2.
When we compared the cleavage of static HJ and mobile HJ induced by 
MUS81/hisEME2, we noticed that both substrates were cleaved to the same 
extent after a 10 min reaction, whereas the static HJ appeared to be preferred 
over the mobile HJ after a 30 min reaction (Figure 4.6A, compare lanes g and h 
with k and I). The difference in the percentage of static HJs or mobile HJs 
cleaved by MUS81/hisEME2 was approximately 2-fold when quantified by 
phosphorimaging (Figure 4.6B). In the case of MUS81/HISEME1, we observed 
that mobile HJs were cleaved approximately 6-fold more efficiently than static 
HJs (Figure 3.8). We cannot explain, at the present time, the observation that 
MUS81/HISEME1 and MUS81/HISEME2 prefer different types of HJs. We have 
not tested whether this might be due to a different binding affinity for static or 
mobile HJs between MUS81/HISEME1 and MUS81/HISEME2.
To compare the cleavage efficiency of MUS81/hisEME1 and 
MUS81/hisEME2 on the same substrate, we incubated equal amounts of 
MUS81/HISEME1 or MUS81/HISEME2 complex in the presence of a replication 
fork substrate (Figure 4.7A). Time-course experiments revealed that 
MUS81/HISEME2 is more active than MUS81/HISEME1 on the replication fork 
substrate (compare lanes b and f). Quantification by phosphorimaging revealed
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a 10-fold difference in the percentage of replication fork cleaved by 
MUS81/HISEME2 or MUS81/hisEME1 (Figure 4.7B). Similar results were 
obtained when 3 ’-flap was used as a substrate (data not shown). It is possible 
that the higher activity of MUS81/hisEME2 compared to MUS81/HISEME1 might 
be a consequence of a more efficient binding of MUS81/hisEME2 to 3 ’-flap/fork 
compared to MUS81/HISEME1. An alternative explanation could be that EME2, 
through the interaction with MUS81, stimulates the catalytic domain of MUS81 
more efficiently than EME1. Further experiments will be required to test these 
hypotheses.
IV. DNA C leavag e  Mechanism o f  Human
MUS81/hisEME1 AND MUS81/hisEME2 COMPLEXES
To investigate if there was any difference in the cleavage mechanism of 
MUS81/hisEME1 and MUS81/HISEME2, we compared the pattern of cleavage 
of MUS81/hisEME1 and MUS81/hisEME2 on a 3’-flap substrate (Figure 4.8A). 
Equal amounts of MUS81/HISEME1 or MUS81/hisEME2 were incubated with 3’- 
flap substrate in a time-course experiment. The cleavage pattern of the static 
HJ XO, produced by a Resolvase A fraction partially purified from HeLa (Section 
2.41), was used as a marker (Figure 4.8A, lane g). The Resolvase A fraction 
incised the static HJ XO at one major site (5’-AGlGA-3’), as previously reported 
(Liu et al., 2004). The position of the Resolvase A incision site allowed us to 
determine the location of the cleavage sites generated by MUS81/hisEME1 or 
MUS81/hisEME2 on the 3 ’-flap substrate. The comparison between 3 ’-flap 
substrate and static HJ XO was possible because both substrates were 5’-32P 
labelled on the common oligonucleotide X0.1 (Table 2.3). We noticed that both 
MUS81/HISEME1 and MUS81/HISEME2 had three major consecutive incision 
sites (5’-T iT iG iC -3 ’; compare lanes c and e). A MUS81 fraction partially 
purified from HeLa (Section 2.41) showed the same incision pattern (lane f). In 
addition to these three incision sites, MUS81/hisEME2 displayed a unique 
major cleavage site (5’-G C lC T-3’; lane e). The three incision sites common to
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both MUS81/HISEME1 and MUS81/HISEME2 (5’-T jT lG JC -3 ’) are 3 to 6 
nucleotides away from the single-stranded region of the 3-flap. The site specific 
to MUS81/hisEME2 (5’-GC jC T-3 ’) is 1 to 2 nucleotides to the 5’-side of the 
three sites 5 ’-TJ,TjG |C -3 ’ (Figure 4.8B).
The positions of the incision sites that we identified for MUS81/HISEME1 
and MUS81/hisEME2 are consistent with previous data describing the cleavage 
sites for S. cerevisiae Mus81/Mms4, S. pombe Mus81/Eme1 and for the 
nuclease domain of P. furiosus Hef (Komori et al., 2002; Whitby et al., 2003). 
Four major cleavage sites have been identified for S. cerevisiae Mus81/Mms4 
and for S. pombe Mus81/Eme1 on a 3 ’-flap structure (Whitby et al., 2003). 
These sites are 3 to 7 nucleotides away from the single-stranded region of the 
3 ’-flap. Three major cleavage sites, located 3 to 6 nucleotides away from single­
stranded region of the 3 ’-flap, were also generated by the nuclease domain of 
P. furiosus Hef (Komori et al., 2002). Although 3 ’-flap structures with different 
sequences were used, the cleavage patterns generated by MUS81 orthologues 
from different species were remarkably similar. From these observations, we 
conclude that MUS81 in complex with its partners has an evolutionarily 
conserved structure-dependent and sequence-independent mechanism of 
cleavage.
As mentioned previously, MUS81/hisEME1 and MUS81/hisEME2 cleave 
3 ’flap/fork structures 75-fold and 12-fold more efficiently than HJs, respectively. 
To analyse the mechanism by which MUS81/hisEME1 and MUS81/hisEME2 
process HJs, we compared the pattern of cleavage on the static HJ X0 
produced by MUS81/hisEME1, MUS81/hisEME2 and the Resolvase A fraction 
from HeLa (Figure 4.9A). We noticed that, while the Resolvase A fraction 
cleaved the static junction primarily one nucleotide to the 3 ’-side of the 
crossover point at the site 5’-AGiGA-3’ (lane e), both MUS81/hisEME1 and 
MUS81/hisEME2 (lanes b and c, respectively) cleaved in the arms of the 
junction, away from the crossover point. In particular, we identified one incision 
site (5’-C T |TG -3’) common to both MUS81/hisEME1 and MUS81/hisEME2 and 
two consecutive major incision sites (5’-G jC lC T -3 ’) specific for 
MUS81/HISEME2. Comparing the intensity of the incisions generated by
away from the 
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MUS81/HISEME1 and MUS81/HISEME2, it is apparent that MUS81/HISEME2 
cleaves the static HJ more efficiently than MUS81/hisEME1 (compare lanes b 
and c). Additional incisions to the 5 ’-side of S’-G jC jC T-S ’ are generated by 
MUS81/HISEME2. However, these may be due to secondary processing of the 
cleavage products of the static junction. The MUS81 fraction purified from HeLa 
cleaved the static junction in the same three positions previously described for 
MUS81/HISEME1 and MUS81/hisEME2 (lane d). The incision site (5’-CTlTG- 
3 ’) common to both MUS81/hisEME1 and MUS81/hisEME2 is 4 to 5 
nucleotides away from the crossover, and the two major incision sites (5’- 
G jC  jC T-3 ’) produced by MUS81/hisEME2 are 2 to 4 nucleotides to the 5-side 
(Figure 4.9B).
It was previously proposed that yeast Mus81 in complex with Eme1 or 
Mms4, rather than processing HJs, could cleave intermediates that precede the 
formation of HJs, like D-loops and nicked HJs (Gaillard et al., 2003; Osman et 
al., 2003). Mus81/Eme1 and Mus81/Mms4 were shown to be capable of 
cleaving nicked HJs more efficiently than 3’-flap and replication fork structures. 
Cleavage sites, generated by Mus81/Eme1 or Mus81/Mms4 on the nicked static 
HJ X0, were mapped to sites located 3 to 6 nucleotides or 4 to 9 nucleotides, 
respectively, away from the crossover on the arm of the junction opposite to the 
nick (Osman et al., 2003). Taking these reports on yeast Mus81/Eme1 (or 
Mms4) together with our observations on human MUS81/hisEME1 and 
MUS81/hisEME2, we can conclude that eukaryotic MUS81, in complex with its 
partners, acts on HJs in an alternative way from a classical HJ resolvase.
V. Iso latio n  of M ussi C omplexes  after 
Fractio natio n  of  HeLa  C ells
To test whether MUS81, EME1 and EME2 interact in vivo, HeLa nuclear 
extracts were fractionated according to the previous scheme developed in our 
lab (Liu et al., 2004) and the elution profile of MUS81, EME1, EME2 was 
followed (Figure 4.10A). HeLa nuclear extracts precipitated by a 25% - 55%
HeLa nuclear extract
Ammonium sultate precipitation
Phosphocellulose
Hepann
SP-sepharose
1 M K C I
Man O MonoQ
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FIGURE 4.10: Fractionation of HeLa cell extracts and analysis of the 
elution profiles of MUS81, EME1 and EME2
A. Fractionation scheme of HeLa nuclear extract for the analysis of 3'-flap 
and Holliday junction resolution activities (Section 2.41).
B. Fractions eluted from the final MonoQ column were immunoblotted 
using antibodies against MUS81 (MTA30 2G10), EME1 (MTA31 7H2), 
EME2 (SWE57; Section 2.22) and were assayed for 3'-flap cleavage activ­
ity (Section 2.45). DNA products were analysed by neutral PAGE followed 
by autoradiography.
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ammonium sulfate cut were resuspended and subjected to phosphocellulose, 
butyl-sepharose, heparin and SP-sepharose column chromatography. Fractions 
with 3 ’-flap cleavage activity, separated by SP-sepharose chromatography from 
fractions having HJ resolution activity, were pooled and loaded onto a MonoQ 
column. The fractions eluted from the MonoQ column were immunoblotted with 
the monoclonal antibodies MTA30 2G10 and MTA31 7H2 raised against 
MUS81 or EME1, respectively, and with the polyclonal antibody SWE57 specific 
for EME2. MonoQ fractions were also assayed for 3 ’-flap cleavage activity. We 
observed that MUS81, EME1 and EME2 were present in the peak of activity 
(Figure 4.10B, fractions 8-11). Two bands were detected using the monoclonal 
antibody against MUS81: a slower migrating band corresponding to the full 
length MUS81 (approximately 60 kDa) and a faster migrating band 
(approximately 50 kDa). The 50 kDa band correlated with the activity more 
precisely than the 60 kDa band. We have not determined whether the 50 kDa 
band is an alternative spliced form or a degradation product of MUS81. While 
the EME1 profile perfectly matched the activity peak, only a weak signal for 
EME2 was detected in fractions 8 and 9. It is possible that MUS81 could 
primarily interact with EME1 in vivo and that only a minor fraction of the pool of 
MUS81 is in complex with EME2. Further experiments will be required to 
understand the functional differences between MUS81/EME1 and 
MUS81/EME2 complexes in vivo.
Chapter Five
Identification of Two Novel 
Members of the MUS81 Family
I. Identification  of a Human O rthologue  of
P. furiosus HEF
As described in Figure 4.4, the human MUS81 family of proteins is composed of 
five members: MUS81, EME1, EME2, XPF and ERCC1. All of these proteins 
are characterised by the presence of an ERCC4 nuclease domain. However, 
this domain is active only in MUS81 and XPF proteins (Figure 4.4). In order to 
verify whether additional proteins of the MUS81 family were present in the 
human genome, a domain search for proteins containing the ERCC4 nuclease 
domain was performed in the InterPro database. Besides MUS81 and XPF, an 
additional protein, called KIAA1596, was identified. KIAA1596 (NCBI # 
BAB13422) is a 1151 amino acid protein, which is encoded by a partial cDNA 
(NCBI # AB046816) missing the ATG start codon. A clone coding for the full- 
length KIAA1596 was purchased from the company Origene (clone # 
TC125463). We re-designated KIAA1596 as human HEF because of the 
similarity with the P. furiousus Hef (Section 1.10). The HEF gene is located in 
chromosome 14 and encodes a 2048 amino acid protein with a predicted 
molecular weight of 250 kDa. Human HEF, like P. furiousus Hef, has the DEAH 
helicase domain and the ERCC4 nuclease domain (compare Figure 1.11 and 
Figure 5.1). Sequence alignment showed that the DEAH domain of human HEF 
(amino acids 70-611) is 28% identical and 24% similar to the DEAH domain of 
P. furiousus Hef and that the ERCC4 domain of human HEF (amino acids 1830- 
2030) is 23% identical and 27% similar to the ERCC4 domain of P. furiousus 
(Appendix 1, Figure 8). The ERCC4 nuclease domain of human HEF has been
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FIGURE 5.1: The human MUS81 family of proteins
Members of the human MUS81 family are represented. Novel members 
identified in this study are highlighted by red boxes. ERCC4 nuclease 
domains (red), HhH motifs (dark violet), DEAH helicase domains (blue) are 
indicated with boxes. Inactive ERCC4 and DEAH domains are indicated with
red and blue crosses, respectively.
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proposed to be inactive due to mutation of the catalytic motif ERlOCgD to 
ERRX3E (amino acids 1864-1870 of human HEF) (Meetei et al., 2005). This 
hypothesis was based on the observation that the endonuclease activity of the 
related human XPF protein was abolished by mutations of the catalytic domain 
ERKX3D either to ERAX3D or.ERlOCgA (Enzlin and Scharer, 2002).
HEF orthologues, which have conserved the DEAH and ERCC4 domains, 
can be found only among vertebrates, like G. gallus, M. musculus, C. familiaris, 
R. norvegicus, T. negroviridis and X. laevis (Appendix 1, Figure 9). Proteins 
containing the HEF DEAH domain only can be identified in insects and in yeast, 
such as D. melanogaster CG7922 and S. cerevisiae Mph1 proteins (Meetei et 
al., 2005; Mosedale et al., 2005).
II. Identificatio n  of a  Potential Hef 
Interacting  Protein
As previously described, human MUS81 and XPF form complexes with their 
partner proteins EME1 (or EME2) and ERCC1, respectively. EME1 and EME2 
share homology with the C-terminus of MUS81 and ERCC1 is related to the C- 
terminus of XPF (Aravind et al., 1999; Gaillard and Wood, 2001). In order to test 
whether HEF could also form a heterodimer with partner proteins that have a 
related C-terminus, we performed a PSI-BLAST search for proteins homologous 
to the C-terminal 300 amino acids of human HEF. Following three PSI-BLAST 
iterations, we identified a human protein named MGC32020 (NCBI # 
NP_689479) as a potential HEF partner. We re-designated MGC32020 as HIP 
(HEF Interacting Protein) based on the experiments described below. The HIP 
gene localises to chromosome 19 and encodes a 215 amino acid protein, which 
has a predicted molecular weight of 24 kDa. HIP is 20% identical and 31% 
similar to the C-terminal 300 amino acids of human HEF (Figure 5.2). Human 
HIP orthologues can be found exclusively in vertebrates, such as B. taurus, M. 
musculus, D. rerio, G. gallus and X. leavis (Appendix 1, Figure 10). We were not 
able to identify HIP orthologues in species that express proteins lacking the C-
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FIGURE 5.2: Sequence alignment between the C-terminus of H. sapi­
ens HEF (amino acids 1749-2048) and H. sapiens HIP
Sequence alignments were carried out as using ClustalW.
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terminal ERCC4 nuclease domain of HEF, such as D. melanogaster CG7922 
and S. cerevisiae Mph1 proteins.
III. In te ra c tio n  o f  Human Hip with H ef
In order to test whether HIP was forming a complex with HEF, we expressed 
and purified HEF alone or in the presence of HIP. Three different HEF 
constructs were cloned into the Gateway entry vector pENTR4: HEF with an N- 
terminal 10HIS tag ( io h isH E F), with an N-terminal 10HIS tag and a C-terminal 
FLAG tag ( io h isH E F flag), and with an N-terminal 10HIS tag and a C-terminal 
Strep tag (-iohisH E F str ep ). N-terminal and C-terminal tags were used in order to 
facilitate the purification of full-length HEF. The cloning of io h isH E F flag in 
pENTR4 is described in Figure 5.3. io h isH E F strep was inserted into pENTR4 
using the same protocol for io h isH E F flag , while io h isH EF was directly cloned 
into pENTR4 (Section 2.6).
Initial attempts to express HEF in yeast cells or in rabbit reticulocyte 
extracts were unsuccessful (data not shown). We therefore decided to express 
HEF in insect cells. For this purpose, io h isHEF, io h isH E F flag and 
io h isH E F strep  were recombined from the Gateway entry vector pENTR4 into 
the expression vector pDEST8 (Section 2.6). p D E S T 8- io h isHEF, pDEST8- 
io h isH E F flag and p D E S T 8 - io h isH E F strep were used to generate three 
baculoviruses expressing io h isH EF, io h isH E F flag and io h isH E F str ep , 
respectively (Section 2.23). io h isHEF, io h isH E F flag and io h isH E F strep  were all 
expressed equally well in High Five insect cells, as detected by immunoblotting 
with anti-HEF SWE98 antibody (Figure 5.4A, lanes a, b and c, respectively) and 
anti-HIS tag antibody (data not shown). Anti-HEF antibody, in addition to 
detecting the full-length io h isHEF, io h isH E F flag and io h isH E F strep 
(approximately 250 kDa), recognised several smaller bands that are most likely 
HEF degradation products. Anti-FLAG antibody specifically recognised 
io h isH E F flag (Figure 5.4B, lane b), while anti-Strep tag antibody failed to detect 
io h isH E F strep  (data not shown). We therefore focused our attention on the 
baculovirus expressing io h isH E F flag .
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FIGURE 5.4: Expression of iohisHEF, ioh isH E Fflag  and iohisH EFstrep  
in insect cells
A. Cell extracts from High Five cells infected with baculoviruses express­
ing io h isH E F, io h isH E F flag or io h isH E F strep (Section 2.25) were run on 
a NUPAGE 4-12% Bis-Tris gradient gel and immunoblotted with the 
polyclonal antibody SWE98 against HEF (Section 2.22). The predicted 
molecular weight for io h isHEF, io h isH E F flag or iohisH EF strep (lanes a, b 
and c, respectively) is approx 250 kDa.
B. Cell extracts described in (A) were immunoblotted with anti-FLAG anti­
body (Section 2.22).
C h a pter  F ive 159
To co-express HEF with HIP in insect cells, we constructed the 
baculovirus vector p F A S T -B A C -D U A L - io h isH E F flag/H IP  as described in Figure 
5.5. Baculoviruses expressing io h isH E F flag/H IP  were then generated (Section 
2.23). Protein complexes were purified from High Five cells infected with 
baculoviruses expressing io h isH E F flag or io h isH E F flag/H IP  by anti-FLAG M2 
and Nickel chromatography (Figure 5.6A). Following visualisation with silver 
staining of the proteins present in the final fractions, we observed the presence 
of a band of approximately 250 kDa in both of the final fractions purified from 
High Five infected with io h is H E F flag or io h isH E F flag/H IP  baculoviruses (lane b 
and c). This band was confirmed to be io h isH E F flag by immunoblotting with 
anti-HEF SWE98 antibody (Figure 5.6B, lanes a and b). Another band of 
approximately 24 kDa was present exclusively in the final fraction purified from 
High Five cells infected with io h isH E F flag/H IP  (Figure 5.6A, compare lanes b 
and c). Immunoblotting with the SWE92 antibody raised against HIP proved that 
the 24 kDa band was HIP (Figure 5.6B, lane b). The remaining bands present in 
the final fractions are probably contaminant proteins (Figure 5.6A, lanes b and 
c). As a result of the purification, we were therefore able to show that HIP forms 
a stable complex with HEF.
In order to define more precisely the interaction between HEF and HIP, we 
analysed in detail the sequences of HEF and HIP. As indicated previously, HIP 
was identified based on its similarity with the C-terminal 300 amino acid region 
of HEF, which contains the ERCC4 nuclease domain. To determine the 
domains present in HIP, a PHYRE search for structures similar to HIP was 
performed. We identified a similarity between HIP and the crystal structure of A. 
pernixXPF (Newman et al., 2005). As observed with ERCC1, EME1, EME2 and 
HEF, HIP appears to have an inactive ERCC4 nuclease domain (Figure 5.1). 
The PHYRE server also predicted the presence of 2 HhH motifs both in HIP and 
in HEF. According to previous reports on P. furiosus Hef (Nishino et al., 2003; 
Nishino et al., 2005a), we expect that the ERCC4 domain and the HhH motifs 
are necessary for the interaction between HEF and HIP.
To test this hypothesis, we constructed a bicistronic bacterial vector to co­
express HIP and a 322 amino acid region of HEF (HEF1727.2048) containing both
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FIGURE 5.5: Construction of the baculovirus vector pFAST-BAC- 
D U A L -io h isH E F fla g /H IP
HIP was cloned into the BarriH I and Not I sites of pFAST-BAC-DUAL fol­
lowed by the insertion of iohisHEFflag into the Nco I and Kpn I sites to 
generate the vector pFAST-BAC-DUAL-iohisHEFflag/HIP (Section 2.6). 
p10 promoter (Pp10), polyhedrin promoter (Pph), Ampicillin resistance 
(Amp), Gentamicin resistance (Gent), 10HIS tag (10HIS), FLAG tag 
(FLAG), HEF and HIP are indicated.
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FIGURE 5 .6 : Purification of io h isH E F flag  and ioh isH E Fflag /H IP  complex 
from insect cells
A. Cell extracts from High Five cells infected with baculoviruses expressing 
io h isH E F flag or io h isH E F flag/H IP  were subjected to anti-FLAG M 2 chroma­
tography followed by Nickel chromatography as described in Sections 2.36 
and 2.37. Final fractions of io h isH E F flag or io h isH E F flag/H IP  were pooled, 
run on a NUPAGE 4-12% Bis-Tris gradient gel and the proteins were 
visualised by silver staining (lanes b and c).
B. Final fractions of io h isH E F flag or iohisH E F flag/H IP  described in (A) were 
immunoblotted with SWE98 and SWE92 antibodies against HEF and HIP, 
respectively (Section 2.22).
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the HhH motifs and the ERCC4 domain (Section 2.6). The bicistronic vector 
pGex-GSTHEF1727_2048/HisHIP was expressed in E. coli BL21-CodonPlus (DE3)- 
RIL as described in Section 2.38. After GST affinity purification and cleavage of 
the GST tag mediated by thrombin, the proteins were further analysed by gel 
filtration (Section 2.38). Following SDS-PAGE and coomassie blue staining of 
the gel filtration fractions, we observed a perfect co-elution of HIP and HEF1727_ 
2048 (Figure 5.7A), as confirmed by western blotting using rabbit polyclonal 
antibodies raised against HEF (SWE98) and HIP (SWE94) (Figure 5.7B). These 
results indicate that the last 322 amino acids of HEF are sufficient to interact 
with HIP. Similar results showed that the last 250 amino acids of XPF form a 
stable complex with ERCC1 (Tsodikov et al., 2005).
Gel filtration has allowed us to determine the molecular weight of the 
HEF1727_2048/HIP complex. The peak of the elution profile of HEF1727.2048/HIP is 
between fractions 28 and 29, which corresponds to an approximate molecular 
weight of 80 kDa. The theoretical molecular weight for HEF1727.2048/HIP, 
assuming that the complex is formed by one monomer of each protein, is 61 
kDa. Instead, the predicted molecular weight of a possible heterotrimeric 
complex formed by one monomer of HEF1727.2048 and two monomers of HIP is 
85 kDa. These data indicate that the HEF1727_2048/HIP complex might be either a 
heterotrimer or a heterodimer with a slightly extended conformation. We favour 
the latter hypothesis, based on the observation that other members of the 
MUS81 family, such as XPF and ERCC1, form a 1:1 heterodimeric complex, as 
determined by gel filtration analysis and crystal log raphic studies (Choi et al., 
2005; Tripsianes et al., 2005).
IV. A c tiv ity  T est  for H ef1727_204</Hip
As previously mentioned, it has been hypothesised that the ERCC4 domain of 
HEF is inactive due to the mutation of the catalytic domain ERKXJD to ERRXaE. 
However, the substitutions of Lysine (K) into Arginine (R) and Aspartate (D) into
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FIGURE 5.7: Gel filtration profile of the HEF1727_2043/HIP complex
A. HEF1727-2048/h ip  complex was purified by gel filtration chromatography 
as described in Section 2.38. Fractions 21 to 34 were run on a NUPAGE 4- 
12% Bis-Tris gradient gel and the proteins were visualised by Coomassie 
blue staining. The positions of the gel filtration markers are indicated in red.
B. Gel filtration fractions of HEF1727_2048/H,P described in (A) were 
immunoblotted with SWE98 and SWE94 antibodies against HEF and HIP, 
respectively (Section 2.22).
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Glutamate (E) could be conservative, because both K and R are positively 
charged amino acids and both D and E are negatively charged. To determined 
whether HEF has nuclease activity, the activity of HEF1727_2048/HIP complex was 
assayed. The activity of the full-length HEF/HIP complex has not yet been 
tested because the large molecular weight of HEF has prevented the 
purification of sufficient amount of full-length HEF/HIP complex from insect cells. 
However, in the case of XPF, it was previously reported that a complex between 
the last 250 amino acids of XPF (XPFA655) and the last 202 amino acids of 
ERCC1 (ERCC1A95) exhibits the same nuclease activity as full length XPF/ 
ERCC1 , although the cleavage efficiency of XPFA655/ERCC1A95 is significantly 
reduced (Tsodikov et al., 2005). In the same study it was noted that a fraction of 
XPFA655/ERCC1A95 complex formed inactive aggregates, such that it was 
necessary to purify the heterodimeric fraction of the XPFA655/ERCC1A95 complex 
(Tsodikov et al., 2005). In order to purify HEF1727_2048/HIP without nuclease 
contaminations, the bicistronic vector pGex-GSTHEF1727_2048/HisHIP was 
expressed in E. coli STL5827 BL21 (DE3)-Exol* Endol' (Section 2.4). HEF1727_ 
2048/h ,p  was ^en  purified by GST affinity chromatography followed by thrombin 
cleavage of the GST tag and gel filtration (Section 2.38). Purified HEF1727_ 
2048/HIP was assayed on 3’-flap substrate but no nuclease activity was detected 
(Figure 5.8, lane b). Similar results were obtained with splayed arm and 
replication fork substrates (data not shown). We think it is unlikely that the 
absence of nuclease activity is due to the use of inappropriate substrates. As 
previously shown, MUS81/EME1 (or EME2) is able to efficiently cleave 3 -flap 
and replication fork substrates (Figure 5.8, lane c; Figure 3.6, lanes j and o; 
Figure 4.5, lanes b and d) and XPF/ERCC1 has been reported to nick splayed 
arm and 3 ’-flap substrates (De Laat et al., 1998a). Based on these 
considerations, we assumed that if HEF has nuclease activity, it should be able 
to process substrates cleaved by the related nucleases MUS81 and XPF. In 
addition to that, we do not think that HEF1727_2048/HIP is inactive because HEF is 
not full-length. As mentioned above, in the case of XPF, the fraction of
3'-flap
—  +  —  H E F 1727.2048 /H ,P
-  -  +  MUS81/hisEME1
a b c
FIGURE 5.8: Activity test for HEF1727_2048/Hlp complex on 3'-flap sub­
strate
Reactions contained 32P-labelled synthetic 3'-flap substrate (approx 3 ng) 
and purified HEF1727_2048/HIP complex (50 nM; lane b) or purified 
MUS81 /hisEM EI (50 nM; lane c). HEF1727.2048/HIP and MUS81/ 
hisEMEI were purified as described in Sections 2.38 and 2.31, respective­
ly. Reactions were incubated at 37°C for 30 min (Section 2.45). DNA prod­
ucts were analysed by neutral PAGE followed by autoradiography. 32P- 
labels are indicated with asterisks.
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XpFA655/ERCC1A95 that forms a heterodimeric complex is active (Tsodikov et 
al., 2005). In our preparation, HEF1727_2048/HIP does not form aggregates and is 
present in what is likely to be a heterodimeric complex (Figure 5.7A). Moreover, 
if we align the sequences of HEF1727_2048 and XPFA655to verify whether potential 
critical residues present in XPFA655 are lacking in HEF1727_2048, it can be noticed 
that HEF1727_2048 contains the entire sequence homologous to XPFA655 with the 
addition of 77 amino acids (Appendix 1, Figure 11). From these observations, 
we can therefore conclude that the ERCC4 nuclease domain of HEF is likely to 
be inactive.
V. H ef/H ip and  Fanconi A nemia
Recent reports identify HEF as a new Fanconi Anemia protein (Meetei et al., 
2005; Mosedale et al., 2005). It has been shown that HEF, both in human and 
chicken cell lines, is part of the FA core complex and is required for FANC-D2 
monoubiquitination. Disruption of HEF  gene in chicken cell lines resulted in 
genomic instability and sensitivity to cross-linking agents (Mosedale et al., 
2005). HEF  has been re-designated FANC-M because it is defective in the FA 
complementation group M (Meetei et al., 2005). In addition, flagFANC-M 
purified from human cells was shown to have translocase but not helicase 
activity, which is mediated by the DEAH helicase domain (Meetei et al., 2005).
The identification of HEF as FANC-M raised the possibility that HIP could 
also be part of the FA pathway. In order to investigate whether HIP could 
interact with HEF/FANC-M and other FA proteins in vivo, antibodies against 
HEF/FANC-M and HIP were raised. Anti-HEF/FANC-M SWE98 and anti-HIP 
SWE94 recognised full-length HEF/FANC-M (approximately 250 kDa; Figure 
5.9A) and HIP (approximately 24 kDa; Figure 5.9B) from HeLa cell extracts, 
respectively.
In collaboration with Weidong Wang (National Institute of Aging/NIH) we 
have shown that HIP interacts with HEF/FANC-M in vivo when 
immunocomplexes from cells stably expressing flagHEF/FANC-M were
191 -
9 7 -
6 4 -
* 9 -  HEF/FANC-M 64 ♦
5 1 -
•
•M* 3 9 -
2 8 -
m § 1 9 -
-  HIP
a HEF/FANC-M a HIP
SWE98 SWE94
FIGURE 5.9: Visualisation of HEF/FANC-M and HIP by western blot­
ting of HeLa extract
A. HeLa extract (Section 2.41) was run on a NUPAGE 4-12% Bis-Tris gra­
dient gel and immunoblotted with the rabbit polyclonal antibody SWE98 
raised against gstHEF1727_2048 (Section 2.22). The predicted molecular 
weight for HEF/FANC-M is 250 kDa.
B.The HeLa extract described in (A) was immunoblotted with rabbit 
polyclonal antibody SWE94 raised against hisHIP (Section 2.22). The pre­
dicted molecular weight for HIP is 24 kDa.
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immunoprecipitated with anti-FLAG antibody (Appendix 2, Figure 1A, lane a). 
Interestingly, HIP did not interact with complexes of flagHEF/FANC-M deleted 
for the C-terminal nuclease domain (Appendix 2, Figure 1A, lane c). This 
observation confirms our in vitro experiments showing that the interaction 
between HEF/FANC-M and HIP is mediated by their C-terminal domains. The 
interaction between HEF/FANC-M and HIP was not disturbed by a K117R 
mutation in the DEAH domain (Appendix 2, Figure 1A, lane b), which has been 
shown to inactivate the translocase activity of HEF/FANC-M (Meetei et al., 
2005). It is not yet known whether the interaction with HIP could be required for 
HEF/FANC-M translocase activity. In this case, the HEF/FANC-M C-terminal 
truncation, which is unable to interact with HIP, would be defective in 
translocation. Experiments in chicken DT40 cells indicate that HEF/FANC-M 
mutants with a C-terminal truncation of the ERCC4 domain are less sensitive to 
cross-linking agents than mutants with a deletion of the N-terminal 725 amino 
acids, which include the DEAH domain and an NLS sequence (Mosedale et al., 
2005). This suggests that the loss of the interaction with HIP might be less 
critical for HEF/FANC-M than the loss of the DEAH domain and the NLS 
sequence.
To test whether HEF/FANC-M and HIP are part of the same complex in 
mammalian cells, HeLa nuclear extracts were fractionated by gel filtration 
chromatography. As shown in Appendix 2, Figure 1B, HEF/FANC-M and HIP 
co-fractionated in a single peak, with an apparent molecular weight of 800 kDa. 
Because the calculated molecular weight of the complex between HEF/FANC-M 
and HIP is approximately 275 kDa, this result suggests that HEF/FANC-M and 
HIP belong to a high molecular weight complex.
To identify the components of the HEF/FANC-M high molecular weight 
complex, the peak gel filtration fractions containing HEF/FANC-M were 
collected and immunoprecipitated with a rabbit polyclonal antibody raised 
against HEF/FANC-M (Meetei et al., 2005). About 10 major polypeptides were 
obtained based on SDS-PAGE followed by Coomassie blue staining (Appendix 
2, Figure 2A, lane b). Mass spectrometric analysis identified the major 
polypeptide with an apparent molecular weight of about 250 kDa as
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HEF/FANCM. Three other major polypeptides between 40-60 kDa were 
similarly identified as FANC-C, FANC-E and FANC-F, all of which are 
components of the FA core complex. Other FA core components, such as 
FANC-A, FANC-G, FANC-B and FANC-L were identified by immunoblotting 
analysis (Appendix 2, Figure 2B, lane a). The fact that HEF/FANCM co- 
immunoprecipitates with multiple components of the core complex is consistent 
with the previous data showing that HEF/FANCM is an integral part of the FA 
core complex (Meetei et al., 2005). It also implies that the other major 
polypeptides isolated could be components of the same complex.
Mass spectrometry also identified the 75 kDa polypeptide as the BLAP75 
protein (Appendix 2, Figure 2A, lane b), which interacts with BLM/TOPOIIIa 
complex (Yin et al., 2005) and stimulates the Holliday junction dissolution 
activity of BLM/TOPOIIIa by recruiting TOPOIIIa to dHJs (Wu et al., 2006). 
BLAP75 has been previously identified in the FA core complex purified by the 
FANCA antibody (Meetei et al., 2003b). We have also detected the presence of 
BLM and TOPOIIIa in the immunoprecipitate by HEF/FANCM antibody (data 
not shown). Thus, the identification of BLAP75 as a HEF/FANCM-associated 
polypeptide provides additional evidence for the association of BLM and FA 
complexes.
In addition to the FA core components and BLAP75, mass spectrometric 
analysis identified the 25 kDa polypeptide as HIP (Appendix 2, Figure 2A, lane 
b). HIP was also detected by immunoblotting of the HEF/FANC-M 
immunocomplex with the anti-HIP SWE94 antibody (Appendix 2, Figure 2B, 
lane a). In order to confirm the possibility that HIP might be part of the FA core 
complex, nuclear extracts were immunoprecipitated with the anti-HIP SWE94 
antibody and immunoblotted for FA core components. As shown in Appendix 2, 
Figure 2B, HIP immunocomplexes contained the FA core complex proteins 
HEF/FANC-M, FANC-A, FANC-B, FANC-G and FANC-L (lane b). Similarly, HIP 
and the FA core components were detected in the FANC-A immunocomplexes 
(Appendix 2, Figure 2B, lane c). Altogether, these results suggest that HIP is a 
novel component of the FA core complex.
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The FA core complex is required for FANC-D2 monoubiquitination after 
treatment with cross-linking agents and for subsequent FANC-D2 localisation to 
foci together with BRCA1, BRCA2/FANC-D1 and RAD51 (Section 1.6). The 
absence of any of the Fanconi core complex proteins results in impaired FANC- 
D2 monoubiquitination. To determine whether depletion of HIP results in 
defective FANC-D2 monoubiquitination after cross-linking agent treatment, 
mammalian cells were transfected with siRNA oligonucleotides against HIP and 
control siRNA (Appendix 2, Figure 3). After treatment with MMC, cells were 
lysed and the protein lysate was immunblotted for HEF/FANC-M, FANC-D2 and 
HIP. Preliminary data indicate that depletion of HIP with both siRNA resulted in 
reduced FANC-D2 monoubiquitination and reduced HEF/FANC-M hyper­
phosphorylation after MMC treatment (Appendix 2, Figure 3, compare lanes d 
and f with b). Because HIP has no recognisable kinase domain, HIP might 
affect HEF/FANC-M hyper-phosphorylation indirectly. HEF/FANC-M hyper­
phosphorylation was shown to be stimulated in response to genotoxic stress, 
such as MMC or HU (Meetei et al., 2005), but the function of this HEF/FANC-M 
modification is still unknown. Future experiments using H lF f' cell lines will be 
necessary to confirm whether HIP is required for FANC-D2 monoubiquitination 
and HEF/FANC-M hyper-phosphorylation.
Among the twelve FA complementation groups so far classified, only the 
FANC-f gene remains to be identified (Section 1.6). To test whether HIP might 
correspond to FANC-I, FANC-I patients were screened for HIP mutations in 
collaboration with Johan De Winter and Hans Joenje (Free University Medical 
Center, Amsterdam). However, no defects in the HIP  gene or in HIP protein 
levels were detected in FANC-I patients (data not shown). In contrast, two 
independent cell lines from FANC-B patients displayed reduced protein levels of 
both HEF/FANC-M and HIP (Appendix 2, Figure 4, compare lanes e, f, g and h 
with a and b). Similarly, reduced levels of FANC-L have been detected in cell 
lines depleted for FANC-B (Meetei et al., 2004). These results indicate that 
FANC-B might be required for the stabilisation of FANC-L (Section 1.6), and it is 
possible that FANC-B could also regulate the stability of HEF/FANC-M and HIP 
proteins. The observation that HIP is unaffected even in the absence of
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HEF/FANC-M (Appendix 2, Figure 4, compare lanes c and d with a and b) 
indicates that the decreased levels of HIP in FANC-B cells might not simply be 
a consequence of HEF/FANC-M destabilisation. Taken together, these data 
provide evidence that HIP is an integral part of the FA core complex.
VI. the  M us81 Fam ily  of Proteins
Based on our database searches, we have identified four novel members of the 
human MUS81 family: EME1, EME2, HEF and HIP (Figure 5.1). We and others 
have previously described four interactions among the members of the MUS81 
family: MUS81/EME1 (Chapter 3), MUS81/EME2 (Chapter 4), XPF/ERCC1 
(Sijbers et al., 1996a) and HEF/HIP (Chapter 5). In order to test whether 
additional interactions are present among the MUS81 family of proteins, 
bicistronic vectors were constructed to co-express twelve combinations of the 
MUS81 family of proteins in E. coli (Figure 5.10 and Section 2.6). Due to the 
difficulty of expressing large proteins such as HEF and XPF in bacteria (250 
kDa and 110 kDa, respectively), C-terminal fragments encoding HEF1727_2048 
and XPFgog.905 were cloned in the expression vector pGex-BICIS-HIS (Section 
2.6). XPF606_905, HEF1727.2048 or MUS81 were expressed as N-terminal GST- 
tagged proteins in combination with EME1, EME2, HIP or ERCC1, all HIS- 
tagged in their N-termini. All proteins expressed equally well, as detected by 
western blotting with antibodies against the GST tag, EME1, EME2, HIP and 
ERCC1 (Figure 5.11 A). Two forms of EME2 were visualised by immunoblotting, 
the lower form probably being a degradation product. Cell-free extracts from E  
coli strains carrying the twelve bicistronic vectors were subjected to GST pull- 
downs with GST-sepharose beads and protein complexes were immunoblotted 
with antibodies against the GST tag, EME1, EME2, HIP and ERCC1 (Figure 
5.11B). As expected, we observed that hisEME2 preferentially interacted with 
gstMUS81 (compare lane j with b and f), hisERCCI with g s tX P F ^ .^  
(compare lane d with h and I) and hisHIP with gstHEF 1 7 2 7 . 2 0 4 8  (compare lane g 
with c and k). Coomassie blue staining of the GST pull-down complexes (Figure
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5.12) confirmed that hisEME2 (approximately 41 kDa) specifically interacted 
with gstMUS81 (approximately 87 kDa; compare lane k with c and g), hisHIP 
(approximately 24 kDa) with gstH EF 1 7 2 7 _2 0 4 8  (approximately 63 kDa; compare 
lane h with d and I) and hisERCCI (predicted 32 kDa, approximately 40 kDa on 
SDS gel) with gstXPF 6 0 6 _9 0 5  (approximately 65 kDa; compare lane e with i and 
m). In contrast, hisEMEI co-precipitated with gstMUS81, as expected, and also 
with gstXPF 5 0 6 - 9 0 5  and gstH E F 1 7 2 7 _2 0 4 8  (Figure 5.11B, lanes a, e and i). As a 
control, we showed that hisEMEI expressed alone was pulled-down specifically 
by Nickel beads and not by GST-sepharose beads (Figure 5.11C). Visualisation 
by Coomassie blue staining confirmed that hisEMEI (predicted 65 kDa, 
approximately 75 kDa on SDS gel) interacted equally well with GSTXPF606.9Q5, 
GSTHEF1727.2048and gstMUS81 (Figure 5.12, lanes b, f and j).
At the present time, it is unknown whether XPF/EME1 or HEF/EME1 
complexes exist in vivo. It is possible that, under physiological conditions, 
ERCC1 and HIP could have higher affinity than EME1 towards XPF and HEF, 
therefore preventing the formation of XPF/EME1 or HEF/EME1 complexes. It 
would then be predicted that, in the absence of either ERCC1 or HIP, EME1 
could bind XPF or HEF. Interestingly, in chicken no ERCC1 and MUS81 genes 
have been reported, although the genome has been fully annotated. However, 
there are genes coding for XPF (NCBI # XP_414734), EME1 (NCBI 
#XP_420107, Appendix 1, Figure 2), EME2 (NCBI # XP_593720, Appendix 1, 
Figure 7), HIP (NCBI # XP_414132, Appendix 1, Figure 10) and HEF (Genscan 
gene prediction chr5_12.11, Appendix 1, Figure 9). Chicken XPF, EME1 and 
EME2 are 76%, 49% and 49% identical to their human orthologues, 
respectively. Due to the absence of both MUS81 and ERCC1, it is likely that 
chicken XPF could form a functional complex either with EME1 or EME2. We 
are currently collaborating with Shunichi Takeda (Kyoto University) to determine 
whether active XPF/EME1 or XPF/EME2 complexes might form in chicken 
DT40 cell lines. It is tempting to speculate, based on our interactions studies, 
that in mammalian cells, under pathological conditions leading to inactivation
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FIGURE 5.12: Visualisation of the complexes of the MUS81 family of 
proteins by Coomassie blue staining
GST pull-down complexes of the various proteins shown above the Figure 
were isolated as described in Section 2.40. The proteins were run on a 10% 
SDS-PAGE gel and visualised by Coomassie blue staining.
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either of MUS81, ERCC1 or HIP, new XPF/EME1 or HEF/EME1 heterodimer 
could form. Whether these complexes might be active is an open question.
CHAPTER SIX
Discussion
In this thesis, we have reported the identification of four novel members of the 
human MUS81 family: EME1, EME2, HEF and HIP (Figure 5.1). Moreover, we 
have defined the interactions among the MUS81 family proteins and have 
characterised three novel complexes: MUS81/EME1, MUS81/EME2 and 
HEF/HIP. The properties of the MUS81/EME1 and MUS81/EME2 complexes 
have been studied in vitro, whereas the function of HEF/HIP has been primarily 
investigated in vivo. The characteristics of each complex will be discussed in 
the next sections.
I. MUS81/EME1 AND MUS81/EME2
Human EME1 and EME2 were identified in a database search using S. pombe 
EME1. The observation that both EME1 and EME2 share sequence homology 
with the C-terminal portion of MUS81 suggests that EME1 and EME2 might 
have evolved from gene duplication of the 3’-region of MUS81, as proposed for 
ERCC1 and X P F (Aravind et al., 1999; Gaillard and Wood, 2001).
MUS81/EME1 and MUS81/EME2 heterodimeric complexes contain a 
single subunit (MUS81) with an active ERCC4 nuclease domain. This 
characteristic is typical of all of the MUS81 family of proteins. As previously 
described, even though archaeal MUS81 family proteins form homodimers with 
two potentially active ERCC4 domains, the homodimeric complex has a single 
active monomer (Figure 1.12) (Newman et al., 2005; Nishino et al., 2005a). In 
eukaryotes, the requirement for a single active nuclease domain in the dimeric 
complex has led to evolutionary-driven divergence of the nuclease domain 
sequence of the inactive subunit. As a consequence, the eukaryotic inactive 
subunit of the heterodimer has acquired other specialised functions. In the case 
of XPF/ERCC1, the inactive ERCC1 subunit is required for DNA-binding,
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which is mediated by the ERCC1 HhH motifs (Figure 1.13B) (Tripsianes et al., 
2005). Similarly, EME1 and EME2 might be involved in targeting MUS81 to 
DNA. The presence of a single HhH motif in EME1 (or EME2), compared to the 
two HhH motifs of ERCC1 (Figure 5.1), could be responsible for the different 
substrate specificities of MUS81/EME1 (or EME2) and XPF/ERCC1 complexes 
(Figure 1.10).
6.1 ACTIVITIES OF MUS81/EME1 AND MUS81/EME2 COMPLEXES
Recombinant human MUS81/EME1 and MUS81/EME2 complexes exhibit 
nuclease activities very similar to recombinant S. pombe Mus81/Eme1 and S. 
cerevisiae Mus81/Mms4 (Doe et al., 2002; Kaliraman et al., 2001; Whitby et al., 
2003). Human MUS81/EME1 and MUS81/EME2 cleave 3’-flap and replication 
fork structures, while exhibiting approximately 75-fold or 12-fold reduced activity 
on HJs, respectively (Figures 3.6, 4.5 and 4.6). Therefore, MUS81/EME1 is 
approximately 6-fold more specific for flaps and fork structures compared to 
MUS81/EME2.
MUS81/EME2 is approximately 10-fold more active than MUS81/EME1, 
when compared on flap/fork substrates (Figure 4.7). The mechanism by which 
these substrates are cleaved by MUS81/EME1 or MUS81/EME2 is similar. 
Indeed, both MUS81/EME1 and MUS81/EME2 exhibit almost identical cleavage 
pattern of 3 ’-flap structures (Figure 4.8), which is consistent with previous 
reports on the activities of archaeal and yeast MUS81 orthologues (Komori et 
al., 2002; Whitby et al., 2003). Therefore, similar to the archaeal MUS81 family 
of proteins (Newman et al., 2005; Nishino et al., 2005a), human MUS81/EME1 
or MUS81/EME2 complex might bridge the duplex arms of the flap/fork structure 
allowing the ERCC4 nuclease domain of MUS81 to bind and cleave near the 
branch point. The incisions are then introduced by human MUS81/EME1 or 
MUS81/EME2 on the duplex region 3 to 6 nucleotides away from the branch 
(Figure 4.8). This is consistent with the observation that S. cerevisiae
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Mus81/Mms4 recognises the 5 ’-end of the DNA strand downstream of the 
branch point of a 3 ’-flap structure and introduces nicks into the duplex region 
between 5 and 6 nucleotides upstream of the branch point (Bastin-Shanower et 
al., 2003). As a consequence, the 3 ’-flap structure is converted by Mus81/Mms4 
into a duplex with a 5 nucleotide gap. It has been shown that Mus81/Mms4 is 
unable to cleave structures with the 5’-end of the downstream DNA strand more 
than 5 nucleotides away from the branch point (Bastin-Shanower et al., 2003). 
Due to the similarity between the cleavage mechanism of yeast and human 
MUS81 complexes, it is likely that similar structures are processed by human 
MUS81/EME1 or MUS81/EME2.
MUS81/EME2 is significantly more efficient than MUS81/EME1 in 
processing HJs (Figure 4.9). Also, MUS81/EME2 has a 2-fold greater 
preference for static HJs, as compared to mobile HJs (Figure 4.6). In contrast, 
MUS81/EME1 exhibits a 6-fold preference for mobile HJs over static HJs 
(Figure 3.8). We have suggested that the ability of MUS81/EME1 to cut mobile 
HJs might be due to the recognition of transient flap structures that are formed 
as the mobile, but not static HJ, undergoes spontaneous thermal denaturation 
(Ciccia et al., 2003). However, this hypothesis does not explain the cleavage of 
static HJs by MUS81/EME2. It is possible that MUS81/EME2 recognises HJs in 
a manner that is different from MUS81/EME1. Interestingly, MUS81/EME2 
exhibits a different pattern of cleavage of static HJs compared to MUS81/EME1 
(Figure 4.9). This could be due to a distinct folding of the HJ induced by 
MUS81/EME2.
Both MUS81/EME1 and MUS81/EME2 cleave HJs with a pattern that is 
quite different from that produced by a HeLa cell fraction containing Resolvase 
A (Figure 4.9). These results are consistent with the observation that MUS81 
and Resolvase A, partially purified from HeLa cells, have distinct activities 
(Constantinou et al., 2002). MUS81 fractions purified from HeLa cells by a
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similar protocol contain primarily the MUS81/EME1 complex, with only traces of 
EME2 (Figure 4.10). In agreement with this, a MUS81 peak fraction has weak 
activity on static HJ, similar to the recombinant MUS81/EME1 complex (Figure 
4.9). HeLa fractions enriched for MUS81/EME2 have not yet been purified. It is 
therefore uncertain whether an activity similar to MUS81/EME2 is present in 
significant amounts in mammalian cells.
Taken together, these results suggest that human MUS81, in complex with 
either EME1 or EME2, is a flap/fork endonuclease. Intact HJs are cleaved by 
MUS81/EME1 or MUS81/EME2 significantly less efficiently than flap/fork 
structures and with a different pattern from a classical RuvC-like HJ resolvase. 
Other flap endonucleases, such as Slx1/Slx4, have been shown to cleave HJs 
by a mechanism distinct from authentic HJ resolvases (Fricke and Brill, 2003). 
The ability of human MUS81/EME1 or MUS81/EME2 to cleave D-loops and 
nicked HJs, as suggested for yeast Mus81/Eme1(Mms4) (Gaillard et al., 2003; 
Osman et al., 2003), has not as yet been tested. However, based on the 
observation that such activities are conserved both in archaeal (Roberts and 
White, 2005) and yeast MUS81 orthologues, it is likely that human 
MUS81/EME1 and MUS81/EME2 complexes will be able to efficiently process 
D-loops and nicked HJs.
6.2 POSSIBLE IN  V IVO  FUNCTIONS OF MUS81, EME1 AND EME2
As previously described in Section 1.10, yeast Mus81 plays a role both during 
mitosis and meiosis, whereas mammalian MUS81 is exclusively involved in 
mitosis. In particular, mammalian MUS81 is required to prevent genomic 
instability during an unperturbed cell cycle (Dendouga et al., 2005; Hiyama et 
al., 2006; McPherson et al., 2004), suggesting that MUS81 is a caretaker gene. 
It is still an object of debate whether MUS81 is a tumour suppressor that can 
predispose to cancer development even when a single copy is mutated 
(Dendouga et al., 2005; McPherson et al., 2004).
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Our biochemical data suggest that the defects seen in mammalian cell 
lines and animals deficient for MUS81 might be due to aberrant processing of 
intermediates arising during the repair of stalled DNA replication forks. Similar 
to its yeast orthologue, mammalian MUS81 could promote the cleavage of 
blocked replication forks (Figure 1.4, step h), D-loop structures (Figure 1.4, step 
f) and 3 ’-flaps after SDSA (Figure 1.3, step j). It is not known whether any of 
these substrates are preferentially processed by mammalian MUS81 in vivo. 
The observation that MUS81'A or EME1'A mammalian cell lines and animals are 
primarily sensitive to DNA cross-linking agents (Abraham et al., 2003; 
Dendouga et al., 2005; Hiyama et al., 2006; McPherson et al., 2004), such as 
MMC, indicates that the substrates cleaved by MUS81/EME1 are intermediates 
generated during ICL repair.
In particular, MUS81/EME1 could cleave replication forks blocked at ICLs 
(Figure 1.8, step 2). However, there is currently no evidence that MUS81/EME1 
generates DSBs at replication forks blocked after MMC treatment. Indeed, the 
formation of DSBs appears to be normal in MUS81'/m cells (Dendouga et al., 
2005), as also observed with ERCC1'A cells (Niedernhofer et al., 2004). The 
possibility that XPF/ERCC1 could have redundant functions with MUS81/EME1 
needs further investigation. Given that chicken cells have XPF, but not MUS81, 
may indicate that XPF could compensate for the absence of MUS81. In an 
alternative to the cleavage of blocked replication fork described above, 
MUS81/EME1 could play a late role in ICL repair and process D-loop structures 
promoted by RAD51 (Figure 1.8, step 11), as suggested by the persistence of 
RAD51 foci in MUS81'/' cells (Dendouga et al., 2005).
The in vivo role of EME2 is still unknown. Whereas EME1 orthologues are 
present among most of eukaryotes species, EME2 is exclusively present in 
vertebrates. Therefore, EME2 might be required for more specialised functions 
than EME1. Sequence analysis of the N-terminal region of most of the EME2 
orthologues has identified the presence of the AP2 clathrin adaptor domain 
(data not shown). This domain plays a central role in linking proteins to clathrin, 
which is responsible for coating vesicles during endocytosis (Owen et al., 2000; 
Pearse et al., 2000). The possible connection between EME2 and clathrin is
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completely unknown. Preliminary in vivo experiments indicate that GFP-EME2 
decorates mammalian cells with a punctated cytoplasmic pattern, which is quite 
different from the nuclear and nucleolar localisation of both GFP-MUS81 and 
GFP-EME1 (data not shown). Moreover, GFP-EME2 appears to localise to the 
actin-myosin ring that separates the two daughter cells during cytokinesis (data 
not shown). It has not yet been determined whether these observations are real 
or are artefacts due to protein over-expression. However, in the case of MUS81, 
the cellular localisation is similar between native (Gao et al., 2003) and GFP- 
tagged protein. To date, EME2-GFP cell lines have not been treated with any 
DNA damaging agents to determine whether EME2-GFP might re-localise into 
the nucleus together with MUS81 upon damage induction. Moreover, in vivo 
interaction studies between MUS81 and EME2 have yet to be performed.
One possibility is that EME2 might have both MUS81-dependent and 
independent functions. The observation that the EME2_testis splice variant 
contains the N-terminal region with the AP2 clathrin adaptor domain but not the 
C-terminal ERCC4 domain and the HhH motif (Appendix 1, Figure 5) suggests 
that the two domains might be functionally separate and that EME2_testis might 
have exclusively a MUS81-independent role. Future genetic experiments are 
required to test the epistatic relationship between EME2 and MUS81.
Taken together, our observations indicate that mammalian MUS81 
appears to interact primarily with EME1. Indeed, both proteins form a stable 
complex after several purification steps from HeLa cells (Figure 4.10), have 
similar cellular localisation and give rise to similar phenotypes when mutated. 
In contrast, EME2 might interact with MUS81 only under specific (and still 
undetermined) conditions.
II. H ef/H ip
Human HEF has been identified in a database search for human proteins 
containing the ERCC4 nuclease domain. The subsequent search for proteins 
homologous to the C-terminal domain of HEF has led to the identification of 
HIP. We have shown that HIP interacts with the C-terminal region of HEF, both
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in vitro (Figure 5.7) and in vivo (Appendix 2, Figure 1A), and that the HEF/HIP 
complex is likely to be a heterodimer (Figure 5.7). Moreover, the regions 
promoting the interaction between HEF and HIP contain the ERCC4 domain 
and two HhH motifs. Altogether, these observations indicate that HEF and HIP 
interact by a mechanism similar to other MUS81 family proteins and therefore 
HEF/HIP represent a novel heterodimeric complex of the MUS81 family.
In vitro interaction experiments among all of the MUS81 family proteins 
have shown that HIP interacts with HEF, but not with XPF or MUS81 (Figure 
5.11). The specificity of the interaction between HEF and HIP might be 
guaranteed by the homology of their C-terminal regions, as observed also in the 
case of MUS81/EME2 and XPF/ERCC1 complexes (Figure 5.11).
6.3 POSSIBLE BIOCHEMICAL FUNCTIONS OF HEF/HIP COMPLEX
Previous studies have shown that human HEF complexes purified from 
mammalian cells have a translocase, but not a helicase activity, which is 
dependent on the N-terminal DEAH helicase domain (Meetei et al., 2005). In 
contrast, the homologous DEAH helicase domains of both P. furiosus Hef and 
S. cerevisiae Mph1 have functional helicase activities (Komori et al., 2004; 
Prakash et al., 2005). The lack of helicase activity in human HEF might be due 
to amino acid changes that impair the helicase activity without interfering with 
the translocase activity. In support of this hypothesis, it has previously been 
shown for the bacterial PcrA protein that mutations that affect dsDNA binding 
can inhibit the helicase activity, leaving the translocase activity intact (Soultanas 
et al., 2000).
The presence of the ERCC4 domain suggests that human HEF might 
have nuclease activity in complex with HIP. However, based on sequence 
analysis, the human HEF nuclease domain has been proposed to be non­
functional (Meetei et al., 2005). In agreement with this hypothesis, we have not 
been able to detect any nuclease activity for a C-terminally truncated human 
HEF in complex with HIP (Figure 5.8). Given that a similarly truncated XPF was 
previously shown to retain nuclease activity in complex with ERCC1 (Tsodikov 
et al., 2005), we suggest that the lack of nuclease activity seen for the truncated
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HEF/HIP complex might also be a characteristic of the full-length HEF/HIP. 
However, future experiments are necessary to confirm this hypothesis.
Alternatively, the interaction between HEF and HIP might be important for 
DNA binding. In particular, HIP could be required to target HEF to branched 
DNA structures, similar to the recent model proposed for ERCC1 and XPF 
(Tripsianes et al., 2005). The important residues for XPF/ERCC1 binding to 
branched DNA structures have been identified in the HhH motifs of ERCC1. In 
particular, the second HhH motif contains a classical Glycine-Hydrophobic 
residue-Glycine (GhG) hairpin, which is important for interacting with DNA 
(Figures 1.13A and 6.1). No DNA contacts have been detected for XPF, 
probably because XPF does not contain classical GhG hairpins in either of the 
two HhH motifs (Figures 1.13A and 6.1). In the case of HIP, the first HhH motif 
has a GhG hairpin (sequence GVG at amino acids 168-170, Figure 6.1), 
whereas a hairpin with a Valine to Glycine substitution is present in the second 
HhH motif (VVG sequence at amino acids 198-200, Figure 6.1). These regions 
have been maintained almost perfectly identical across many species 
throughout evolution (Appendix 1, Figure 10). In contrast, none of the two 
hairpins of human HEF has a GhG motif (Figure 6.1). Moreover, the two 
hairpins of human HEF have remained less conserved during evolution. In fact, 
comparing amino acids 2013-2015 of human HEF with the respective 
sequences of HEF from other species, it is apparent that QVT is changed to 
RVS in G. gallus, CMS in T. negroviridis or KHR in X. laevis (Appendix 1, Figure 
9). Taken together, these observations indicate that HIP is the only subunit of 
the HEF/HIP complex that contains the critical residues for DNA binding to 
branched DNA structures.
The HEF/HIP complex may also interact with DNA through the DEAH 
helicase domain of HEF. The crystal structure of the N-terminal DEAH domain 
of P. furiosus Hef has identified a novel DNA binding domain, which is inserted 
in between two domains containing the seven helicase motifs of SF2 helicases 
(Nishino et al., 2005b). This DNA binding domain plays a critical role for the 
recognition of branched DNA structures, such as replication fork substrates. 
Indeed, the DEAH helicase domain of P. furiosus Hef can bind and unwind
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FIGURE 6.1: Sequence alignment between the C-termini of H. sa p iens  
XPF (amino acids 832-886), H. sa p ie n s  ERCC1 (amino acids 230-285), 
H. s a p ie n s  HIP (amino acids 153-207) and H. s a p ie n s  HEF (amino 
acids 1966-2022)
The two hairpin sequences (hi and h2) of the HhH motifs are indicated in 
blue boxes. Conserved hydrophobic residues are in red and Glycine resi­
dues of the hairpins are highlighted by red filled boxes. Sequence align­
ments were carried out using ClustalW.
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replication fork structures (Komori et al., 2004). In contrast, although the DEAH 
domain of human HEF possesses a DNA binding domain similar to P. furiosus 
Hef, it binds replication fork structures very weakly (Mosedale et al., 2005). It 
may be that amino acid changes in the DEAH DNA binding domain of human 
HEF, compared to the same domain of P. furiosus Hef, have decreased the 
interaction with branched DNA substrates. The ability of human HEF to bind 
these structures could therefore depend primarily on HIP.
Despite binding fork structures poorly, the DEAH domain of human HEF 
interacts strongly with ssDNA (Mosedale et al., 2005). This interaction might be 
relevant for the translocase activity of HEF. In one possible model (Figure 
6.2B), HEF/HIP could bind and translocate along the DNA through the DEAH 
domain of HEF. A similar mechanism has been proposed for the translocation 
of A. pernix XPF on DNA mediated by the interaction with PCNA (Figure 6.2A) 
(Newman et al., 2005). Once HEF/HIP encounters branched DNA structures, 
which could arise from replication fork blockage, the complex could recognise 
them by the HIP HhH motifs (Figure 6.2B) and then promote the repair of 
blocked replication forks, as described in the next section.
6.4 ROLE OF HEF/HIP IN FANCONI ANEMIA
HEF has been previously shown to correspond to FANC-M and to be part of the 
FA core complex (Meetei et al., 2005). We have reported that HIP is a novel 
component of the FA core complex, since it can be identified in HEF/FANC-M or 
FANC-A immunocomplexes (Appendix 2, Figure 2). Moreover, preliminary data 
indicate that depletion of HIP might affect the levels of FANC-D2 
monoubiquitination after MMC treatment (Appendix 2, Figure 3). The absence of 
HIP could result in defective recognition of blocked replication fork structures by 
the FA core complex. This could possibly decrease the efficiency by which 
FANC-D2 might be monoubiquitinated by FANC-L. In agreement with this 
hypothesis, HEF depletion in chicken cells reduces the ability of the FA core 
complex to bind to chromatin after MMC treatment (Mosedale et al., 2005). 
Future experiments are required to test whether the FA core complex can 
localise to chromatin without HIP.
as describe
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It is not known whether the FA core complex is preformed throughout the 
cell cycle or it assembles exclusively when the FA pathway is activated. 
According to the former hypothesis, HEF/FANC-M could bind to DNA in 
complex with all of the FA core components (Figure 6.3). As mentioned above, 
HEF could then promote DNA translocation of the FA core complex until a 
blocked replication fork is recognised by HIP (Figure 6.3, step a). This could 
induce FANC-D2 monoubiquitination promoted by FANC-L (Figure 6.3, step b). 
Alternatively, HEF/FANC-M could translocate along DNA only in complex with 
HIP. Following the recognition of the blocked replication fork by HIP (Figure 6.3, 
step d), the rest of the FA core complex could bind to HEF/FANC-M and HIP 
(Figure 6.3, step e). This step might be regulated by post-translational 
modifications of HEF/FANC-M. Previous experiments have shown that 
HEF/FANC-M is hyper-phosphorylated in response to DNA damage (Meetei et 
al., 2005). Interestingly, HEF/FANC-M hyper-phosphorylation is dependent on 
the presence of HIP (Appendix 2, Figure 3). This observation reinforces the 
hypothesis that the recognition of blocked forks by HIP might induce 
HEF/FANC-M hyper-phosphorylation (Figure 6.3, step d). It has been proposed 
that ATR could be responsible for HEF/FANC-M hyper-phosphorylation, since 
several ATR phopshorylation sites have been predicted from the HEF/FANC-M 
sequence (Meetei et al., 2005). This could represent a mechanism by which 
ATR regulates FANC-D2 monoubiquitination (Andreassen et al., 2004; Meetei 
et al., 2005). Once the FA core complex is assembled and FANC-D2 is 
monoubiquitinated (Figure 6.3, step f), the repair of the blocked fork could start.
The initial step of the repair process consists of the cleavage of the 
blocked fork (Figure 6.3, steps c and g). As described in Sections 1.6 and 1.10, 
it is not clear how DSBs are formed after replication fork blockage at ICLs. DSB 
formation is not dependent on MUS81 (Dendouga et al., 2005) or XPF/ERCC1 
(Niedernhofer et al., 2004). Our biochemical data on HEF/FANC-M do not 
support the hypothesis that HEF/FANC-M in complex with HIP might cleave 
blocked replication forks. However, it would be interesting to test whether 
FANC-M  deficient cell lines are proficient in DSB formation after MMC
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treatment. Following replication fork cleavage, DSB repair could then require 
ICL unhooking, TLS and HRR (Figure 6.3, step h), as described in Section 1.6.
III. The Mus8i Fam ily and In te rs tra n d  C ro ss ­
lin k  Repair: F u tu re  Perspectives
All of the human MUS81 family proteins, apart from EME2, appear to be 
involved in ICL repair. However, the in vivo function of most of them is still 
unknown, because of the extreme complexity of ICL repair. We predict that 
understanding the role of the members of this family will shed some light on the 
still obscure mechanisms by which ICLs are repaired.
The characterisation of HEF/FANC-M and HIP might provide some critical 
information on the nature of the lesion that is sensed during ICL repair. The 
DNA binding activity of HIP should provide important insights into this process. 
Moreover, future studies of HEF/FANC-M and HIP could help us to understand 
how ICL repair is coordinated. Indeed, by targeting the FA core complex into 
DNA, HEF/FANC-M and HIP could promote the interaction of TLS and HRR 
factors with the FA core complex. In particular, the interaction of BLM, TOPOII la 
and BLAP75 with the FA core complex might be mediated by HEF/FANC-M and 
HIP.
Several steps of ICL repair involve DNA cleavage. MUS81/EME1 and 
XPF/ERCC1 might represent the main endonucleases in the repair of ICLs. 
Understanding the exact function of MUS81/EME1 and XPF/ERCC1 could also 
have clinical applications. Some of the most potent chemotherapeutic drugs 
currently used are cross-linking agents, such as c/s-platin, MMC and nitrogen 
mustards. Specific inhibition of ICL repair in tumours treated with cross-linking 
agents might increase the efficiency of cancer therapy (McHugh et al., 2001). In 
particular, endonucleases such as MUS81/EME1 and XPF/ERCC1 could be 
potential therapeutic targets to decrease the efficiency of ICL repair. Indeed, 
MUS81 and XPF have well defined nuclease domains, which could be suitable 
targets for developing specific inhibitors.
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The study of MUS81 family proteins could also prove to be important for 
understanding the etiology of cancer. It is possible that heterozygous mutations 
in HEF/FANC-M  or HIP  might increase the risk of the development of some type 
of cancers, such as acute myeloid leukaemia, pancreatic cancer, breast and 
ovarian cancer, as previously reported for other FA genes (Kennedy and 
D1 Andrea, 2005). Moreover, should the cancer-prone phenotype of MUS81'A 
mice (McPherson et al., 2004) be confirmed, it would be important to test 
whether MUS81 mutations could predispose to cancer development in humans. 
Therefore it is possible that MUS81 family proteins might have caretaker 
functions that protect against cancer formation.
Recently, it has been suggested that tumours could arise from stem cells 
that accumulate mutations and become cancerous (Reya et al., 2001). It is 
known that mammalian cells deficient for FA genes, ERCC1 and MUS81 have 
defects in the proliferation of stem cells (Agoulnik et al., 2002; Dendouga et al., 
2005; Park and Gerson, 2005; Prasher et al., 2005), which might derive from 
spontaneous genomic instability. Under these conditions, genomic instability 
could select for cells that have a growth advantage, which could potentially 
become cancer stem cells. It would therefore be interesting to investigate in 
detail the role of MUS81 family proteins during the proliferation of stem cell 
progenitors. We hope that further understanding of the basic mechanism by 
which MUS81 family proteins operate might one day contribute to ameliorate 
human health.
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Identical and similar residues are indicated in filled and unfilled red boxes, 
respectively. Sequence alignments were carried out using ClustalW.
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APPENDIX 1, FIGURE 3: Sequence alignment between H. sapiens 
EME2_predicted and H. sapiens EME2_HeLa
H. sapiens EME2_predicted (NCBI # XM_113869) was identified based to 
its s im ila rity  to EM E1. Sequence alignments were carried out using 
ClustalW as described in Figure 3.1.
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APPENDIX 1, FIGURE 4: Sequence alignment between H. sapiens 
EME2_genscan and H. sapiens EME2_HeLa
H. sapiens  EM E2 genescan prediction N T_037887.92 (NCBI # 
NP_001010865) is indicated as EME2_genscan. Sequence alignments 
were carried out using ClustalW as described in Figure 3.1.
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APPENDIX 1, FIGURE 5: Sequence alignment between H. sapiens 
EME2_HeLa and H. sapiens EME2_testis
Sequence alignments were carried out using ClustalW.
H. sapiens EME1 i h a l k k s s p s l d s g d s d s e e l p t f a f l k i c e p s s t k r r q p e r e b k i v v v d i s d c b a s c p p a p e l f s p p v p d i
H. sapiens E M E 2_testis  .......................................................................................................................................................................................................................
H. sapiens EM E1 71 aetvtqtqpvrllssesedeeefiplaqrltckflthkqlspedssspvksvldhqnnegascdwkkpfp
H. sapiens E M E 2_testis  .......................................................................................................................................................................................................................
H. sapiens EME1  
H. sapiens EM E2_testis
141 KI PEV PLHDT P ERSAADNKDLILDPCCQLPAYI
H. sapiens EME1  
H. sapiens EM E2_testis
H. sapiens EME1  
H sapiens E M E 2  testis
H. sapiens EME1  
H. sapiens EM E2_testis
H. sapiens EME1 421 AEEALVDLQL.HTEAQAQIVQSWKELADFTCAFff'KA|vA{i;QraFKKLraDETTFSFCig2gDWA^Vl<
H. sapiens EM E 2_testis  232........................................................................................................LAR |A G tS3w G A G Q N G . h l c s g H £ ; S t f p ® h s
H. sapiensEM E1 491 lHlvHrIrqiL . lnQvslemasavvnayps pqllvqayqoHfSd kerqnlladiqvrrHeIg vGstsrf
H. sapiens EM E 2_testis  269 pM p rH pIs a g |r r|wkH p ................................................................wy B s 0 ............................................. B d rn H c Y w w i
H. sapiens EM E1 56i Ie l s r r i  y l q m t t l q p h l s l d s a d
H. sapiens EM E 2_testis  303 g T ................................................................
APPENDIX 1, FIGURE 6: Sequence alignment between H. sapiens 
EME1 and H. sapiens EME2_testis
Sequence alignments were carried out using ClustalW.
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APPENDIX 1, FIGURE 7: Sequence alignment of vertebrate EME2 
orthologues
Homo sapiens EME2 corresponds to Homo sapiens EME2_HeLa (Figure 
7.3). Rattus norvegicus EME2 (NCBI # XP_220231), Pan troglodytes 
EME2 (NCBI # XP_523262), Bos taurus EME2 (NCBI # XP_593720) Mus 
musculus EME2 (NCBI # AAH92228) and Gallus gallus EME2 (NCBI # 
XP 414715) were identified by BLAST search for orthologues of H. sapi­
ens EME2. Sequence alignments were carried using ClustalW.
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APPENDIX 1, FIGURE 10: Sequence alignment of vertebrate HIP 
orthologues
Bos taurus HIP (NCBI # XP_587996), Mus musculus HIP (NCBI # 
AAH96687), Danio rerio HIP (NCBI # XP_687903), Gallus gallus HIP 
(NCBI # XP_414132) and Xenopus laevis HIP (NCBI # AAH87430) were 
identified by BLAST search for orthologues of Homo sapiens HIP.
Sequence alignments were carried out using ClustalW.
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APPENDIX 1, FIGURE 11: Sequence alignment between H. sapiens 
HEF1727-2048 and H■ sapiens XPFA655
Sequence alignments were carried out using ClustalW.
appendix two
HIP and Fanconi Anemia 
Core Complex*
The experiments described in the figures of this appendix have been 
performed in Weidong Wang’s lab (National Institute of Aging/NIH)
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APPENDIX 2, FIGURE 1: Interaction of HEF/FANC-M and HIP in mamma­
lian cells
A. Extracts from HeLa cells expressing either flagHEF/FANC-M or K117R 
mutant flagHEF/FANC-M or C-terminal deleted flagHEF/FANC-M (lanes a, 
b, and c respectively) were immunoprecipitated using anti-FLAG antibody 
and immunoblotted using rabbit polyclonal antibodies raised against 
HEF/FANC-M (Meetei et al., 2005) and HIP (SWE94). Nuclear extract (NE) 
was used as a control (lane d).
B. The final fractions of HeLa nuclear extracts subjected to Superose 6 gel 
filtration chromatography were immunoblotted against HEF/FANC-M and 
HIP, as described in (A). The fraction number and the position of the 670 
kDa gel filtration marker is indicated.
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APPENDIX 2, FIGURE 2: HEF/FANC-M and HIP immunocomplexes in 
mammalian cells
A. Complexes immunoprecipitated from HeLa nuclear extract with a rabbit 
polyclonal anti-HEF/FANC-M antibody (Meetei et al., 2005) were run on 
SDS-PAGE and visualised with Coomassie blue staining (lane b). The identi­
ties of the polypeptides in the HEF/FANC-M immunocomplex, as detected by 
mass-spectrometric analysis, are indicated on the right side of the gel.
B. Extracts from mammalian cells were immunoprecipitated with rabbit 
polyclonal antibodies against HEF/FANC-M (Meetei et al., 2005), FANC-A 
(Waisfisz et al., 1999) and HIP (SWE94). Supernatant and immunopre­
cipitated fractions (lanes e-g and a-c, respectively) were immunoblotted with 
antibodies against HEF/FANC-M (Meetei et al., 2005), FANC-A (Waisfisz et 
al., 1999), FANC-B (Meetei et al., 2004), FANC-G (Waisfisz et al., 1999), 
FANC-L (Meetei et al., 2003a) and HIP (SWE94). Input fraction was used as 
a control (lane d). The asterisk indicates a non-specific band recognised by 
the FANC-B antibody.
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APPENDIX 2, FIGURE 3: Depletion of HIP by siRNA in mammalian cells
Mammalian cells were transfected with siRNA 1 or 2 against HIP or with con­
trol siRNA. Extracts from siRNA transfected cells, with or without mitomycin 
C (MMC) treatment (lanes b, d and f or a, c and e, respectively), were 
immunoblotted with antibodies against HEF/FANC-M (Meetei et al., 2005), 
FANC-D2 (Meetei et al., 2003a) and HIP (SWE94). The phosphorylated form 
of HEF/FANC-M (H E F /F A N C -M -® ) and the monoubiquitinated form of 
FANC-D2 (FANC-D2- ^b ])  are indicated.
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APPENDIX 2, FIGURE 4: Protein levels of HEF/FANC-M and HIP in 
Fanconi Anemia cell lines
Cytoplasmic (C) and nuclear extracts (NE) from WT (lanes a and b), 
FANC-M (lanes c and d) and two FANC-B cell lines (FANC-B-2, lanes e 
and f; FANC-B-1, lanes g and h) were run on SDS-PAGE and immuno- 
blotted with rabbit polyclonal antibodies against HEF/FANC-M (Meetei et 
al., 2005) and HIP (SWE94). A control for equal loading of cytoplasmic or 
nuclear extracts is shown.
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